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The ability of motor cortex to plan, execute, and refine different movements 
depends on the coordinated activity of many neurons found across its laminar structure. 
Layer 5b (L5b), a deep cortical layer that drives output signals from the cortex, contains 
excitatory pyramidal neurons that innervate many subcortical areas of the brain. In the 
motor cortex, L5b is thicker and contains more pyramidal neurons than L5b of other 
cortical areas. Electrophysiological, anatomical, and RNA-Seq profiling of neurons in the 
motor cortex suggests there are diverse pyramidal neuron types within L5b. However, the 
precise identities of these distinct populations and their defining traits have been difficult 
to assess. Determining the cell type-specific properties of distinct L5b pyramidal neurons 
will not only help in understanding how the motor cortex is able to execute its varied 
functions, but may also reveal how selective vulnerability is established in 
neurodegenerative diseases that affect the motor cortex, such as Amyotrophic Lateral 
Sclerosis (ALS). Despite being expressed in all cells of the body, mutations associated 
with ALS lead to specific loss of LMNs in the brainstem and the ventral horn of the spinal 
cord, and UMNs in L5b of the motor cortex. For this reason, it is important to characterize 
the unique molecular profiles that may underlie an increased vulnerability of these cell 
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types to the ubiquitously expressed mutations. In the motor cortex, this requires us to 
determine the characteristics that differentiate vulnerable L5b cells from other resistant 
cell types in the same area, and understand how these features may contribute to their 
death in ALS. This study aims to understand how anatomical traits and molecular 
properties, defined at the level of gene expression, vary across subpopulations of L5b 
pyramidal neurons in the motor cortex. We show that there are two distinct, but closely 
related, pyramidal neuron subtypes in mouse primary motor cortex which occupy discrete 
sublayers of L5b. In the SOD1-G93A mouse model of ALS, we observe loss of only one 
of these cell types, establishing the other as an analogous resistant L5b population. Using 
TRAP (Translating Ribosome Affinity Purification) with RNA-Seq, we show that these 
cells have important baseline differences in gene expression in healthy tissues, and that 
they display differential molecular responses to SOD1-G93A expression. Together, these 
findings reveal that the gene expression differences between the distinct L5b populations 
not only reflect their diverse cortical and subcortical anatomy, but may also establish 
selective vulnerability in ALS.
 iii 
 “ Be sure your self and your own Reach to know, 
How far your Genius, Taste, and Learning go; 
Launch not beyond your Depth, but be discreet, 
And mark the Point where Sense and Dulness meet; 
Nature to all things fix’d the Limits fit, 
And wisely curb’d proud Man’s pretending wit. ” 
- Alexander Pope 
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I couldn’t have done this without you. 
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CHAPTER 1: 
Study Introduction and Objectives 
The function of the central nervous system (CNS) fundamentally relies on 
communication between many unique cell types. The myriad functions that are carried 
out by the brain via these connections reflect the diverse anatomy, morphology, and 
physiology of these CNS populations. Underlying this diversity are unique patterns of 
gene expression that provide the necessary elements for constructing each distinct cell 
type, both during development and in adulthood. For the mammalian neocortex, a hub 
for cognition and integrative processing in the brain, this means defining the laminar 
distribution of neuron populations that makes up its cytoarchitecture. The adult cortex is 
classically organized into 6 anatomically and functionally distinctive layers that each 
contain different subtypes of excitatory and inhibitory neurons (Brody, 1955; Jones and 
Wise, 1977; Krieg, 1946; Lorente de No, 1938; Wise and Jones, 1977a). The excitatory 
cortical populations are often referred to as pyramidal neurons because of the pyramid 
shape of their cell bodies (see O'Leary, 1941; Ramón y Cajal, 1911). Each layer of the 
cortex contains pyramidal neurons that differ in morphology, size and connectivity 
(Figure 1.1). The most superficial layer, Layer 1 (L1), houses the distal dendritic 
processes, or “apical tufts”, of deeper layer pyramidal neurons, which receive input from 
various modulatory subcortical areas (Lorente de No, 1938; Vaughan and Peters, 
1973). Layers 2 and 3, in rodents often combined as a single Layer 2/3 (L2/3), contain 























Figure 1.1: Pyramidal neuron distribution across the layers of the mammalian 
cortex. Model of cortical laminar cell types. L2/3 contains small neurons (pink) that 
project to deep layer neurons within the cortical column, and in other areas of cortex. L4 
receives inputs from sensory regions of the brain. L5a cells (blue) are slightly larger, and 
send projections to the striatum and across other regions of cortex, include contralateral 
cortex. L5b is a thick layer that contains some of the largest pyramidal neurons in the 
cortex (green) that send projections to many different subcortical nuclei, the brainstem, 
and the spinal cord. L6a contains small neurons (yellow) that project to the thalamus.
2
3 
column, as well as across other cortical regions (Gilbert and Kelly, 1975; Vogt and 
Pandya, 1978). Layer 4 (L4), where present, is an important input layer of the cortex, 
receiving the axon terminals of many sensory input neurons from other regions of the 
brain (Shatz and Stryker, 1978; Woolsey and Van der Loos, 1970). Layer 5 (L5), is 
composed of two major subdivisions. Layer 5a (L5a) contains large pyramidal cells that 
innervate neurons in the striatum and other regions of the cortex, including the opposite 
hemisphere, or “contralateral” cortex (Jones et al., 1975; 1977). Layer 5b (L5b) is an 
important effector output layer of the cortex, containing the largest pyramidal neurons 
that send their long-range axons to distal targets throughout the subcortical regions of 
the brain (Domesick, 1969; Wise and Jones, 1977b; 1977a; Wise et al., 1979). Layer 6 
(L6) is primarily represented by layer 6a (L6a), which includes pyramidal neurons that 
are important in feedback signaling with the thalamus (Wise and Jones, 1977b). 
This laminar architecture is highly conserved across different functional areas of 
the cortex, such as visual and auditory regions (Krieg, 1946). However, in the primary 
motor cortex (M1) and accessory motor regions such as anterolateral motor cortex 
(ALM), there are two notable differences. (1) These areas do not contain a prominent 
L4, and (2) they show a broader L5b thickness (Jones and Wise, 1977). Because L5b of 
the cortex is a key computational output layer, the greater number of pyramidal neurons 
that are accommodated by this widening reflect the importance of motor cortex output 
for signaling in motor function. The proper execution of movement requires many stages 
of preparatory and executive computation, and the pre-motor and motor cortices of 
diverse species are indispensible in this multifaceted processing. These areas help to 
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prepare and initiate voluntary movement (Chen et al., 2017; Churchland and Shenoy, 
2007; Day et al., 1989; Economo et al., 2018; Evarts, 1968; Inagaki et al., 2018; 
Penfield, 1954; Roland et al., 1980; Thach, 1978), participate in the initiation and 
execution of dexterous movements (Evarts, 1966; Graziano et al., 2002; Gu et al., 
2017a; Guo et al., 2015; Shibasaki et al., 1993), and are important in the coordination 
and refinement of gross movements that takes place during motor learning (Fischer, 
1967; Kawai et al., 2015; Lashley, 1942). Accomplishing these varied forms of 
processing requires signaling to many areas of the CNS, and therefore many axonal 
outputs from these motor areas. And to carry these efferent messages, L5b in these 
regions may contain diverse populations of subcortical projection neurons, also known 
as corticofugal neurons, that contribute to different aspects of functional output from the 
motor cortex (Figure 1.2, see Yu et al., 2008). 
Evidence of the heterogeneity of motor cortical neuron populations has been found 
in rodents, where different approaches have been employed to determine the neuronal 
cell type composition of the different layers. For instance, using electrophysiology, it has 
been revealed that in motor areas, the activity of different cells during distinct temporal 
and spatial phases of movement is key to the preparation and execution of the 
movement (Chen et al., 2017; Economo et al., 2018; Guo et al., 2015; 2014; Harrison et 
al., 2012). Importantly, these cells receive electrophysiological input from different 
sources depending on their depth in the cortex (Hooks et al., 2013; Mao et al., 2011; 
Petreanu et al., 2009; Ueta et al., 2014; Yu et al., 2008). Additionally, their 


























Figure 1.2: Cell types of the primary motor cortex layers may be more diverse than 
originally thought. The current thinking of motor cortical cytoarchitecture given 
published findings and the findings of this study. M1 is agranular and contains no L4. L5b 
is thicker in these areas and may contain distinct populations projection neurons. These 
cells may send projections to distinct subcortical areas throughout the brain.
5
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the spike-frequency adaptation necessary for maintaining persistent activity (Hattox and 
Nelson, 2007; Oswald et al., 2013; Sheets et al., 2011; Suter et al., 2013; Tantirigama 
et al., 2016; 2014). Another approach used to address the heterogeneity of pyramidal 
neurons in the motor areas is anatomical tracing, whereby one can label neurons that 
project to different areas of the brain by injecting retrograde dyes and reporter-
expressing viruses into these target regions. Using these labeling methods, the 
projections from L5b of the motor cortex haven been shown to target several different 
regions of the subcortex, including the thalamus, the superior colliculus, the pons, the 
brainstem, and the spinal cord (Figure 1.3; Arlotta et al., 2005; Economo et al., 2018; 
Feng et al., 2000; Gerfen et al., 2016; Oswald et al., 2013) Distinct subpopulations of 
L5b neurons appear to have specific combinations of collateral projections rather than 
each innervating all of these regions (see Economo et al., 2018). Finally, using high-
throughput sequencing methods that assay whole cortical areas, it has been shown that 
even within individual sublayers, there may be distinct populations of cells that are 
differentiated by their gene expression patterns (Fame et al., 2017; Sugino et al., 2006; 
Tasic et al., 2016; 2018). Together these findings have all suggested that the cell type-
composition of the distinct layers of motor cortical areas may be more heterogeneous 
than originally suspected. However, it has been difficult to consolidate the findings of 
these diverse studies into a comprehensive atlas of L5b cell types and their respective 
features. This is due to the fact that, within the same animal, it is challenging to carry 
out all of the various physiological, anatomical, and molecular assays used to describe 









Figure 1.3: The long-range projections of L5b cells of M1. Sagittal illustration of 
projection patterns for the distinct L5b subpopulations of L5b cells, from recent published 
studies as well as findings from this study. Together, these populations send long-range 
projections to more proximal and distal regions of the subcortex, including the ventral 




a specific cell in the tissue. Without reproducible anatomical and molecular access to 
the individual distinct cell types of L5b, we will not be able to define the unique features 
of these neurons across the varied experimental paradigms used to define neuronal 
subpopulations. 
The ability to visualize specific neuronal populations and profile their specific 
patterns of gene expression across experimental assays is the cornerstone of the 
Translating Ribosome Affinity Purification (TRAP) technique (Doyle et al., 2008; Heiman 
et al., 2008). The ability to introduce transgenes into the mouse genome by using 
Bacterial Artificial Chromosomes (BACs) was key to the development of the technique 
(Gong et al., 2010; 2003; Shizuya et al., 1992). TRAP relies on the expression of a 
subunit of the large ribosomal complex (L10a) fused to a green fluorescent protein 
(EGFP; EGFP-L10a). In order to express EGFP-L10a in specific cellular population of 
interest, a region of the genome that contains a gene selectively expressed in these 
cells is converted into a BAC, where EGFP-L10a is inserted by homologous 
recombination downstream of the promoter of the cell type-specific gene. The modified 
BAC is then introduced by microinjection into a fertilized mouse zygote, where it 
incorporates into the genome by recombination. The cell type-specific gene promoter 
then drives transcription of EGFP-L10a in any cells that express that gene. The 
fluorescent EGFP allows for the anatomical visualization of this cell type in tissue, and 
when isolated by immunoprecipitation (IP), also provides access to the mRNA 
molecules that are bound to the ribosomal complex during translation. This technique 
has been broadly applied in the study of the molecular underpinnings of cell type-
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specific features across the CNS in both healthy and dysfunctional physiology 
(Nakajima et al., 2014; Schmidt et al., 2012; Virk et al., 2016). The TRAP technique is 
therefore ideally suited to revealing underlying molecular differences across L5b 
pyramidal neuron types that, starting at the level of gene expression, help establish 
unique neuronal properties. 
 While differing patterns of gene expression can impart unique functional properties 
and establish anatomical diversity, they can additionally create vulnerabilities to 
biological insult. In fact, the selective vulnerability of specific neuron populations is a 
hallmark of many neurodegenerative diseases. In these diseases, ubiquitously 
expressed mutations cause discrete populations of vulnerable cells to die because the 
specific molecular environment found in those cells is not able to mitigate the insult. In 
the case of Amyotrophic Lateral Sclerosis (ALS), loss of two different cell types is 
observed: upper motor neurons (UMNs) in L5 of the primary motor cortex and lower 
motor neurons (LMNs) in the ventral horn of the spinal cord (Charcot and Joffroy, 1869; 
Hammer et al., 1979). Progressive loss of these two motor neuron populations is 
catastrophic to motor function, and is therefore lethal to the patient. ALS patients 
typically become symptomatic at an average age of 55 (als.org and alsa.org), with initial 
symptoms often including muscle weakness and tremors. Almost 6000 patients are 
newly diagnosed with ALS every year in the US alone, and although disease 
progression rates can vary from case to case, patients typically do not survive beyond 5 
years post-diagnosis. The vast majority of ALS cases (90%) occur sporadically (sALS) 
with no detectable heritable cause (Rowland and Shneider, 2001; Tandan and Bradley, 
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1985). For the remaining 10% of cases, heritable mutations to several genes- including 
Superoxide dismutase 1 (SOD1), C9orf72, Tar-DNA binding protein (TDP-43), and 
Fused in sarcoma (FUS)- account for most familial ALS (fALS) cases (DeJesus-
Hernandez et al., 2011; Kwiatkowski et al., 2009; Renton et al., 2011; Rosen et al., 
1993; Sreedharan et al., 2008; Vance et al., 2009)). 
It is not fully understood how mutations in these ubiquitously expressed genes 
cause degeneration of UMNs and LMNs specifically, and no effective treatments for 
ALS have been developed. Nevertheless, mouse models of ALS that express mutations 
in the fALS-associated genes (SOD1, TDP-43, FUS, and C9orf72) have allowed us to 
probe disease mechanisms in a controlled context. (Gurney et al., 1994a; Liu et al., 
2016; Verbeeck et al., 2012; Wegorzewska et al., 2009). These models recapitulate 
different features of the cellular pathologies often observed in human ALS tissues, such 
as cytoplasmic inclusions and cellular atrophy (Bentmann et al., 2013; Jara et al., 2012; 
Tsao et al., 2012; Turner and Talbot, 2008). They additionally show some of the motor 
deficits that are reminiscent of the symptoms developed by human ALS patients. In 
particular, the commonly used SOD1-G93A model (Chiu et al., 1995; Gurney et al., 
1994b) shows the progressive loss of motor function and degeneration of UMNs and 
LMNs that is the pathological definition of ALS. As in humans, however, it is not known 
how ubiquitously expressed mutant SOD1 in these mice inevitably causes death of 
motor neurons. Yet, the field has gleaned many insights into the cellular dysfunctions 
that occur in response to mutant SOD1 expression (see Cleveland and Rothstein, 2001; 
Turner and Talbot, 2008). 
11 
In healthy cells, SOD1 acts to convert the highly reactive superoxide generated as 
part of various cellular functions into less reactive hydrogen peroxide (McCord and 
Fridovich, 1969). Mutations to 70 of the 153 SOD1 amino acids have been linked to 
fALS and sALS (see Turner and Talbot, 2008). Mouse models that express many of 
these human SOD1, including the glycine-to-alanine mutation at the 93rd amino acid 
(G93A), have been generated in an effort to study the effects of mutant SOD1 to cellular 
function. Across various SOD1 mutants appear to aggregate (Johnston et al., 2000), 
mislocalize to mitochondria (Higgins et al., 2002; Jaarsma et al., 2001), lose metal ion 
binding ability (Goto et al., 2000; Williamson et al., 2000), and cause downstream 
oxidative damage via nitric oxide and hydrogen peroxide substrates (Andrus et al., 
1998; Beal et al., 1997; Bruijn et al., 1997a; Casoni et al., 2005; Estévez et al., 1999; 
Ferrante et al., 1997; Singh et al., 1998). Many of these dysfunctions have been 
described in studies of the SOD1-G93A model, where one of the cumulative 
consequences of these SOD1 phenotypes is the loss of LMNs of the spinal cord (Chiu 
et al., 1995; Gurney et al., 1994b).  Characterizing the cellular changes occurring in 
LMNs during disease progression has been the primary focus of much ALS research in 
the SOD1-G93A mouse. This is primarily due to the fact that LMNs are readily 
distinguishable from other spinal cell types by their ventral localization and large size 
(Aitken and Bridger, 1961; Light and Metz, 1978), and are therefore relatively easy to 
selectively visualize in tissue. From these studies, several of the molecular responses 
that take place in these cells during ALS progression have been uncovered, including 
oxidative stress (Beal et al., 1997; Bruijn et al., 1997b; Casoni et al., 2005), axon 
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transport defects (Warita et al., 1999; Williamson and Cleveland, 1999; Zhang et al., 
1997), dysregulation of glutamate-mediated neurotransmission and excitotoxicity (see 
Kuner et al., 2005; Tateno et al., 2004; Trotti et al., 1999), and misfolded protein 
aggregation (Bruijn et al., 1997b; Johnston et al., 2000; Watanabe and Nakamura, 
2000). While determining these phenotypes is necessary for the future development of 
treatments and therapies, it is important to remember that ALS is clinically defined by 
the loss of both LMNs of the brainstem and spinal cord, and UMNs of the motor cortex. 
Understanding what molecular changes occur in UMNs, in complement with the 
responses observed in LMNs, will allow us to more effectively determine what 
phenotypes lead to cell type-specific loss in ALS.  
 Characterizing the molecular changes that occur in UMNs of the motor cortex 
during disease has proven challenging. Because the pyramidal neuron types in the 
cortex are heterogeneous, even within L5b (Krieg, 1946), visualizing these cells 
requires a targeted labeling approach. Using retrograde anatomical tracing methods in 
mouse models of ALS, including SOD1-G93A, it has been possible to study the 
disease-related changes that take place in corticofugal L5b cells of rodent M1 during 
ALS progression (Kim et al., 2017; Ozdinler et al., 2011; Yasvoina et al., 2013; Zang 
and Cheema, 2002), also (see Jara et al., 2014). Many of these changes are 
reminiscent of phenotypes observed in LMNs, such as hyperexcitability (Fogarty et al., 
2015), atrophy (Ozdinler et al., 2011; Zang and Cheema, 2002), and vacuolization (Jara 
et al., 2012). But because the anatomical approaches used in the majority of UMN 
studies do not provide the ability to assess molecular cell type heterogeneity, it is still 
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not fully understood whether these disease phenotypes represent cell type-specific 
changes, or are more indicative of global L5b responses to ALS-causing mutations. 
Without a method that allows for reliable visual and molecular access to individual 
neuronal subtypes within the potentially heterogeneous population of L5b cells, 
including the vulnerable UMN population, we cannot hope to fully advance our 
understanding of how mutant SOD1 expression can cause motor neuron-specific loss. 
The TRAP technique presents an ideal opportunity to anatomically characterize and 
molecularly profile the different L5b populations of the motor cortex in ALS to determine 
any subpopulation-selective responses. Additionally, and perhaps more importantly, the 
technique would allow us to interrogate how the cell type-specific features of the most 
vulnerable population of L5b neurons may be exploited by a ubiquitously expressed 
ALS mutation to cause selective degeneration. 
In this work, we set out to uncover what unique characteristics define the 
vulnerable population of M1 L5b neurons relative to closely related L5b neurons in both 
healthy and ALS contexts (Figure 1.4). We first generated transgenic BAC transgenic 
mouse lines that expressed EGFP-L10a in L5b cells of M1, via the Colgalt2 and Gprin3 
promoters respectively. The EGFP expression in these lines provided us with visual 
access to these two L5b populations, which we used to determine the laminar 
localization and projection patterns of these cells. We show that Colgalt2 cells are found 
in an upper sublayer of L5b (UL5b) and project to the pons and not the spinal cord, 
while the Gprin3 population is found in a discrete lower sublayer of L5b (LL5b) and 











Figure 1.4: The general findings of this study. A summary of the relevant properties of 
L5b cells characterized in this study. Upper L5b (UL5b) Colgalt2 cells (purple) project to 
the pons, but not the spinal cord, and are not vulnerable in an ALS mouse model. Lower 




perform Translating Ribosome Affinity Purification (TRAP) to molecularly profile the cells 
by their gene expression patterns. We determine that while these cells are very similar, 
they show several molecular differences that may have consequences on their neuronal 
function. To determine the specific vulnerability of LL5b Gprin3 cells but not UL5b 
Colgalt2 in ALS by crossing our lines to the SOD1-G93A ALS mouse model, we then 
performed TRAP in these two cell types across healthy and ALS conditions to 
understand what cell-type specific responses take place in a vulnerable and resistant 
population of neurons during disease progression. We show that these cells diverge in 
their molecular responses to SOD1-G93A expression across disease stages, showing a 
particularly contrasting response in mitochondrial gene expression modulation. We then 
show that these cells show changes in mitochondrial structure during disease that will 
need to be explored further in future studies. And lastly, we endeavor to determine 
whether LL5b Gprin3 cells are representative of the neurons that are thought to be ALS-
vulnerable in the human motor cortex, with an eye towards to identifying markers that 
effectively visualize potentially disease-relevant populations. 
As a whole, this study represents an assessment of the underlying anatomical and 
intrinsic molecular differences between M1 L5b cell types, their differential vulnerability 
and responses in ALS, and the translatability of their molecular identity to human motor 
cortex. The data collected as part of this work should serve to inform future studies of 




Anatomical and molecular characterization of Colgalt2 and Gprin3 bacTRAP cell 
populations 
The mammalian neocortex is responsible for the processing of associated inputs 
from diverse brain regions into relevant functional outputs. But while each cortical region 
receives different types of information, i.e. auditory vs. visual, the cortex classically 
employs the same laminar organization of neurons to process these diverse inputs. 
Each of five anatomically distinct layers (L2/3, L4, L5a, L5b, L6a) contains excitatory 
pyramidal neurons that participate in the tiered processing of afferent information (Brody, 
1955; Jones and Wise, 1977; Krieg, 1946; Weiler et al., 2008). The output of this 
computation is ultimately transmitted out of the cortex by neurons found in its deep 
layers, with large L5b pyramidal neurons being important drivers of functional 
downstream signaling. The laminar distribution of L5b pyramidal neurons across the 
cortex is remarkably uniform in rodents (Krieg, 1946). In mice, it is consistently found at 
~50% depth from the pial surface of the cortex, with a thickness of about 150µm 
(Franklin and Paxinos, 2008; Lein et al., 2007). In primary motor cortex (M1), the 
thickness of L5b doubles, however (Caviness, 1975; Cederquist et al., 2013). Because 
the proper functioning of motor cortex in motor learning (Kawai et al., 2015) and 
execution (Anderson et al., 2010; Chen et al., 2017; Guo et al., 2015) is highly 
dependent on its outputs to other brain regions, it was theorized that this thickening 
creates space to accommodate all of the increased number and types of subcortical 
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projection neurons required to carry out these motor behaviors (see Yu et al., 2008). 
Very recently, using a combination of viral tracing and single cell RNA-Seq, it was 
shown that, indeed, L5b of M1 and anterolateral motor (ALM) cortices may contain 
diverse pyramidal neuron types, and that together, these cells function in different 
stages of preparation and execution of motor output (Economo et al., 2018; Tasic et al., 
2018). These cells also appear to diverge in projection pattern, with some cells showing 
collateral projections to proximal regions of the mid- and hindbrain, including the 
thalamus, the pons, and the superior colliculus, and others projecting to the superior 
colliculus, the pons, and distal brainstem regions (Figure 1.3; Chen et al., 2017; 
Economo et al., 2018). Alongside their differences in circuit participation, there is still 
very little known about the distinct molecular profiles of the cell types in L5b, and how 
their unique differences may contribute to the distinct functional properties observed for 
each.  
 Targeting L5b pyramidal neuron types for further study requires the ability to 
reliably visualize the cells separately across experimental paradigms. Previously 
generated transgenic mouse lines that target L5b, such as the commonly used Thy1-
EYFP line (Bareyre et al., 2005; Feng et al., 2000; Yu et al., 2008) and Uchl1-EGFP line 
(Yasvoina et al., 2013), show expression of reporters and constructs across all 
pyramidal neurons of L5b rather than individual subtypes, and would therefore not be 
suitable for studies into the properties that uniquely define each subpopulation. In order 
to target these cells for anatomical and molecular characterization, we set out to 
generate BAC Transgenic mouse lines (Gong et al., 2010) that express the EGFP-
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tagged ribosomal subunit L10a necessary for performing Translating Ribosome Affiinity 
Purification (TRAP; Doyle et al., 2008; Heiman et al., 2008) in specific subsets of L5b 
neurons. TRAP is a powerful gene expression profiling technique that allows for the 
isolation of actively translated mRNAs from specific cell types in tissues. By 
immunoprecipitating EGFP-tagged ribosomes that are expressed in these populations 
by cell type-specific promoters, one can interrogate the gene expression patterns of 
neuronal populations of interest. Expression of the GFP-tagged subunit in L5b cells 
additionally provides reliable and reproducible visualization (across generations and 
individuals) of each population, allowing us to carefully characterize the anatomical 
properties of these cell types, such as cortical localization and subcortical projection 
patterns. We therefore employed L5b TRAP lines to characterize the unique anatomical 
and molecular properties of the two subopulations of L5b projection neurons. 
2.1 Anatomical distribution of EGFP-labeled cells in the Colgalt2-TRAP DU9 
mouse line 
In order to gain molecular and anatomical access to L5b pyramidal neurons, we 
set out to express the TRAP EGFP-L10a construct in L5b cells in M1 by creating a set 
of diverse BAC transgenic animals. The GENSAT project (Gong et al., 2003; 
gensat.org) produced many cell-type specific gene expression anatomical maps of the 
mouse brain. From these atlases, a number of genes were selected for their specific 
laminar expression patterns in L5 of the cortex. BACs were created to express the 
EGFP-L10a construct under the control of these cell-type specific gene promoters. 
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From the mice that resulted from this BAC transgenic approach (Figure 2.1), two of the 
mouse lines generated, Colgalt2-TRAP DU9 and Gprin3-TRAP ES152, showed strong 
expression of the TRAP construct across many cells in apparent upper and lower L5b, 
with expression driven by the Colgalt2 and Gprin3 BAC promoters, respectively. 
Colgalt2-TRAP is expressed almost exclusively in the cortex, with very few cells 
observed in subcortical areas (Figure 2.2). Between +2.00-1.50 mm anterior to bregma 
(Figure 2.2A), Colgalt2 cells are observed at approximately half the thickness of the 
cortex, at a depth visually consistent with L5b across all cortical areas. In prelimbic and 
agranular insular cortex, some L6a cells show low levels of expression of the construct. 
In the dorsal transition zone, a small cluster of Colgalt2+ cells can also be seen. From 
+1.00-0.00 mm anterior to bregma (Figure 2.2B), cells spanned all cortical areas and 
appeared to be restricted entirely to L5b, with some cells again detected in L6a of 
insular cortex. Near bregma, the distribution of Colgalt2+ cells becomes even more 
restricted to L5b, but labeled cells are still observed across the entire extent of cortex. 
At -1.00 mm from bregma (Figure 2.2C), L5b expression of Colgalt2 is maintained, but a 
small number of cells are additionally observed in the medial CA2 region of 
hippocampus and the ventral piriform cortex/cortical-amygdalar transition region. 
Between -2.00-3.00 mm from bregma (Figure 2.2D), fewer cells are observed in L5b of 
retrosplenial cortex, with L5b in other cortical areas still showing many labeled cells. A 
small cluster of labeled cells was also observed in the medial hippocampus, beginning 
at the fasciola cinereum and spreading laterally into medial CA1 in more caudal 
sections. More caudally in this range, a more superficial population of labeled cells is 
C920006C10Rik Colgalt2 Gprin3 Nefl Kcnq2 Hcn2
Figure 2.1: Expression of EGFP-L10a in mouse L5b using BAC Transgenics. 
Representative brightfield images of GFP immunostaining in mouse lines generated to 
express the TRAP EGFP-L10a construct specifically in L5b. Gross laminar distribution 
(top row) shows specific expression in L5b of M1, with more detailed distributions shown 
below (bottom row). Among the promoters used to drive expression of the TRAP 
construct, Colgalt2 and Gprin3 showed expression in the greatest numbers of cells in 
L5b, and thus were chosen for further assessment. 
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Figure 2.2: Expression of EGFP-L10a in Colgalt2-TRAP DU9 mice is observed in 
L5b across the entire cortex. EGFP-L10a expression visualized by GFP 
immunostaining and DAB deposition in brightfield-imaged coronal sections of a 
Colgalt2-TRAP DU9 mouse. Sections are representative of ranges of anterior-posterior 
locations. (A-C) The M1-containing extent of cortex shows labeled Colgalt2 cells across 
the whole extent of cortex. Black arrows indicate the boundaries of M1 in the 
medial-lateral axis. (D-E) In posterior regions of the brain, Colgalt2 is still observed across 
most cortical areas. Section thickness is 40µm. Listed coordinates are approximate to 
Paxinos atlas coordinates.
-1.35  mm -2.60  mm







also visible in perirhinal cortex. At -3.30 mm from bregma (Figure 2.2E), the perirhinal 
population of Colgalt2 cells becomes more prominent, while L5b labeling in other 
cortical areas is maintained. A very sparse population of labeled cells is observed dorsal 
to the substantia nigra reticularis, possibly occupying a ventral area of the 
mesensephalic reticular formation. Overall, the Colgalt2-TRAP DU9 line spans L5b of 
almost all cortical areas, and would serve as an excellent line for visualizing this output 
layer across many different contexts. 
 
2.2 Anatomical distribution of EGFP-labeled cells in the Gprin3-TRAP ES152 
mouse line 
 Broadly, Gprin3-TRAP is expressed in many subcortical regions across the brain, 
as well as in L5b of certain anterior regions of the cortex (Figure 2.3). At +2.25 mm from 
bregma, Gprin3 cells are only observed in a wide band of pyramidal neurons at a depth 
consistent with L5b across secondary and primary motor cortex regions. At +2.00 mm 
from bregma (Figure 2.3A), Gprin3 cells in the cortex can be seen in a wide band 
beginning medially in secondary motor cortex and extending laterally to insular cortex. 
Ventrally, a cluster of cells can be seen in the shell of the nucleus accumbens, as well 
as a more ventral structure surrounding the ventral pallidum. At +1.00 mm from bregma, 
cortical Gprin3 cells can be seen in L5b, again beginning medially in secondary motor 
cortex, and extending laterally through secondary somatosensory cortex. Through M1, 
the labeled pyramidal neurons appear to “dip” to a lower sublayer of L5b, however, 
suggesting Gprin3 cells may have a LL5b identity in this area. Subcortically, Gprin3+  
Figure 2.3: Expression of EGFP-L10a in Gprin3-TRAP ES152 is localized to anterior 
areas of cortex, and found in many subcortical areas of the brain. EGFP-L10a 
expression visualized by GFP immunostaining and DAB deposition in brightfield-imaged 
coronal sections of a Gprin3-TRAP ES152 mouse. Sections are representative of ranges 
of anterior-posterior locations. (A) In an anterior area of cortex, cortical Gprin3 cells are 
observed along much of the medial-lateral extent. A small number of cells is observed 
subcortically. Black arrows indicate the medial-lateral extent of M1. (B) Closer to Bregma, 
in the lateral-to-medial transition between somatosensory cortex and the lateral boundary 
of M1, GFP labeled cells appear to dip deeper into the cortex and remain there through 
to the medial boundary of M1. GFP+ cells are also seen in the striatum and other 
subcortical areas in this range. (C) As M1 begins to disappear in this more posterior area, 
GFP+ cells in the cortex become sparser. Subcortical GFP cells are found in many 
diverse regions here. (D-E) In posterior regions of the brain, GFP labeling is heavily 
concentrated to subcortical areas, and the CA3 region of hippocampus. Section thickness 












cells can be seen in the striatum in a sparsely scattered pattern. Several subpopulations 
of labeled cells can be found in the accumbens shell, with a small number also located 
in the accumbens core region. A dense population of Gprin3+ cells is visible in a very 
ventral area of this brain region, possibly occupying the olfactory tubercle. Cells can 
also be seen in the lateral and medial septal nuclei and in what appears to be the island 
of Calleja between the accumbens shell and the spetal nuclei. At +0.50 mm from 
bregma (Figure 2.3B), the same distribution of labeled L5b neurons is observed in the 
cortex between secondary motor and secondary somatosensory cortex, with the “dip” in 
primary motor cortex still clearly visible. The sparse but highly expressing striatal 
neurons are also observed. The number of cells found in the accumbens shell is greatly 
reduced, with a large number of highly-expressing cells visible in the medial septal 
nucleus and in various ventral nuclei around the olfactory tubercle. Around bregma, the 
distribution of labeled cells in L5b of the cortex becomes much sparser, with fewer cells 
generally visible from secondary motor cortex to secondary somatosensory cortex. 
Many cells are still observed in the striatum, with a large number of highly-expressing 
cells found ventral to the anterior commissure in the various ventral nuclei found in this 
region. A small cluster of cells can also be seen in the anteromedial bed nucleus of the 
stria terminalis. An additional sparse cluster of neurons can be observed in the 
septofimbrial nucleus. At -0.50 mm from bregma, the number of cortical L5b cells has 
noticeably decreased, with some cells still remaining in the lateral regions of cortex, 
including the insular cortex. Subcortically, a large number of highly-expressing cells can 
be found in the globus pallidus and the thin band that comprises the bed nucleus of the 
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stria terminalis at the coordinate. A cluster of low-expressing cells can also be seen in 
the central medial thalamic nucleus. The ventral regions of the midbrain here, including 
the hypothalamus and the anterior amygdalar area, contain many labeled cells showing 
varying levels of expression. From -1.00-1.50 mm from bregma (Figure 2.3C), almost all 
labeled cortical neurons have disappeared. Gprin3+ cells are primarily localized to 
subcortical areas, including the dorsal striatum, the globus pallidus, the lateral 
habenula, the central medial, rhomboid, and reuinens nuclei of the thalamus, the zona 
incerta, and almost all nuclei of the hypothalamus and the medial forebrain bundle. A 
number of labeled cells can also be seen in the CA3 region of the hippocampus. At -
2.00 mm from bregma, fewer cells are observed in the ventromedial regions of the 
hypothalamus, with some still remaining in the peduncular region of the lateral 
hypothalamus. The zona incerta still contains a dense population of labeled cells, as 
well as the lateral habenula, the pregeniculate nucleus, and many dorsomedial nuclei of 
the thalamus. Gprin3+ neurons can still be seen in the CA3 region of hippocampus, with 
an additional cluster of cells observed in the polymorph area of the dentate gyrus. At -
2.75 mm from bregma (Figure 2.3D), Gprin3+ cells occupy almost the entire midbrain, 
with the exception of a lateral horn of the thalamus composed of the lateral posterior 
thalamic nuclei and the dorsolateral geniculate nucleus through to the retroethmoid 
nucleus. In the hippocampus, the CA3, polymorph dentate gyrus and the dorsal 
subiculum regions also contain labeled cells. The midbrain is densely populated with 
labeled cells through to -3.00 mm from bregma (Figure 2.3E), where the only region 
containing no Gprin3+ cells is the medial geniculate nucleus. At this coordinate, a 
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sparse population of cells in the substantia nigra reticularis and the interpeduncular 
nucleus can also be seen. More posterior, the superior colliculus also shows many 
labeled cells, along with the periaqueductal gray. The Gprin3-TRAP ES152 line is 
therefore useful for the study of L5b cells anterior to bregma, in anterolateral motor 
regions, primary motor cortex, and the accessory motor/somatosensory regions. A very 
large and diverse population of labeled cells is also found subcortically and in the CA3 
region of hippocampus, making the Gprin3 line potentially useful in the molecular and 
anatomical characterization of these regions. 
 
2.3 Colgalt2 and Gprin3 neurons represent two distinct populations of layer 5b 
pyramidal neurons in primary motor cortex of mouse. 
 Because both Colgalt2 and Gprin3 cells occupy L5b of M1, we wanted to perform 
a closer examination of the precise laminar distribution of the cells. We immunostained 
for GFP in Colglat2-TRAP and Gprin3-TRAP mice and imaged the M1 sections by 
confocal microscopy (Figure 2.4A-B). We then measured the depth of GFP+ cells using 
a custom program that measures the Euclidean distance between the pial surface and 
the dorsal surface of white matter. These analyses revealed that in the Colgalt2-TRAP 
mouse, GFP+ neurons are found at approximately 50% depth from the pial surface to 
the dorsal edge of the white matter of the corpus callosum (CC). This depth is 
consistent with a superficial sublayer of L5b (Economo et al., 2018), or upper L5b 
(UL5b, Figure 2.4C). The Colgalt2 cells are found between 50-60% depth in other areas 









































































Figure 2.4: Colgalt2 and Gprin3 cells show distinct sublayer distribution within L5b 
of M1. (A-B) Representative images of M1 in (A) Colgalt2-TRAP and (B) Gprin3-TRAP 
mouse. Immunostaining for GFP (green) shows location of TRAP cells amongst all 
NeuN+ neurons of the cortex (red). Colgalt2 cells appear to occupy an upper sublayer of 
L5b (UL5b) relative to Gprin3 cells, which instead dip into a lower sublayer of L5b (LL5b) 
in this area. Cortical layers were delineated based on approximate depth and size of cell 
bodies composing each layer (scale bar = 500 µm). (C) Heatmaps indicating the 
frequency at which GFP labeled cells from Colgalt2 and Gprin3 M1 were found at each 
depth of the cortex, represented as percent depth from pial surface of the cortex. In M1, 
Colgalt2 cells (purple; n = 209) are found more superficially than Gprin3 cells (green; n = 
163). In other cortical areas, both cell types are found at the same depth. Frequencies ≥
6 cells are shown in the same shade of color to more readily highlight depths that contain 
the most labeled cells.
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M1 of Gprin3 animals, GFP+ neurons were instead observed at a depth of 60-75% from 
the pial surface, suggesting they occupy the lower sublayer of L5b (LL5b). In other 
cortical areas, Gprin3 cells appeared to reside primarily at 50-60% depth, similar to 
Colgalt2 cell depth, suggesting that these two cell types anatomically converge in other 
regions of the cortex, and that the sublayer divergence is unique to M1. Together these 
data indicate that the Colgalt2 and Gprin3 mice represent the first transgenic lines that 
target expression to the two distinct sublayers of M1 L5b, allowing for the consistent and 
reliable visualization of these neuron populations without the use of tracers or viruses. 
2.4 Colgalt2 and Gprin3 neurons share long-range projection neuron identity, but 
project to distinct targets. 
Because L5b has been well established as an output layer of the cortex, 
containing large pyramidal neurons that display long-range projections targeting 
different areas throughout the brain, we wanted to confirm that our Colgalt2 and Gprin3 
cells are indeed long-range projection neurons. We first immunostained for Ctip2, a 
known marker of subcortical-projection neurons, in our Colgalt2 and Gprin3 brains in 
order to assess co-localization with the GFP from our cells (Figure 2.5A). In Colgalt2 
brains, 79% of sampled GFP+ cells were Ctip2+, and in Gprin3 mice, 94% of GFP+ 
cells were Ctip2+ (Figure 2.5B). Colgalt2 and Gprin3 cells additionally showed larger 
soma size than other pyramidal neurons in the cortex, with median Colgalt2 soma size 
being 233 µm2 and median Gprin3 soma size being 238 µm2, compared to 180 µm2 for 













































Figure 2.5: Colgalt2 and Gprin3 cells are both positive for Ctip2, a marker for 
subcortical projection neurons of the cortex. (A) Representative confocal images of 
GFP+ (green) Colgalt2 and Gprin3 cells with staining for the subcortical projection neuron 
marker Ctip2 (red, scale bar = 50 µm). (B) Quantification of co-localization of Ctip2 with 
Colgalt2 GFP (purple; n = 191 cells) and Gprin3 GFP (green; n = 135 cells) reported as 
percent of GFP+ cells that show Ctip2 labeling. Bars show mean±SEM (n.s. = not 
significant by two-tailed t-test). (C) Quantification of soma size (µm2) for GFP+ Colgalt2 
cells (purple; n = 292 cells), Gprin3 cells (green; n = 285 cells), and other neurons across 
layers of cortex (grey; n = 1253 cells). Colgalt2 and Gprin3 cells show larger soma sizes 
relative to other neurons in the cortex. Box and whisker plots show median and quartile 
boundaries (****p < 0.0001 by one-way ANOVA).
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these data suggest that both UL5b Colgalt2 and LL5b Gprin3 neurons share the long-
range projection identity that is classically observed in L5b. 
We then set out to identify the targets of the presumptive long-range axonal 
projections of Colgalt2 and Gprin3 cells. Across different cortical areas and species, L5b 
cells have been shown to project to the thalamus, superior colliculus, pons, brainstem, 
and spinal cord (Hattox and Nelson, 2007; Jones et al., 1977; Moya et al., 2014; Oswald 
et al., 2013; Wise and Jones, 1977b; Wise et al., 1979). Because UL5b and LL5b cells 
were recently shown to share a projection to the pons, but diverge in projections to 
more caudal regions (Economo et al., 2018), we chose to first assess whether our 
Colgalt2 and Gprin3 cells project to the pons or the cervical spinal cord. We therefore 
injected the retrograde tracer cholera toxin beta (CTB) into the pons and C6 cervical 
spinal cord (Figure 2.6A-B, left panels) in adult Colgalt2 and Gprin3 mice and visualized 
the retrogradely labeled cells in M1 by confocal microscopy following immunostaining 
for GFP and CTB (Figure 2.7A-B, left panels). The distribution of pons-CTB+ neurons 
varied by injection site, but cells were often observed across L5b of many different 
cortical areas. Neurons that were pons-CTB+ were found in both upper and lower L5b 
of M1, at similar depths to both Colgalt2 and Gprin3 cells, extending from 45-75% depth 
from the pial surface, with bimodal peaks at ~50% and ~70% depth, matching the peak 
depths of Colgalt2 and Gprin3 cells respectively (Figure 2.8A). When we quantified co-
localization of GFP in CTB+ cells, we found that 38% of pons-CTB+ cells across both 
sublayers were positive for Colgalt2. When co-localization is measured only within the 
dorsal half of L5b that comprises UL5b, 64% of pons-CTB+ cells were positive for 
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Figure 2.6: Retrograde tracing from pons and cervical spinal cord labels L5b 
neurons in M1. (A) Schematic representations of CTB (red) injection targets in the pons 
and cervical spinal cord with expected corresponding retrograde labeling in the cortex. (B, 
top row) Representative confocal images of CTB at the site of injection in pons (left) and 
C6 of the cervical spinal cord (right). Cytoarchitecture is shown with NeuN labeling (cyan). 
Corresponding retrograde labeling in M1 is shown with CTB staining (red). Pons 
injections retrogradely labeled cells across both sublayers of L5b (bottom row, left), while 
C6 injections only appeared to label LL5b cells (bottom row, right). Pial surface outlined 
with solid white line, target grey matter/white matter boundary outlined with dashed white 
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Figure 2.7: Retrograde tracing from pons and cervical spinal cord labels Colgalt2 
and Gprin3 cells. (A) Schematic representations of CTB (red) injection targets in the 
pons and cervical spinal cord with expected corresponding retrograde labeling in the 
cortex. (B) Immunostaining for GFP (green) revealed CTB (red) overlap with Colgalt2 (top 
row) and Gprin3 (bottom row) cells. Pontine CTB cells appeared to overlap with both 
Colgalt2 and Gprin3 cells across both sublayers of L5b. Spinal CTB cells only appear to 
spatially overlap with Gprin3 cells in LL5b. Pial surface outlined with solid white line, 
































































































Figure 2.8 : Colgalt2 cells project to the pons, while Gprin3 cells project to both the 
pons and the cervical spinal cord. (A) Heatmaps showing frequency of depth 
localization of retrogradely labeled CTB+ cells (red), compared to depths of Colgalt2 
(purple; n = 209 cells) and Gprin3 (green; n = 163 cells) cells in M1 following CTB 
injections into the pons and C6 of cervical spinal cord. Pontine CTB cells (n = 651 cells) 
distributed bimodally across both sublayers of cortex, overlapping in depth with Colgalt2 
and Gprin3 cells. Spinal CTB cells (n = 192 cells) were located deeper in M1, overlapping 
with the Gprin3 population. Frequencies ≥ 6 cells are shown in the same shade of color
to more readily highlight depths that contain the most labeled cells. (B) Quantification for 
co-localization of CTB with GFP from Colgalt2 (purple) and Gprin3 (green) cells following 
CTB injection into pons or cervical spinal cord, reported as percent of total CTB+ cell 
observed for each injection. 38% of pontine CTB in all of L5b cells co-localize with 
Colgalt2 (n = 318 cells), with 48% co-localizing with Gprin3 (n = 613 cells). More 
specifically, 64% of pontine CTB in UL5b co-localized with Colgalt2 cells, and 77% of 
pontine CTB cells in LL5b co-localized with Gprin3 GFP. Only 9% of spinal CTB 
co-localized with Colgalt2 (n = 190 cells), while 82% co-localized with Gprin3 cells (n = 
127 cells; bars represent mean ± SEM).
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Colgalt2 GFP (Figure 2.8B). In Gprin3 brains, 48% of pons-CTB+ cells across both 
sublayers were Gprin3 GFP positive. When only the ventral half of L5b, or LL5b, is 
assessed for co-localization, we found that 77% of pons-CTB+ cells co-localize with 
Gprin3 GFP. Additionally, ~20% of pons-CTB+ cells in UL5b co-localize with Gprin3 
GFP, due to the small proportion of Gprin3 cells that occupy this sublayer. Together, 
these data indicate that Colgalt2 and Gprin3 neurons account for a very large majority 
(~85%) of pons-projecting cells of M1 L5b. 
To assess spinal cord-projection identity for Colgalt2 and Gprin3 cells, we injected 
CTB into cervical spinal cord at the level of C6 (Figure 2.6A-B, right panels) and 
visualized retrogradely labeled cells in M1 by confocal microscopy (Figure 2.7A-B, right 
panels). C6-CTB+ cell distributions varied by injection site, but were primarily observed 
in M1 between 1.00 mm and -0.40 mm from Bregma. C6-CTB+ cells were primarily 
located at ~70% depth from pia, in what appeared to be LL5b, and at a similar depth to 
Gprin3 (Figure 2.8A). In Gprin3, 82% of C6-CTB+ cells were positive for Gprin3 GFP, 
while in Colgalt2 brains, GFP co-localization was only observed for 9% of C6-CTB+ 
cells (Figure 2.8B). This suggests that in addition to a projection to the pons, the 
majority of Gprin3 neurons have a collateral projection to the cervical spinal cord. 
Colgalt2 cells, in contrast, project to the pons, but not to the spinal cord. These findings 
confirm that UL5b and LL5b cells have divergent collateral projection patterns, and 
further establish the Colgalt2 and Gprin3 mouse lines as useful for the reliable 
visualization of divergent long-range projection L5b neuron types. 
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2.5 Gprin3 cells project to spinal motor neurons through an intermediate 
population of neurons in the central spinal cord. 
Projections to the spinal cord from the cortex terminate in different functionally 
organized regions of the spinal grey matter (see Watson et al., 2008). We therefore 
wanted to determine the anatomical localization of axon terminals originating from the 
LL5b cells that are represented by our Gprin3 cells. To accomplish this, we injected an 
rAAV2 carrying a Cre-dependent EYFP construct into M1 of Gng7-Cre KH67 mice, 
which express Cre in all L5b cells of the cortex (Figure 2.9A). We collected the cervical 
spinal cord of these mice for sectioning, and visualized the EYFP-labeled terminals of 
the L5b cells by immunostaining and confocal microscopy. We observed labeled 
terminals in an intermediate region of the spinal grey matter, concentrated in lamina 5, 
6, and 7 (Figure 2.9B). Only 1.64% of the ventral horn area occupied by ChAT+ alpha 
motor neurons showed EYFP signal (Figure 2.9C-D), suggesting that LL5b cells do not 
directly project onto these motor output cells. This intermediate corticospinal projection 
pattern that we observe additionally confirms previously reported anatomical results 
(Bourane et al., 2015; Hantman and Jessell, 2010; Ueno et al., 2018), where cortical 
L5b cells were shown to project to interneuron populations within this central region of 
the spinal cord. 
The cervical spinal cord contains neurons that function in the control of muscles of 
the neck, shoulders, and forelimbs (see Bachmann et al., 2014). But given that the 
axons of LL5b cells do not terminate directly on alpha motor neurons, we wanted to 

















































Terminal DensityMeasuring terminal density
Figure 2.9: Anterograde labeling of LL5b cells in M1 reveals projections to 
intermediate regions of spinal grey matter. (A) Schematic illustration of 
Cre-dependent viral construct targeting to cortex in Gng7-Cre animal, with expected 
labeling of EYFP-expressing cells and their primary axons. (B) Representative confocal 
image of labeling observed in cervical spinal cord following Cre-dependent EYFP 
injection into M1. Corresponding map of spinal grey anatomy shown on the right. EYFP 
axons (green) show axon terminals of LL5b cells expressing the viral construct at the M1 
injection site. ChAT+ cells (red) show the location of spinomuscular alpha motor neurons 
in the ventral horn. EYFP+ terminals are primarily apparent in the intermediate lamina 5, 
6, and 7, and are not visible in the ventral horn (scale bar = 300 µm). (C) Representation 
of strategy for measuring density of labeled terminals in different anatomical areas of the 
spinal grey matter. White outlines show examples of region-of-interest boundaries used 
for measurement. Location of ChAT signal (red) was used to determine boundaries of 
ventral horn areas, while intermediate laminar areas were selected at random from 
regions showing EYFP signal (green; scale bar = 250 µm). (D) Quantification of percent 
of region-of-interest areas that showed EYFP terminal labeling after thresholding EYFP 
signal channel. 25% of intermediate laminar areas were occupied by EYFP+ terminals. 
2% of ventral horn areas were occupied by EYFP+ terminals (****p < 0.0001 by two-tailed 
t-test; bars represent mean ± SEM).
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We employed a trans-synaptic retrograde pseudorabies (PRV) viral tracing strategy to 
accomplish this. When injected into a target site, PRV enters the cell at the pre-synaptic 
terminal, and is retrogradely transported to the cell body of this primary neuron. The 
virus is then passed upstream across dendritic synapses, labeling any cells that project 
to the primary cell. This trans-synaptic transfer continues until the animal is sacrificed, 
labeling any cells that eventually innervate the primary neuron through indirect 
projections. We injected PRV293.mCherry into the upper forelimb muscles (bicep, 
tricep, trapezius, deltoid) of Colgalt2 and Gprin3 mice to determine if these cells 
indirectly participate in spinomuscular circuitry (Figure 2.10A). We then visualized 
mCherry reporter expression in cells after 5 days (Figure 2.10B). Consistent with our 
retrograde CTB injections, Colgalt2 GFP was found in 19% of forelimb-mCherry+ cells, 
suggesting they do not significantly contribute to forelimb spinomuscular output (Figure 
2.10C). Surprisingly, while we observed many forelimb-mCherry+ cells adjacent to our 
Gprin3 neurons, only 30% of forelimb-mCherry+ cells co-localized with Gprin3, whereas 
CTB injections into C6 of the spinal cord showed an 80% overlap with Gprin3 cells. 
Together, these data indicate that while Gprin3 cells project to the spinal cord, they do 
not appear to substantially participate in forelimb control circuitry. In addition to forelimb 
alpha motor neuron pools, however, the cervical spinal cord contains motor neurons 
that control dorsomedial shoulder and neck muscles. It is therefore possible that the 
Gprin3 cell projections to cervical spinal cord instead participate in the control of these 
more anteromedial muscle groups, although more tracing experiments must be carried 
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Gprin3
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Figure 2.10: PRV tracing reveals that neither Colgalt2 nor Gprin3 cells participate 
in proximal forelimb muscle control circuitry. (A) Schematic illustration showing PRV 
expression and labeling paradigm with expected mCherry (red) expression pattern. After 
injection into forelimb muscles, PRV is retrogradely transported to cell bodies of 
innervating alpha motor neurons in the ventral horn. The virus is trans-synaptically 
passed retrogradely until it reaches cortical L5b cells that terminate in the spinal grey 
matter. (B) Representative confocal images following immunostaining for Colgalt2 (top) 
and Gprin3 (bottom) GFP (green), and mCherry expressed by PRV (red). mCherry+ cells 
appear below UL5b Colgalt2 cells and amongst LL5b Gprin3 cells. (C) Quantification for 
co-localization of mCherry with Colgalt2 GFP (purple) and Gprin3 GFP (green), reported 
as a percentage of all mCherry+ cells observed. 19% of mCherry+ cells co-localized with 
Colgalt2 GFP (n = 124 cells). 30% of mCherry+ cells co-localized with Gprin3 GFP (n = 
206 cells). This suggests that neither cell type greatly participates in forelimb muscle 
control circuitry (n.s. = not significant by two-tailed t-test; bars show mean ± SEM).
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2.6 Colgalt2 and Gprin3 neurons represent two molecularly related, but 
nevertheless distinct, populations of L5b pyramidal neurons. 
Because Colgalt2 and Gprin3 cells have historically been very difficult to 
distinguish from each other anatomically as well as molecularly, we wanted to 
determine if their similarity is reflected at the level of mRNA by comparing the gene 
expression profiles of Colgalt2 and Gprin3 cells to other cell types in the cortex. For this, 
we took advantage of the controlled expression of the EGFP-L10a ribosomal subunit in 
our two mouse lines to perform TRAP, a technique that provides access to cell type-
specific mRNAs via immunoprecipitation (IP) of the tagged ribosomal subunit (Doyle et 
al., 2008; Heiman et al., 2008). Ribosome bound mRNA molecules from Colgalt2 and 
Gprin3 cells were IP’ed from whole cortex homogenates and polysome-bound mRNAs 
were analyzed by high throughput RNA sequencing. We determined the success of the 
isolation by confirming that known pyramidal neuron marker genes were enriched and 
glial genes were depleted in each dataset. We then set out to determine how similar 
Colgalt2 and Gprin3 mRNA expression patterns are relative to other cell types in the 
brain. By PCA, these cells cluster closely together, along with L6a cells (Figure 2.11A). 
In contrast, Colgalt2 and Gprin3 cells cluster away from striatal neurons, L4 neurons in 
the cortex, and samples from the S100a10 mouse line that expresses in L5a neurons 
and endothelial cells. Next, we assessed Euclidean distance between these cell types 
by measuring the distances between samples in the whole transcriptome-dimensional 
normalized counts space. Hierarchical clustering of these distances revealed that 
Colgalt2 and Gprin3 cells, as well as deep L6a neurons, exist closer together in this 




































































Figure 2.11: Colgalt2 and Gprin3 cells have gene expression profiles that suggest 
that, among other neuronal populations, they are closely related. (A) Principal 
component analysis (PCA) showing relative positioning of different TRAP sample 
replicates along the first two principal components. (B) Heatmap showing hierarchically 
clustered Euclidean distances between TRAP replicate samples for different cell types. 
Each row/column represents one replicate sample. Bold black box shows deep layer 
cortical cells, including UL5b Colgalt2 cells and LL5b Gprin3 cells, which cluster together 
and show relatively short distances between each other, suggesting they are more 
related to each other than to other neuronal cell types (C) Heatmap of Pearson correlation 
values between TRAP replicate samples for different cell types. Each row/column 
represents one replicate sample. Bold black box highlights the deep layer populations of 
UL5b Colgalt2 cells, LL5b Gprin3 cells, and L6a Ntsr1 cells, which all correlate highly, 
suggesting that they show similar patterns of gene expression (magenta = S100a10 L5a 
IP samples, purple = Colgalt2 UL5b IP samples, orange = Ntsr1 L6a IP samples, green = 
Gprin3 LL5b IP samples, grey = whole cortex input samples, yellow = Cdh6 L4 IP 
samples, cyan = Drd1 striatal IP samples, blue = Drd2 striatal IP samples).
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space than they do to other cell types (Figure 2.11B). Pearson correlation of normalized 
gene expression counts similarly showed that deep layer neurons are highly correlated 
with each other (Figure 2.11C). Together, these results confirm that in the context of the 
whole transcriptome, UL5b Colgalt2 and LL5b Gprin3 cells are more similar to each 
other than to other cell types in the cortex and subcortex.  
Next, we performed differential expression (DE) analysis between Colgalt2 and 
whole cortex input, and between Gprin3 and cortex input to determine whether known 
L5b marker genes are enriched in these cells relative to whole cortex (Figure 2.12A-B). 
We generated a list of marker genes for glutamatergic L5b neurons using the DE tool 
available for cortical single cell RNA-Seq data available through the Allen Brain Atlas 
(http://celltypes.brain-map.org/rnaseq/mouse). Both Colglat2 and Gprin3 cells 
expressed marker genes for L5b pyramidal tract neurons at high levels relative to whole 
cortical input samples (Figure 2.12C). Together, these data confirm that our Colgalt2 
and Gprin3 datasets reveal a potentially fundamental molecular identity for these cells, 
namely that of L5b pyramidal neurons. To determine what genes instead define the 
molecular differences between Colgalt2 and Gprin3 cells, we performed DE analysis 
directly between Colgalt2 and Gprin3 cells (Figure 2.13A). Genes that showed 
significant (adjusted p-value < 0.05) enrichment in either cell type and with a mean 
Log10 counts per million (CPM) expression value greater than 3 across Colgalt2 and 
Gprin3 were run through gene ontology (GO) analysis to determine what pathways, 
classes, or groups of genes were enriched between the two cell types. GO categories 


































































Colgalt2 vs. Whole Cortex Gprin3 vs. Whole Cortex
Enriched in Colgalt2
Figure 2.12: Colgalt2 and Gprin3 cells are related in part by their expression of 
known L5b genes. (A-B) MA Plot showing average Log10 counts per million (cpm) value 
and Log2 fold enrichment in IP over cortical input from differential expression (DE) 
analysis. Genes that showed significant enrichment (adjusted p < 0.05 and Log2 fold 
enrichment < -1 or > 1) in either IP or cortex are shown in pink. All other genes shown in 
grey. Genes that were highly expressed (Log10 cpm > 3) and significantly enriched in IP 
samples are shown in purple for Colgalt2 cells (A) and green for Gprin3 cells (B). These 
genes were considered to be highly expressed in their respective cell type. (C) Heatmap 
showing Log2 fold enrichment over cortical input for Allen Brain Atlas L5b marker genes 
in Colgalt2 and Gprin3 cells. Glial gene enrichment shown as a control. Sidebars show 
whether the gene represented in that row was significantly enriched (pink) or not 
significantly different (grey; n.s. = not significant). Both Colgalt2 and Gprin3 cells appear 
to highly express many of the known L5b marker genes, further confirming their laminar 


























































Figure 2.13: Differential expression between Colgalt2 and Gprin3 cells reveals 
molecular differences between UL5b and LL5b cell types. (A) MA Plot showing 
average Log10 counts per million (cpm) value and Log2 fold enrichment in IP over cortical 
input from differential expression (DE) analysis. Genes that showed significant 
enrichment (adjusted p < 0.05 and Log2 fold enrichment < -1 or > 1) in either IP or cortex 
are shown in pink. All other genes shown in grey. Genes that were highly expressed 
(Log10 cpm > 3) and significantly enriched in IP samples are shown in purple for Colgalt2 
cells and green for Gprin3 cells. (B) Genes highlighted as highly enriched in Colgalt2 or 
Gprin3 cells were assayed for gene ontology (GO) enrichment. Classes of genes that 
were enriched in Colgalt2 cells (purple bars) primarily represent signaling pathways. 
Classes of genes enriched in Gprin3 cells (green bars) contain mitochondrial pathways 
(bars represent Log10 p-values for enrichment of each cateogory). 
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involved in maintaining neuronal structure and function (Figure 2.13B, left panel). In 
Gprin3 cells, many mitochondrial genes, particularly Oxphos-associated genes, showed 
enrichment over Colgalt2 (Figure 2.13B, right panel). While all of these data together 
confirm that UL5b Colgalt2 and LL5b Gprin3 cells share a basic molecular L5b identity, 
further highlighting the utility of transgenic lines that can distinguish between these cell 
types, our sequencing data also provide us with the ability to identify potentially 
important functional differences between the two cell types. 
2.7 Discussion 
Here, we present two transgenic lines that target expression of the EGFP-L10a 
TRAP construct to distinct populations of L5b cells in M1. We found that Colgalt2-TRAP 
DU9 cells are found all across the cortex, and are restricted to an upper sublayer, UL5b 
(Figure 2.14, left panel). Gprin3-TRAP ES152 cells are instead found primarily in rostral 
areas of the cortex, mostly restricted to LL5b of ALM and M1. While in M1, the 
distribution of Colgalt2 and Gprin3 cells is clearly divided into UL5b and LL5b, while in 
other areas of cortex, Colgalt2 and Gprin3 cells converge in the same layer. While the 
thickness of each of the 6 cortical layers often varies across the different functional 
regions of cortex, this subdivision of L5b appears to be unique to the motor region of 
cortex. The laminar distribution of L5b is likely programmed during cortical patterning in 
late pre-natal development. Because deep layers of the cortex are established first 
during cortical neuron migration in laminar development (Rakic, 1974), the differential 
intersections of expression gradients for cortical patterning factors such as Fgf8 
Figure 2.14: Summary of UL5b and LL5b anatomical divergence. We show that L5b 
in mouse M1 is subdivded into two discrete sublayers, upper L5b (UL5b) and lower L5b 
(LL5b) containing molecularly distinct populations of cells (left panel). We additionally 
show that cells found in UL5b (purple) only project to the pons, while LL5b cells (green) 
project to both the pons and the intermediate regions of the cervical spinal cord (right 
panel).















(Fukuchi-Shimogori and Grove, 2001; Garel et al., 2003) and Emx2 (Bishop et al., 2002; 
Hamasaki et al., 2004) may influence the timing and duration of L5b cell migration and 
differentiation. These timing differences could establish different thicknesses of L5b 
throughout the cortex, with more anteromedial regions such as M1 and ALM developing 
a thicker L5b than other cortical areas. Additionally, these gradients may help determine 
the medial-lateral and anterior-posterior extents of Colgalt2 and Gprin3 cell identity. 
Once positioned in the cortex, L5b pyramidal neurons begin to send projections to 
various long-range target regions. Here we show that UL5b Colgalt2 cells and LL5b 
Gprin3 cells diverge in long-range projection patterns. While Colgalt2 cells have 
pyramidal tract (PT) collaterals that terminate in the pons but not the spinal cord, Gprin3 
cells send PT axon collaterals to both the pons and spinal cord (Figure 2.14, right 
panel). For L5b cells, subcortical vs. intratelencephalic (IT, or cortico-cortical) projection 
is the first hierarchy of projection identity that must be determined. Expression of Fezf2 
and Ctip2 (Chen et al., 2008), and absence of Satb2 (Alcamo et al., 2008) are 
necessary and sufficient to specify that a L5b axon should be directed subcortically. 
Once out of the cortex, the unique sets of transcription factors found in each cell type 
influence the expression of axon guidance receptors that specifically respond to 
attractive and repulsive cues, establishing correct collateral targeting for each neuron 
class (for review, see Lodato et al., 2015). The distinct subcortical projection pattern that 
we observe for M1 L5b cells suggests that Colgalt2 and Gprin3 cells express different 
genes during axon guidance that are responsible for differentiating their projection to the 
spinal cord and other areas. In fact, developmental evidence suggests that both UL5b 
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and LL5b cells develop a collateral to the spinal cord during post-natal axon outgrowth, 
but the collateral axon is lost for UL5b cells (Wang et al., 2017). When Lmo4 is 
conditionally knocked out from Emx1+ neurons during development, M1 L5b sublayer 
lamination is correctly established, but UL5b cells instead maintain the collateral to the 
spinal cord into adulthood (Cederquist et al., 2013). It would therefore be interesting to 
determine if in an Lmo4 conditional knock-out mouse, Colgalt2 cells would show a 
spinal collateral in adulthood, allowing us to probe the molecular origin of PT neuron 
projection divergence. Additionally, expression of the TRAP construct in this context 
may help to uncover the downstream receptors responsible for generating such precise 
axonal targeting during L5b projection patterning. 
Establishing appropriate connectivity during development is critical to the proper 
functioning of many cortical circuits. For L5b cells, the targeting of neuronal signaling to 
precise areas over long distances is even more important, as they represent an 
important output layer of the cortex. L5b cells of M1 participate in motor planning, 
learning, and execution via these projections (Gu et al., 2017b; Guo et al., 2015; Kawai 
et al., 2015; Lashley, 1942; Suter et al., 2013). In the latter case, projections to the 
spinal cord communicate the information necessary for alpha motor neurons to direct 
the contraction of appropriate muscle groups. Our data reveal, however, that Gprin3 
axons do not project directly onto alpha motor neurons of the cervical spinal cord, but 
instead terminate in an intermediate spinal grey area around lamina 5, 6, and 7. 
Together with the results from our trans-synaptic retrograde PRV tracing from forelimb 
muscles, these data additionally reveal that Gprin3 cells do not heavily participate in the 
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control of forelimb muscles through this projection. Motor neurons that control other 
more anterior muscle groups in the body are also found in the cervical spinal cord, and 
using more trans-synaptic tracing targeted to these areas, we will be able to address 
whether Gprin3 cells instead participate in the control of these muscle groups. 
In primates, the motor cortex is important for the execution of voluntary 
movement (Evarts, 1968; Lee and Tatton, 1975; Thach, 1978), and the sophisticated 
repertoire of dexterous movements that are displayed by non-human primates, apes, 
and humans benefit from the direct projection of a subpopulation of L5b cells, namely 
corticomotoneurons, onto alpha motor neurons in the spinal cord (Iwatsubo et al., 
1990). Conversely, the relative simplicity of movement patterns seen in lower mammals 
likely explains the lack of direct projections from M1 LL5b cells onto spinal motor 
neurons, although this is not fully understood (see Gu et al., 2017b). To address the 
functional contribution of LL5b Gprin3 cells to motor output in the mouse, we must first 
carefully delineate the muscle groups that receive indirect input from these cells. 
Additionally, specifically ablating Gprin3 cells, using either virally-delivered toxins or 
optogenetic silencing, can allow us to observe the behavioral consequence to these 
muscle groups during motor output, and begin to uncover a potential functional 
relationship between corticospinal neurons in the mouse and the ones found in 
primates. 
The functional properties of distinct neuron types are influenced by the 
differential expression of channels, receptors, and other signaling components, both 
during development and in adulthood. The molecular diversity of L5b cells was recently 
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shown to be greater than originally known (Economo et al., 2018; Tasic et al., 2018). 
Here, we show that Colgalt2 and Gprin3 cell gene expression patterns suggest they are 
closely related, and that genes associated with establishing/maintaining L5b excitatory 
pyramidal neuron identity likely drive this similarity. However, Colgalt2 and Gprin3 cells 
show differences in gene expression that may contribute to differences in function. For 
instance, mitochondrial genes appear to be enriched in our Gprin3 population, perhaps 
because of the extra lengths of dendrites and axon that have to be energetically 
maintained in these cells. It would be interesting to see how the Lmo4 cKO that causes 
UL5b cells to develop an axonal projection to the spinal cord affects the expression 
level of these genes, and to determine what physiological differences in ATP-synthesis 
already exist between Colgalt2 and Gprin3 cells. 
Overall, we show that Colgalt2 and Gprin3 cells diverge in both laminar 
distribution and projection identity, with both cell types displaying different distributions 
across whole cortex. We confirm that UL5b Colgalt2 cells in M1 project to the pons, and 
that M1 LL5b Gprin3 cells innervate both the pons and the spinal cord. The spinal 
collaterals displayed by these anterior Gprin3 cells terminate on an intermediate 
population of neurons rather than on alpha motor neurons directly, and these terminals 
do not appear to participate in upper forelimb muscle control circuits, instead potentially 
influencing the control of anteromedial muscles, such as neck and shoulder, indirectly. 
Finally, Colgalt2 and Gprin3 cells show gene expression patterns that suggest that while 
these cells are very similar to each other, they show key differences that may 
corroborate their anatomical and functional uniqueness. 
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CHAPTER 3: 
Generating tractable models for studying cell-type vulnerability and resistance in 
the primary motor cortex of SOD1-G93A mice. 
Amyotrophic Lateral Sclerosis (ALS) is a fatal motor neuron disease that is 
clinically and pathologically defined by the loss of lower motor neurons (LMNs) of the 
spinal cord and upper motor neurons (UMNs) of the cortex (Tandan and Bradley, 1985). 
The cellular features that make these populations the most vulnerable to ALS-causing 
mutations are not known, and the pathways that ultimately lead to death of these two 
populations are likewise not entirely understood. To begin to uncover these 
mechanisms, LMNs have been primarily targeted, as they are readily identifiable among 
the diverse cell types of the spinal cord by their large size, unique morphology, and 
ventral localization (Aitken and Bridger, 1961; Light and Metz, 1978). In fact, many of 
the insights into disease pathology, mechanisms, and progression have thus far 
originated from studies of LMNs for this reason (see Turner and Talbot, 2008). UMNs of 
the primary motor cortex, by virtue of being localized among cells that are 
morphologically very similar and share many of the same markers, have proven more 
difficult to study with such rigor in the disease. To understand the full spectrum of cell 
type-specific pathology, and if effective therapies are ever to be developed, It is 
essential that the molecular responses of UMNs in disease be characterized in a 
targeted manner. 
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In mouse models of ALS that express human disease mutations in TDP-43 
(Wegorzewska et al., 2009), FUS (Verbeeck et al., 2012), and SOD1 (Gurney et al., 
1994a), have begun to provide insights into cortical pathologies in ALS (Huang et al., 
2011; Jara et al., 2015; Ozdinler et al., 2011; Tsai et al., 2010). Some of the most 
commonly used models leverage human mutants of Cu/Zn superoxide dismutase 1 
(SOD1) to recapitulate the disease in mice (Turner and Talbot, 2008). SOD1 is an key 
antioxidant enzyme that converts highly reactive superoxide, generated during 
biological processes such as electron transport in oxidative phosphorylation (Oxphos) 
and in the ER (Chance et al., 1979), into less reactive hydrogen peroxide (McCord and 
Fridovich, 1969). The most studied mutation to SOD1 is a glycine-to-alanine missense 
mutation at the 93rd amino acid position, G93A. It is unclear how the SOD1-G93A 
mutation causes disease. At the structural level, the G93A mutation causes the Cu/Zn 
binding regions of the protein appear to be more disordered, potentially encouraging 
aggregation of the protein (Galaleldeen et al., 2009). At the enzymatic level, the activity 
level of human SOD1-G93A appears to increase when expressed in mice (Gurney et al., 
1994a), but it is unclear whether this is true in patients with SOD1 mutations 
(Robberecht et al., 1994). The SOD1-G93A transgenic mouse line, 
Tg(SOD1*G93A)1Gur, that expresses ~25 copies of human mutant SOD1-G93A on 
chromosome 12 and shows disease progression and progressive motor deficits that are 
characteristic of human ALS (Chiu et al., 1995). More importantly, it has been shown 
that in addition to spinal motor neurons, neurons in L5b of M1 appear to degenerate in 
this model, with the spinal-projecting subpopulation of these cells appearing to be the 
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most vulnerable (Kassa et al., 2009; Ozdinler et al., 2011; Spalloni et al., 2011; Zang 
and Cheema, 2002). These cells additionally show early signs of disease in the form of 
ER stress, dendritic atrophy, and changes in excitability (Fogarty et al., 2015; Jara et al., 
2015; 2012; Kim et al., 2017; Spalloni et al., 2011). But how mutant SOD1 disrupts 
cellular function and leads to death of these neurons is largely not known. Likewise, it is 
not understood how, even with ubiquitous expression of mutant SOD1, death is specific 
to motor neurons. For this reason, having molecular access to the specifically 
vulnerable population of UMNs would allow us to probe the causal changes that lead to 
downstream pathophysiology, as well as the underlying properties that may be exploited 
by the mutation to cause cell-type specific death. 
 The vulnerable population of cortical neurons has been shown to reside in L5b of 
M1 across species (Eisen et al., 1992; Kassa et al., 2009; Mochizuki et al., 2011; 
Ozdinler et al., 2011; Spalloni et al., 2011; Tandan and Bradley, 1985; Zang and 
Cheema, 2002), but it has not been determined whether there is a sublayer specificity to 
this vulnerability, i.e. whether the degenerating cells reside in UL5b, LL5b, or across all 
of L5b. Our Colgalt2 and Gprin3-TRAP lines are therefore ideally suited to first 
determine the sublayer specificity of ALS UMN vulnerability, and then to molecularly 
profile the vulnerable cells during disease progression. We therefore set out to generate 
mice that express our L5b-specific TRAP constructs in the SOD1-G93A mouse. By 
visualizing Colgalt2 and Gprin3 cells during disease progression, we determined 
whether they degenerate in this ALS model, laying the foundation for carrying out 
assessments of cell type-specific gene expression changes in disease. 
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3.1 Breeding SOD1-G93A mice to Colgalt2 and Gprin3-TRAP mice does not 
disrupt disease progression. 
In order to generate an ALS model that would provide us with molecular access to 
L5b cells, we crossed the SOD1-G93A mouse to our Colgalt2-TRAP DU9 and Gprin3-
TRAP ES152 mice. To confirm that crossing these mice to SOD1-G93A does not impair 
or alter disease progression, we evaluated the general behavior and symptom 
development of SOD1-G93A mice expressing either Colgalt2-TRAP or Gprin3-TRAP. 
Both Colgalt2 and Gprin3 mice crossed to SOD1-G93A showed no differences in 
survival compared to uncrossed SOD1-G93A mice (Figure 3.1A). Median survival age 
was approximately 160 days for all mice, consistent with published survival times for the 
SOD1-G93A model (Gurney et al., 1994a). Classically, the SOD1-G93A mouse begins 
showing signs of disease around post-natal day 60 (P60). Hindlimb tremors and rigidity 
appear first, followed by hindlimb weakness that progresses rostrally toward the 
forelimbs. These gross symptoms were observed at similar ages in our SOD1-G93A 
mice crossed to our TRAP lines, suggesting that disease progression in our transgenic 
mice was not affected. For a more quantitative assessment of disease progression, we 
tested the performance of our crossed mice on an accelerating rotating rod (rotarod 
test). Both Colgalt2 and Gprin3 mice crossed to SOD1-G93A showed progressively 
shorter latencies to fall off the rotarod, with disease mice falling after ~100 seconds 
(Figure 3.1B-C). These deficits are consistent with the disease progression observed in 
the SOD1-G93A model that is not crossed to TRAP lines, with rotarod performance 
deficits appearing around P90 (Oliván et al., 2015). Taken together, these data show 














































































Figure 3.1: Expression of EGFP-L10a in Colgalt2 and Gprin3 mice does not alter the 
progression of disease in a SOD1-G93A context. (A) Survival curves showing the 
lifespan of SOD1-G93A mice, both uncrossed, and when crossed to either 
Colgalt2-TRAP DU9 or Gprin3-TRAP ES152 mice. Expression of the TRAP construct in 
either Colgalt2 or Gprin3 mice has no effect on survival. SOD1-G93A median survival = 
163 (n = 8), Colgalt2-TRAP::SOD1-G93A median survival = 158 (n = 7) 
Gprin3-TRAP::SOD1-G93A median survival = 164 (n = 5). (B) Rotarod performance of 
Colgalt2-TRAP mice, WT vs. SOD-crossed, measured as latency to fall in seconds. 
Colgalt2 mice that express SOD1-G93A show a shorter latency to fall in later weeks 
relative to WT littermates, suggesting they develop a motor deficit over disease 
progression. Data presented as mean±SEM (WT group n = 4, SOD group n = 3). (C) 
Rotarod performance of Gprin3-TRAP mice, WT vs. SOD-crossed, measured as latency 
to fall in seconds. Gprin3 mice expressing SOD1-G93A also show a shorter latency to fall 
in later weeks when compared to WT littermates, highlighting a progressive motor deficit 




that the expression of the TRAP construct in the SOD1-G93A model, either under the 
control of the Colgalt2 or the Gprin3 promoter, does not affect disease progression, 
establishing these two lines as potentially useful for the characterization of cell type 
vulnerability and molecular responses of L5b cells when SOD1-G93A is expressed. 
3.2 Both Colgalt2 and Gprin3 mice show activated glial invasion when SOD1-
G93A is expressed. 
In order to confirm that our TRAP-crossed SOD1-G93A mice show hallmark signs 
of neurodegeneration in tissue, we first looked for signs of neuro-inflammation by 
staining for the activated astrocyte marker GFAP. Invasion of activated glia has been 
observed in ALS tissues, across spinal cord and cortex (Bruijn et al., 1997b; Jaarsma et 
al., 2000; Kassa et al., 2009; Ozdinler et al., 2011). We therefore cervical spinal cord at 
a symptomatic stage of disease (> P100) to confirm broad mutant SOD1-mediated 
inflammation, and cortical tissue to visualize possible neuroinflammation around 
Colgalt2 and Gprin3 cells. Coronal sections of cervical spinal cord and cortex were 
made and immunostained for GFAP, as well as markers for cell types of interest: either 
alpha motor neuron ChAT (spinal cord) or Colgalt2/Gprin3 GFP (cortex). Images of 
immunostaining were collected by confocal microscopy. In the spinal cord sections at 
this symptomatic stage, invasion of GFAP+ activated astrocytes can be readily seen 
around ChAT+ alpha motor neurons of the ventral horn when SOD1-G93A is expressed 
(Figure 3.2A). Staining for astrocytosis in the cortex revealed the presence of activated 








































Figure 3.2: GFAP-positive astrocytes invade L5b in Colgalt2 and Gprin3 mice that 
express SOD1-G93A. (A) Confocal images of WT and SOD1-G93A ventral horn of 
cervical spinal cord at the level of C6 at symptomatic age, stained for ChAT (green) to 
label alpha motor neurons and GFAP (red) to visualize activated astrocytes. In 
SOD1-G93A, GFAP signal is observed in this area, but ChAT+ neurons disappear as they 
degenerate (scale bar = 100µm). (B) Representative confocal images of Colgalt2 and 
Gprin3 cortex, WT vs. SOD1-G93A symptomatic age, cropped to highlight depth of 
labeled cell populations. Colgalt2 and Gprin3 cells labeled with GFP (green), and 
activated astrocytes labeled with GFAP (red). Activated astrocytes can be seen in L5 
around GFP+ cells in SOD1-G93A (scale bar = 100 µm). (C) Quantification of 
activated-astrocyte depth in WT and SOD TRAP cortex represented as a frequency 
distribution for percent depth from the pial surface. In SOD cortex, the presence of 
activated astrocytes in L5 appears to increase dramatically (WT group n = 3 animals, 86 
cells. SOD group n = 3 animals, 130 cells).
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(Figure 3.2B). The GFAP+ signal varied in depth, but was largely observed in L5, 
around the GFP+ TRAP cells (mean depth of GFAP+ cells at 54% from pia, Figure 
3.2C). These data confirm that our Colgalt2 and Gprin3 transgenic mice develop one 
classic sign of neurodegeneration around our cells of interest, further establishing M1 as 
an important region to anatomically and molecularly characterize during disease 
progression. 
 
3.3 Gprin3 cells are vulnerable to degeneration in SOD1-G93A, while Colgalt2 
neurons are resistant. 
 Since L5b cells of M1 with long-range subcortical projections appear to be the 
most vulnerable in SOD1-G93A mice (Ozdinler et al., 2011; Zang and Cheema, 2002), 
and because UL5b Colgalt2 and LL5b Gprin3 cells both have long-range projections to 
the pons and, in the case of Gprin3 neurons, to the spinal cord, we set out to determine 
if either or both Colgalt2 and Gprin3 cells show vulnerability when SOD1-G93A is 
expressed. In order to determine direct vulnerability of Colgalt2 and Gprin3 cells to 
SOD1-G93A, we collected coronal brain sections from pre-symptom onset (Pre, ~P70) 
stage and post-symptom onset/symptomatic (Post, ~P110) stage of disease, and 
counted the number of GFP+ cells in 20X fields of view (FOVs, Figure 3.3). Notably, 
Colgalt2 cells along the extent of M1 did not show a difference in number in mice 
expressing SOD1-G93A (Figure 3.4A). Gprin3 neurons, in contrast, showed a 
significant decrease in number of around 23% at symptomatic stage (Post) across all of 
M1. When cell counts were instead assessed for individual anatomical positions along 


















Figure 3.3: GFP staining reveals loss of Gprin3 cells in SOD1-G93A mice, but no 
loss of Colgalt2 cells. Representative confocal images from Colgalt2 and Gprin3 M1, in 
WT and SOD1-G93A showing 20X field-of-view that was used to assess density of GFP+ 
cells. Colgalt2 and Gprin3 cells were visualized by GFP staining (green). Images are 
shown for pre-symptomatic age (“Pre”) WT, Pre SOD1, and post-symptom onset age 
(“Post”) SOD1. A decreased density of GFP+ cells can be seen in symptomatic age 
Gprin3 M1 when SOD1-G93A is expressed (scale bars = 100 µm).
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Figure 3.4: Gprin3 cells are lost in SOD1-G93A mice, but Colgalt2 cells remain. (A) 
GFP+ cells per 20X field in Pre and Post age Colgalt2 M1 (upper panel) and Gprin3 M1 
(lower panel) between WT and SOD1-G93A, averaged across full AP extent of M1, and 
reported as percent of corresponding WT mean. No change in Colgalt2 cell number is 
observed at any stage of disease, whereas Gprin3 cells show a 23% decrease at 
symptomatic stage (*p < 0.05; bars show mean±SEM, Colgalt2 WT Pre n = 6, SOD Pre n 
= 7; Colgalt2 WT Post n = 4, SOD Post n = 5; Gprin3 WT Pre n = 8, SOD Pre n = 4; Gprin3 
WT Post n = 7, SOD Post n = 5). (B) GFP+ cells per 20X field in Pre and Post age 
Colglat2 M1 (upper plots) and Gprin3 M1 (lower plots), averaged per anatomical position 
along the AP axis of M1, and reported as percent of corresponding WT mean. Again, 
Colgalt2 cells show no change in number during disease progression, but Gprin3 cells 
show a decrease in posterior areas of M1 of ~55% (bars show mean±SEM, Colgalt2 WT 
Pre n = 5, SOD Pre n = 8; Colgalt2 WT Post n = 7, SOD Post n = 5; Gprin3 WT Pre n = 
8, SOD Pre n = 5; Gprin3 WT Post n = 7, SOD Post n = 5).
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the anterior-posterior axis of M1, we observed a greater, although non-significant, loss 
of Gprin3 cells (up to 55% decrease) at more posterior M1 coordinates, revealing a 
potential posterior-to-anterior axis for progressive loss of cells (Figure 3.4B). We did not 
observe a loss of Colgalt2 cells at any coordinate along this AP extent. This loss of 
Gprin3 neurons but not Colgalt2 neurons in the presence of SOD1-G93A confirms that 
spinal-projecting neurons of M1 L5b are the most vulnerable cortical population in this 
model. The greatest loss of Gprin3 cells was observed in more posterior regions of M1, 
suggesting that even within this cell type, there may be differential vulnerability to 
SOD1-G93A. The data also broadly implicate an intrinsic molecular difference between 
Colgalt2 and Gprin3 cells as potentially underlying the distinct sensitivity to mutant 
SOD1 observed between the two cell types. 
3.4 Discussion 
Cells of L5b in rodent M1 have been shown to be vulnerable in the SOD1-G93A 
mouse model (Ozdinler et al., 2011; Thomsen et al., 2014; Zang and Cheema, 2002). 
Using molecular marker staining and retrograde tracing from subcortical regions, a 
temporally progressive loss of L5b neurons is observed throughout disease. Here, we 
show that the vulnerability of neurons observed for L5b is specific to LL5b where Gprin3 
cells are found, with UL5b Colgalt2 neurons showing resistance to degeneration in 
SOD1-G93A mice (Figure 3.5). These findings confirm that corticospinal neurons of 
LL5b are likely the most vulnerable to SOD1-G93A insult. And by contrast, cells that 
have long-range projections to more proximal regions, such as the thalamus and pons, 














Figure 3.5: Summary of cell type-specific loss observed in L5b in SOD1-G93A mice. 
The We show that in SOD1-G93A mice, UL5b Colgalt2 cells (purple) do not degenerate, 
while LL5b Gprin3 cells (green) decrease in number. Invasion of activated astrocytes is 
also observed in L5b of these mice (red).
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show no obvious vulnerability to degeneration. The relationship between projection 
identity and disease vulnerability is still a very open question, however. And given the 
differences in motor circuit participation for UL5b and LL5b cells, it is not understood 
how loss of LL5b neurons in the ALS models affects the function of motor circuitry in 
these animals. ALS-associated motor dysfunction in the SOD1-G93A model begins in 
hindlimb regions and progresses in a posterior-to-anterior manner as the animal ages, 
eventually affecting forelimb, shoulder and neck muscle groups (Gurney et al., 1994a). 
Because Gprin3 cells are found in areas that functionally map to control of anterior 
muscle groups (see Chapter 2), it is possible that these cells are the last to be affected 
during disease progression. This could explain why we observe a posterior-to-anterior 
gradient of Gprin3 cell loss, as cells that map to more posterior muscle groups would be 
lost first. In this scenario, however, it would be unlikely that loss of Gprin3 has any 
obvious outward consequence to gross motor output. Instead, it is possible that loss of 
Gprin3 cells affects the more subtle aspects of motor control, namely preparation, 
learning, and execution of dexterous movement (Chen et al., 2017; Guo et al., 2015; 
Kawai et al., 2015; Ueno et al., 2018). Unfortunately, none of the behavioral tests that 
we carried out in this study fully parse the cortical contribution to motor control from the 
spinal contribution, and therefore do not address these possibilities. It would be 
interesting to determine whether there is a progressive change in the ability of the mice 
to carry out tasks that are specifically shown to depend on M1 input. It would 
additionally be interesting to specifically drive loss of cortical motor neurons via toxin or 
Cre-dependent ablation, to more carefully assay what effect, if any, loss of the cortical 
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component of the motor circuit, particularly for anterior muscle groups, has on functional 
motor output. 
It is not understood what mechanisms cause the loss of motor neurons in the 
spinal cord and cortex: two cell types that are distinct in regional localization, 
morphology, and molecular identity, but that nevertheless share a functional connection. 
Theories about a prion-like spread of disease between these two cell types have left 
many open questions (see Braak et al., 2013a; Münch et al., 2011; Polymenidou and 
Cleveland, 2011). Some experiments have been done to address a “dying-forward” 
hypothesis, where corticospinal neuron dysfunction promotes disease in the 
downstream alpha motor neurons of the spinal cord (Eisen et al., 1992). For instance, 
when mutant SOD1-G93A is knocked down in the cortex of ALS model rats, the 
degeneration of both upper and lower motor neurons is slowed (Thomsen et al., 2014). 
This suggests that the degeneration of lower motor neurons is at least tied to, and at 
most caused by, the degeneration of the upper motor neurons. In rodents, the 
innervation of UMNs onto LMNs is, as discussed previously, not direct and has an 
intermediate interneuron populations in between (Bourane et al., 2015; Hantman and 
Jessell, 2010; Ueno et al., 2018). How this interneuron population responds to disease 
in the context of dying-forward from the cortex is not known, but is key to understanding 
the mechanism by which disease is “transmitted” downstream. In humans, a direct 
projection between a subset of corticospinal neurons and alpha motor neurons spinal 
cord provides a better foundation for a direct propagation of disease between upper and 
lower motor neurons. For instance, hyperexcitability observed in motor cortex could 
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drive stress in alpha motor neurons, which may promote death of the cells (Menon et al., 
2015; Vucic and Kiernan, 2006; Vucic et al., 2008). For these reasons, carefully 
assessing the point of origin of disease using cell-type specific ablations or more 
targeted expression of SOD1-G93A becomes important for understanding how this 
disease is able to affect two distinct cell types. Additionally, mechanisms of disease 
propagation would make very good targets for therapeutic intervention for halting or 
slowing of progression, as long as these molecular mechanisms can be said to reflect 
human disease pathology.  
For any study that attempts to uncover innate biological properties of neurons using 
transgenic mouse lines, it is important to discuss the limitations in interpreting the 
findings. As a model for ALS, the SOD1-G93A mouse shows the loss of upper and 
lower motor neurons (UMNs and LMNs) that exemplifies the human disease. However 
there are some who question the representative capacity of the SOD1-G93A mouse for 
human ALS (Turner et al., 2013). This primarily derives from an inability to translate 
treatments that successfully slow disease progression in the mouse model into human 
patients (Benatar, 2007). Additionally, SOD1 models do not recapitulate all cellular 
pathologies observed in human patients, such as TDP-43 inclusions (Robertson et al., 
2007). And while this may be explained in part by the fact that the model overexpresses 
mutant SOD1 at extremely high levels, it is possible that any changes that we observe 
in our SOD1-G93A experiments are not representative of changes that occur in human 
UMNs in ALS. This uncertainty cannot be resolved until a validation of mechanisms 
observed in this mouse model is undertaken in human tissues in the future. However, it 
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is important to remember, that while the pathological mechanisms that lead to cell death 
may not be similar in ALS across species, the selective vulnerability of motor neurons is 
still observed in the SOD1-G93A mouse. The model therefore still provides an important 
and useful platform for studying motor neuron-specific vulnerability to certain genetic 
perturbations, and its associated molecular changes across cell types. 
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CHAPTER 4: 
Molecular responses to SOD1-G93A observed by TRAP in Colgalt2 and Gprin3 
neurons. 
Studies into molecular mechanisms of neurodegeneration focus primarily on 
understanding what pathways lead to cell-specific dysfunction and death. In particular, 
the goal is to understand how ubiquitously expressed mutations leverage unique cell 
type features during disease progression. In ALS, it is not known how expression of 
mutant SOD1 in the whole CNS causes specific death of UMNs in the cortex and LMNs 
in the spinal cord. A first step in understanding this phenomenon is characterizing the 
molecular changes that occur in these cells during disease. Neuronal dysfunction 
phenotypes, such as hyperexcitability and dendritic atrophy in UMNs, are now being 
uncovered in models of ALS (Fogarty et al., 2015; Genç et al., 2017; Jara et al., 2015; 
Kim et al., 2017; Ozdinler et al., 2011; Saba et al., 2015; Wegorzewska et al., 2009). 
Using a variety of sequencing approaches, the field has also begun to understand how 
gene expression changes that occur during disease progression may contribute to the 
phenotypes that precede cell death in the mutant SOD1 context (Bandyopadhyay et al., 
2013; de Oliveira et al., 2013; 2014; Malaspina et al., 2001; Saxena et al., 2009; Sun et 
al., 2015). These studies have shown that underlying the gross neuronal changes are 
early signs of ER stress, unfolded protein response, and mitochondrial dysfunction. But 
because it is not trivial to isolate specific neuron populations from each other in this 
model (although see Saxena et al., 2009), it has been difficult to determine whether 
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these changes occur specifically in the vulnerable population or in the assayed tissues 
as a whole. Developing successful treatments or therapies for ALS will require us to 
determine the disease phenotypes that are specific to motor neurons over other cell 
types, and by contrast, the molecular coping mechanisms of cell types that are resistant 
to degeneration. 
Despite being molecularly similar to disease-vulnerable LL5b Gprin3 (Chapter 2), 
our UL5b Colgalt2 cells did not appear to degenerate in the SOD1-G93A model 
(Chapter 3). From a disease mechanism standpoint, this presents a unique opportunity 
to study what specific disease-triggered gene expression changes in Gprin3 cells may 
lead to their selective degeneration. And more importantly, having molecular access to 
Colgalt2 gene expression allows us to interrogate potential coping strategies for 
surviving mutant SOD1 expression. Understanding these changes could then lead us to 
probe how the underlying intrinsic differences between these two cell types may 
contribute to their respective molecular responses, and inevitably cause specific 
vulnerability of one population over the other. 
We therefore set out to determine what gene expression changes occur in 
Colgalt2 and Gprin3 during disease progression by performing TRAP at two different 
time points in SOD1-G93A animals. An early pre-symptomatic time point was assayed 
in order to reveal potential early regulatory mechanisms of later stage dysfunction. A 
symptomatic time point was collected to determine how late disease mechanisms may 
lead to death of LL5b Gprin3 cells, and survival of UL5b Colgalt2 cells. We then 
attempted to compare the findings from these disease datasets to results from our 
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original comparison of intrisinic cell type differences in an effort to understand how the 
disease-sensitive mechanisms differ between the two cell types to begin with. 
 
4.1 Isolating mRNA from Colgalt2 and Gprin3 cells expressing SOD1-G93A. 
 When Colgalt2 and Gprin3 mice are crossed to SOD1-G93A, only a loss of LL5b 
Gprin3 neurons is observed. In order to understand what cell-type specific gene 
expression changes occur in these two distinct cell types in SOD1-G93A mice, we 
performed TRAP in our crossed mice. We isolated mRNAs from both healthy and 
diseased Colgalt2 and Gprin3 cells at two time points: pre-symptom onset (“Pre”, ~P70), 
and post-symptom onset (“Post”, ~P110; Figure 4.1). After sequencing 
immunoprecipitated (IP’ed) mRNAs, we first wanted to confirm that samples in these 
cohorts were enriched for genes that we knew from previous Colgalt2 and Gprin3 TRAP 
samples to be cell-type specific. We broadly assessed expression of these cell-type 
genes using aligned reads visualized in IGV viewer. Colgalt2 disease cohort samples 
shared expression profiles with benchmark Colgalt2 sample across cell type-specific 
genes such as Ctip2, Fezf2, Colgalt2, Tmem200a, Fam84b, and Kcng1 (Figure 4.2A). 
They additionally showed lower levels of expression for astrocyte genes highly 
expressed in the Aldh1l1 TRAP line. Gprin3 disease cohort samples in turn shared 
expression profiles for Gprin3 marker such as, Crabp1, Klhl1, Rasgrp2, and Ctip2, and 
were also depleted for astrocyte markers (Figure 4.2B). Additionally, replicate samples 
for each cell type were highly correlated with each other in whole genome expression 
profiles by Pearson correlation (Figure 4.2C). Together, these gene expression patterns  
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Figure 4.1: Summary of all TRAP IP samples from Colgalt2 and Gprin3 ALS cohorts. 
(A-B) Schematic illustrations showing approximate M1 location of cell types interest for 
RNA-Seq in the SOD1-G93A model. Accompanying tables indicate what samples were 
collected and named for each timepoint of healthy (control, WT) and disease (SOD) 
conditions. (A) The pre-symptomatic “Pre” timepoint (~P70) samples for Colgalt2 cells 
were named for “Colgalt2 WT Pre” (light grey) and “Colgalt2 SOD Pre” (light blue) for 
healthy and disease conditions respectively. Symptomatic “Post” timepoint (~P110) 
samples for Colgalt2 cells were called “Colgalt2 WT Post” (dark grey) and “Colgalt2 SOD 
Post” (blue) for control and disease conditions respectively. (B) The pre-symptomatic 
“Pre” timepoint (~P70) samples for Gprin3 cells were called for “Gprin3 WT Pre” (light 
grey) and “Gprin3 SOD Pre” (light blue) for healthy and disease conditions respectively. 
Symptomatic “Post” timepoint (~P110) samples for Gprin3 cells were named “Gprin3 WT 
Post” (dark grey) and “Gprin3 SOD Post” (blue) for control and disease conditions 
respectively.
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Cell type gene expression from disease cohort IP’s - Colgalt2


















































































































































































































Figure 4.2: Colgalt2 and Gprin3 TRAP IP samples from ALS cohorts show 
expression of benchmark cell type-specific genes. (A-B) IGV Tracks showing aligned 
reads from RNA-Seq samples. (A) Colgalt2 WT Pre (light grey), SOD Pre (light blue), WT 
Post (dark grey), and SOD Post (blue) samples appear to match expression patterns for 
the selected genes (black box) that are enriched in the benchmark Colgalt2 replicates 
(purple). Additionally, the cells appear to be depleted for Aldh1l1 astrocyte marker genes 
relative to the astrocyte cell type (red). Gprin3 benchmark samples (green) and whole 
cortex input samples (black) are also shown. (B) Gprin3 WT Pre (light grey), SOD Pre 
(light blue), WT Post (dark grey), and SOD Post (blue) samples appear to match 
expression patterns for the selected genes (black box) that are enriched in the 
benchmark Gprin3 samples (green). Additionally, the cells appear to be depleted for 
astrocyte marker genes relative to the Aldh1l1 astrocyte samples (red). Colgalt2 
benchmark samples (purple) and whole cortex input samples (black) are also shown. 
Biological replicate tracks are overlaid to better show where reads aligned most 
consistently across replicate samples. (C) Heatmap of Pearson correlation values for 
different ALS cohort samples, compared to benchmark Colgalt2 and Gprin3 samples 




indicate that RNA isolations from our populations of interest were successful and could 
be used for assessment of gene expression changes in disease. 
4.2 Pre-symptomatic changes in gene expression in Colgalt2 and Gprin3 cells. 
Changes in gene expression that precede cell loss can provide some insight into 
the mechanisms that lead to the initiation of cell death mechanisms. For this reason, we 
wanted to determine what changes occur in the degeneration-resistant Colgalt2 and 
vulnerable Gprin3 populations at the “Pre” disease stage in the SOD1-G93A context. 
We performed differential expression (DE) analysis between healthy and SOD1-G93A 
TRAP samples using DESeq2 with default parameters. We found that no gene fold-
changes met statistical significance when the Benjamini-Hochberg-adjusted p-values 
were used to disprove the null hypothesis. For this reason, we opted to use the un-
adjusted p-values (determined by Wald test in DESeq2; Love et al., 2014) as a more 
subjective measure of potential biological significance. This provided us with more 
genes to interrogate in later analyses and experiments, at the expense of potentially 
increased Type I, or false positive, error.  We generated lists of genes that were up- or 
down-regulated in SOD1-G93A animals relative to healthy animals at this pre-
symptomatic time point (by un-adjusted p < 0.05). In Colgalt2 cells, we observed 219 
genes that were differentially expressed in SOD1-G93A. 128 genes were up-regulated, 
with 91 down-regulated (Figure 4.3A). Gene ontology (GO) enrichment analysis was 
performed using Metascape (Zhou et al., 2019) on these changed genes to determine 
groups and classes of genes that may be regulated in response to SOD1-G93A 
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Figure 4.3: Pre-symptomatic Colgalt2 samples reveal early changes in gene 
expression in UL5b cells in response to SOD1-G93A. (A) MA scatter plot showing all 
genes plotted by average Log10 counts per million (CPM; x-axis), and Log2 fold change 
(FC; y-axis) in SOD (n = 2 replicates) relative to WT (n = 3 replicates) by differential 
expression (DE) analysis. Grey dots represent individual genes, with genes that were 
significantly (unadjusted p-value < 0.05) up-regulated in SOD colored light orange, and 
down-regulated colored in light blue. (B) Bar plots show gene ontology (GO) categories 
of genes that were significantly enriched among the genes that showed significant up- or 
down- regulation by DE analysis. Categories found in up-regualted genes (left, light 
orange) were primarily ribosomal. Down-regulated genes (right, light blue) included 
nucleotide binding genes. Bars represent Log10 p-values from GO enrichment analysis.
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expression (Figure 4.3B). P-values for enriched GO categories were calculated by 
Metascape using the hypergeometric test and Bejamini-Hochberg correction. Ribosomal 
categories were enriched among up-regulated genes, suggesting that there may be 
increased translation in Colgalt2 cells during early stages of disease. GO categories 
enriched among down-regulated genes included cytoskeletal genes, implicating 
potential early morphological rearrangement in UL5b cells. 
At this pre-symptomatic stage, Gprin3 cells showed differential regulation of 140 
genes: 61 were up-regulated and 79 were down-regulated with SOD1-G93A expression 
(Figure 4.4A). GO analysis revealed that categories associated with ion transport were 
significantly enriched among the genes up-regulated in Gprin3 cells expressing SOD1-
G93A (Figure 4.4B). This could indicate early changes in excitability in these cells. To 
further implicate this mechanism, the ion transport category was also enriched among 
down-regulated Gprin3 genes at this early time point. Early changes in gene expression 
could underlie later stage disease mechanisms, but how the changes that we observe 
here affect disease progression is something that needs to be further investigated. 
4.3 Symptomatic changes in gene expression in Colgalt2 and Gprin3 cells reveal 
opposing molecular responses to SOD1-G93A expression. 
To elucidate mechanisms that are differentially regulated during symptomatic 
stages of disease, we performed differential gene expression analysis between WT and 
SOD1-G93A at “Post” stage, for both Colgalt2 and Gprin3. Because Colgalt2 cells are 
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Figure 4.4: Pre-symptomatic Gprin3 samples reveal early changes in gene 
expression in LL5b cells in response to SOD1-G93A. (A) MA scatter plot showing all 
genes plotted by average Log10 counts per million (CPM; x-axis), and Log2 fold change 
(FC; y-axis) in SOD (n = 3 replicates) relative to WT (n = 2 replicates) by differential 
expression (DE) analysis. Grey dots represent individual genes, with genes that were 
significantly (unadjusted p-value < 0.05) up-regulated in SOD colored light orange, and 
down-regulated colored in light blue. (B) Bar plots show gene ontology (GO) categories 
of genes that were significantly enriched among the genes that showed significant up- or 
down- regulation by DE analysis. Categories found in up-regualted genes (left, light 
orange) included transcription-associated genes. Down-regulated genes (right, light blue) 




molecular strategies for successfully coping with mutant SOD1 expression. In Colgalt2 
cells, many more genes were significantly regulated (un-adjusted p < 0.05) between WT 
and SOD1-G93A at this stage compared to the “Pre” stage. 1076 showed significant 
changes in gene expression in SOD: 628 showing an up-regulation and 448 showing a 
down-regulation. For GO analysis, we selected genes that had a mean Log10 CPM 
expression value ≥ 2.5 to limit analysis to highly expressed genes whose modulation 
may have more functional consequence to the cells (Figure 4.5A). GO categories that 
were enriched in up-regulated genes were associated with oxidative phosphorylation 
(Oxphos) and translation (Figure 4.5B). The Oxphos gene category included Atp5l, 
Ndufa4, and Cox6b1, from separate components of the electron transport chain (ETC). 
Categories that were enriched among down-regulated genes in Colgalt2 cells at “Post” 
stage appeared to primarily be associated with maintaining DNA integrity. Together, 
these patterns suggest that Colgalt2 cells may be increasing their levels of respiration 
while dampening a response to DNA damage and transcription. To understand whether 
these changes were specific to resistant Colgalt2 cells, we assessed whether the genes 
that showed significant up- or down-regulation in Colgalt2 cells were similarly changed 
in Gprin3. We compared the directionality of WT vs. SOD LogFCs for these genes 
between the two cell types (Figure 4.5C). Very few of the genes that were significantly 
changed in Colgalt2 cells were similarly modulated in Gprin3 cells, with many genes 
even showing an opposing change in these cells. This finding suggests that the gene 
expression changes occurring in Colgalt2 cells at the symptomatic stage are specific to 
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Figure 4.5: Symptomatic Colgalt2 samples reveal late changes in gene expression 
in resistant UL5b cells in response to SOD1-G93A. (A) MA scatter plot showing all 
genes plotted by average Log10 counts per million (CPM; x-axis), and Log2 fold change 
(FC; y-axis) in SOD (n = 3 replicates) relative to WT (n = 2 replicates) by differential 
expression (DE) analysis. Grey dots represent individual genes, with genes that were 
highly expressed (CPM > 2.5) and significantly (unadjusted p-value < 0.05) up-regulated 
in SOD colored dark orange, and down-regulated colored in blue. (B) Bar plots show 
gene ontology (GO) categories of genes that were significantly enriched among the 
genes that showed significant up- or down- regulation by DE analysis. Categories found 
in up-regualted genes (left, dark orange) included ribosomal and mitochondrial genes. 
Down-regulated genes (right, blue) included DNA-associated genes. Bars represent 
Log10 p-values from GO enrichment analysis. (C) Heatmap shows the fold-change 
values of genes that showed significant change in disease in Colgalt2 cells, juxtaposed 
with the fold-change values for the same genes from DE analysis in Gprin3 cells. Genes 
changed in disease in Colgalt2 cells did not generally show the same directionality or 
magnitude of change in Gprin3 cells in SOD, suggesting contrasting changes in response 
to SOD1-G93A between Colgalt2 and Gprin3 cells.
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Gprin3 cells showed  620 significantly (un-adjusted p < 0.05) regulated genes in 
disease: 381 up-regulated and 239 down-regulated genes. For performing GO analysis, 
we once again selected genes that showed base mean Log10 CPM of ≥ 2.5, to enrich 
for highly expressed genes (Figure 4.6A). GO categories enriched for up-regulated 
genes in Gprin3 cells were primarily centered around neuronal functions and behavior 
(Figure 4.6B). Surprisingly, and in contrast to Colgalt2 cells, one of the categories that 
appeared enriched among down-regulated genes in Gprin3 cells was the Oxphos 
category, which included Cox5b, Ndufc1, and Atp5e. Again, to determine the cell-type 
specificity of these changes, we compared the LogFC directionality of significantly 
changed genes from Gprin3 cells to LogFCs from “Post” DE in Colgalt2 cells. We found 
that genes changed in “Post” Gprin3 cells rarely showed the same directionality of 
change in Colgalt2 cells in disease (Figure 4.6C), suggesting that the changes observed 
in Gprin3 cells are specific to this vulnerable LL5b cell type. A down-regulation of 
Oxphos genes in Gprin3 cells at this disease time point, contrasting the up-regulation of 
the same class of genes in Colgalt2, additionally suggests that depending on the 
directionality, modulating respiration during disease may have different consequences 
to cell survival. 
4.4 Oxidative phosphorylation genes are differentially regulated in SOD1-G93A 
between Colgalt2 and Gprin3 cells. 
Oxphos genes appeared to be up-regulated in Colgalt2 cells and down-regulated 
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Figure 4.6: Symptomatic Gprin3 samples reveal late changes in gene expression in 
vulnerable LL5b cells in response to SOD1-G93A. (A) MA scatter plot showing all 
genes plotted by average Log10 counts per million (CPM; x-axis), and Log2 fold change 
(FC; y-axis) in SOD (n = 3 replicates) relative to WT (n = 3 replicates) by differential 
expression (DE) analysis. Grey dots represent individual genes, with genes that were 
highly expressed (CPM > 2.5) and significantly (unadjusted p-value < 0.05) up-regulated 
in SOD colored dark orange, and down-regulated colored in blue. (B) Bar plots show 
gene ontology (GO) categories of genes that were significantly enriched among the 
genes that showed significant up- or down- regulation by DE analysis. Categories found 
in up-regualted genes (left, dark orange) were of varying subcellular association. 
Down-regulated genes (right, blue) notably included mitochondrial genes. Bars represent 
Log10 p-values from GO enrichment analysis. (C) Heatmap shows the fold-change 
values of genes that showed significant change in disease in Gprin3 cells, juxtaposed 
with the fold-change values for the same genes from DE analysis in Colgalt2 cells. Genes 
changed in disease in Gprin3 cells did not generally show the same directionality or 
magnitude of change in Colgalt2 cells in SOD, once again suggesting contrasting 
changes in response to SOD1-G93A between the two cell types.
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if these changes reflected a broader change in whole mitochondrial gene expression. 
We plotted individual LogFCs from “Pre” and “Post” disease DE in Colgalt2 and Gprin3 
cells for different functional classes of mitochondrial genes, such as citric acid cycle 
(TCA) genes and antioxidant genes (Figure 4.7A). In Colgalt2 cells, Oxphos genes 
showed a particularly high proportion of significantly changed genes for “Post” stage 
DE, though most functional groups of mitochondrial genes appeared to skew towards 
up-regulated. And while fewer genes were significantly changed in Gprin3 cells at the 
“Post” time point, there were several significantly changed genes in the Oxphos 
category, with the median LogFC (black bar) for Oxphos genes indicating a general 
down-regulation of this category (Figure 4.7B). 
We next validated these TRAP findings by performing qPCR on a subset of 
representative mitochondrial genes from Colgalt2 and Gprin3 ALS cohort cDNA 
libraries. Assayed genes were chosen from differentially expressed genes from either 
Colgalt2 or Gprin3 disease DE to represent either a subunit of the ETC, or a particular 
functional pathway. We quantified differences in the expression of these genes between 
conditions using the comparative cycle time (CT) method (ddCT) normalizing to Actb 
and Gapdh expression in each condition. P-values were calculated by two-tailed t-test 
on dCT replicate values between WT and SOD conditions. Colgalt2 cells showed an 
increased level of mitochondrial transcripts in disease relative to WT across many of the 
mitochondrial genes tested, especially at the “Post” disease time point (Figure 4.8A), 
although most of these differences were not significant. Gprin3 cells showed a slightly 


































































































Figure 4.7: Between Colgalt2 and Gprin3 cells, mitochondrial genes show 
contrasting changes in gene expression in response to SOD1-G93A. (A-B) 
Scatterplots showing the Log2 fold-change in SOD relative to WT by RNA-Seq DE 
analysis for different functional categories of mitochondrial genes. Plots are shown for 
“Pre” DE fold-changes (light blue, upper panel) and “Post” DE fold-changes (blue, lower 
panel). Genes that showed a significant change (unadjusted p-value < 0.05) are colored 
in red. (A) Log2 fold-change scatterplots show that Oxphos genes are up-regulated in 
Colgalt2 cells during disease progression, along with mitochondrial genes from other 
functional groups. (B) Log2 fold-change scatterplots reveal that, in contrast to Colgalt2 
cells, several Oxphos genes are down-regulated in symptomatic Gprin3 cells. A small 
subset of other mitochondrial genes also show down-regulation at this disease stage. 
Black bars indicate median values for each category.
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B Gprin3 - Mito gene fold changes by qPCR







































































































Figure 4.8: qPCR for mitochondrial genes confirm contrasting changes in gene 
expression for disease Colgalt2 and Gprin3 cells. (A-B) Colgalt2 and Gprin3 qPCR 
Log2 fold-change data for different mitochondrial genes at “Pre” (light blue bars) and 
“Post” (blue) stages. Values were calculated by ddCT between SOD and WT. Actb and 
Gapdh were used as housekeeping gene controls (bars show mean ± SEM). (A) In 
Colgalt2 cells, genes associated with Oxphos (left) and appear to be increased in 
expression in SOD relative to WT. Other mitochondrial genes (right) also appear to be 
up-regulated in SOD. (B) In Gprin3 cells, Oxphos genes appear to be down-regulated in 
SOD samples at the “Post” disease stage, while other mitochondrial genes don’t appear
to change (* p < 0.05 by two-tailed t-test of dCT values).
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4.8B), but did not show similar decreases for other non-Oxphos mitochondrial genes. 
Again, the majority of these differences were not statistically significant. These data 
partly confirm the changes in Oxphos gene expression that we observed by TRAP, and 
indicate that among all functional groups of mitochondrial genes, Oxphos genes appear 
to be the most strongly targeted for gene expression modulation, particularly in the 
vulnerable LL5b population. 
4.5 Oxphos genes that show expression changes in SOD1-G93A are differentially 
expressed between healthy Colgalt2 and Gprin3 cells. 
Because we observed contrasting regulation of Oxphos genes in Colgalt2 and 
Gprin3 cells during disease, we wanted to understand how the baseline expression 
levels of these genes in healthy Colgalt2 and Gprin3 cells may contribute or predispose 
to the changes we observe during disease. We first plotted the Log2 fold-enrichment 
from Gprin3 vs. Colgalt2 TRAP DE for the different functional groups of mitochondrial 
genes (Figure 4.9A). Consistent with the GO analysis discussed previously (Chapter 2), 
many of the functional categories of mitochondrial genes, including Oxphos, showed 
genes that were enriched in Gprin3 cells. To confirm these TRAP results, we performed 
qPCR on Colgalt2 and Gprin3 cDNA libraries, for a representative subset of 
mitochondrial genes (Figure 4.9B). P-values were calculated from dCT values using 
two-tailed t-test. Oxphos genes appeared to be enriched in Gprin3 cells over Colgalt2 
cells, anywhere between 1-fold and 3-fold (log2), although only Atp5g3 and Sod1 

















































































































Enrichment of mitochondrial genes in Gprin3 over Colgalt2 by TRAP
Figure 4.9: Mitochondrial genes, including Oxphos genes, are enriched in Gprin3 
cells relative to Colgalt2 cells. (A) Scatterplots showing Log2 fold-enrichment from 
Gprin3 vs. Colgalt2 DE for different functional groups of mitochondrial genes. Individual 
green dots represent single genes. Red dots indicate genes that were significantly 
enriched. (B) Bar graph shows the Log2 fold-enrichment of different mitochondrial genes 
in Gprin3 cells relative to Colgalt2 cells by qPCR. Enrichment was calculated by ddCT, 
using Actb and Gapdh as housekeeping gene controls. Genes associated with Oxphos 
(shown on the left) appear to be enriched in Gprin3 cells (green bars). Other 
mitochondrial genes do not consistently show the same level of enrichment in Gprin3 
cells, however. Purple bar shows where genes were enriched in Colgalt2 cells (bars show 
mean ± SEM; * p < 0.05 by two-tailed t-test of dCT values).
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enrichment between the two cell types. These findings leave open the question of how 
underlying differences in mitochondrial gene expression may contribute to selective 
vulnerability to mutant SOD1, an enzyme closely tied to mitochondrial function. 
Experiments to address the functional connection between levels of mitochondrial gene 
expression and mitochondrial biology in these neurons, particularly in the context of 
SOD1-G93A, should be carried out to answer this question. 
4.6 A respiratory transcription factor is differentially expressed between Colgalt2 
and Gprin3 neurons. 
We next wanted understand how the genes that are up- or down-regulated in 
disease may be modulated by upstream transcriptional regulation mechanisms. We 
performed HOMER TF Motif analysis, which searches the sequences found upstream of 
a set of genes of interest to determine if they share any TF binding motifs, and by 
extension, regulatory TFs. We performed this analysis on the cohort of genes that were 
significantly changed in “Post” disease in our two cell types. These analyses revealed 
several canonical TF binding motifs for these genes (Figure 4.10A). To understand how 
these TFs may contribute to the cell-type specific disease changes that we observe, we 
then set out to determine whether the TFs associated with these motifs showed 
differential expression between healthy Colgalt2 and Gprin3 cells. TFs for further 
analysis were selected if their associated motif was enriched in a statistically significant 
way (p < 0.05) in motif analysis above. We assessed relative expression values (z-
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Figure 4.10: Transcription factor motif analysis reveals motifs and factors 
associated with genes that change in disease. (A) Examples of HOMER transcription 
factor (TF) motifs that were enriched among the genes that were up- (bottom row) or 
down-regulated (top row) during “Post” disease stage in Colgalt2 cells (left column) and 
Gprin3 cells (right column). (B) Heatmap showing z-scores of Colgalt2 and Gprin3 WT 
Pre relative gene expression values of TFs that were enriched by HOMER TF motif 
enrichment analysis. Several TFs appear to be differentially expressed between Colgalt2 
and Gprin3 cells at this age. Of note, Nrf1, a TF that is key to mitochondrial biogenesis 
appears to be expressed more highly in Gprin3 cells. Annotation above the heatmap 
indicates whether the TF motif came from Colgalt2 disease genes (purple), Gprin3 
disease genes (green), or was seen in both (yellow).
85
86 
many of these TFs show differential levels of expression between these two cell types 
(Figure 4.10B). Notably, Nuclear Respiration Factor 1 (Nrf1), a TF important in the 
regulation of expression of genes associated with ETC and Oxphos, showed higher 
levels of expression in Gprin3 cells relative to Colgalt2 cells. These TF motif analyses 
suggest that distinct changes in gene expression may be influenced by differential 
expression of upstream factors across these two cell types, but more data are needed 
to understand whether there is a causal link between these two findings. 
4.7 Discussion 
The mutations that cause neurodegenerative disease are often found on genes 
that are ubiquitously expressed, but death is typically only observed for specific cell 
types. For many neurodegenerative diseases, it is not known how these mutations 
trigger the cell-type specific molecular responses that inevitably lead to death. Our 
Colgalt2 and Gprin3 lines present us with a unique opportunity to understand how the 
SOD1-G93A mutation molecularly affects two related but distinct L5b cell types, where 
one shows vulnerability and the other resistance to degeneration in this model. Through 
TRAP and RNA-Seq, we show that two distinct populations of L5b cells regulate the 
expression of different classes of genes in the SOD1-G93A ALS model. In particular, it 
appears that these two cell types differentially regulate Oxphos gene expression (Figure 
4.11). The resistant UL5b Colgalt2 population shows an up-regulation of Oxphos genes, 
while the vulnerable LL5b Gprin3 population shows a down-regulation of these genes. 













Figure 4.11: Summary of TRAP and RNA-Seq findings from SOD1-G93A 
Colgalt2-TRAP and Gprin3-TRAP animals. Colgalt2 cells (purple) up-regulate Oxphos 
gene expression at a symptomatic stage of disease (left panel), while Gprin3 cells (green) 
appear to instead down-regulate Oxphos genes at this stage. In healthy brains, Gprin3 
cells show ~2.8x higher levels of Oxphos gene expression than Colgalt2 cells
87
88 
express Oxphos genes at higher levels than the closely-related resistant UL5b cell type, 
suggesting that there may be underlying differences in the levels of energetic demand 
of these cells, and that perhaps these differences contribute to differential sensitivity to 
SOD1-G93A overexpression. 
Mitochondrial dysfunction has been observed for many neurodegenerative 
diseases and their models (see Lin and Beal, 2006). In fact, changes in mitochondrial 
fission and fusion, as well as mitophagy are hallmarks of many neurodegenerative 
diseases (Bossy-Wetzel et al., 2003; Burté et al., 2015; Chen and Chan, 2009; Itoh et 
al., 2013; Knott et al., 2008). In models of ALS, many phenotypes associated with 
mitochondrial structure or function have been reported (Lopez-Gonzalez et al., 2016; Lu 
et al., 2012; Mattiazzi et al., 2002; Menzies et al., 2002; Vehviläinen et al., 2014). By 
gene expression analysis, changes in Oxphos gene expression can also be observed in 
disease (Bandyopadhyay et al., 2013; Olsen et al., 2002), which may manifest as 
changes in the protein composition of mitochondria in cells (Li et al., 2010). Additionally, 
a decrease in ETC enzyme activity can be observed in the spinal cord of human ALS 
patients (Borthwick et al., 1999; Wiedemann et al., 2002). However, many ETC and 
Oxphos genes are expressed throughout the body, leaving open the question of how a 
ubiquitously expressed disease mutation can cause cell type-specific mitochondrial 
dysfunction, and how cell-type specific features may affect the levels of gene 
expression for key cell biological pathways. 
Regulation of mitochondrial gene expression is influenced by many different 
functional signaling pathways in the cell. A principal effector of these signals is Pgc1a, 
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and the nuclear respiratory factors Nrf1 and Nrf2, which directly bind the promoters of 
metabolic genes to increase their expression (Scarpulla, 2011; Virbasius et al., 1993a; 
1993b; Wu et al., 1999). Homeostatic sensing mechanisms regulate the activation of 
these factors in an effort to maintain the levels of ATP production necessary for proper 
cellular functions. For neurons, this energetic tuning, as well as mitochondrial Ca2+ 
buffering, is essential for carrying out neuronal functions such as pre- and post-synaptic 
signaling, axon transport, and action potential propagation (Kann and Kovács, 2007; 
Zenisek and Matthews, 2000). SOD1-G93A overexpression is thought to cause many 
disruptions in neuronal function (see Geevasinga et al., 2016; Ilieva et al., 2009), but it 
is not known whether mitochondrial dysfunction is a direct result of mutant insult or 
indirectly caused by other disease pathologies. It is similarly not understood how the 
changes in mitochondrial gene expression commonly observed in neurodegenerative 
diseases lead to death or survival of cells. In our case, the resistant Colglat2 cells 
showed a striking up-regulation of Oxphos genes in disease. It is not clear whether this 
change represents a successful coping strategy for SOD1-G93A overexpression, or if it 
reflects a response to other cellular dysfunctions not measured here. It is likewise not 
clear whether a down-regulation of Oxphos genes in vulnerable Gprin3 cells is causal to 
death or merely a hallmark of general dysfunction caused by SOD1-G93A. Testing the 
causal relationship between mitochondrial gene expression changes and cellular 
pathologies would not be trivial, as regulating the abundance, localization, or function of 
an entire organelle requires very careful control over the many cellular mechanisms and 
factors, such as Pgc1a and Nrf1, that modulate its features. It is nevertheless essential 
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that this relationship be studied carefully to understand what role mitochondria play in 
cell-type specific vulnerability in disease. 
Our data additionally reveal that in the healthy brain, there appear to be underlying 
differences in mitochondrial gene expression between L5b cells. It is not known how 
different cellular properties and features influence the relative levels of mitochondrial 
gene expression that may differ from neuron type to neuron type. More specifically, why 
does a LL5b neuron express Oxphos genes at higher levels than an UL5b neuron? One 
possible explanation for this takes into consideration a difference in cell size due to 
differing lengths of axonal projections. Additional collaterals to long-range targets, such 
as the spinal cord, could require more ATP for active transport across their lengths. 
Another possible explanation considers that different neuron types within a region of 
cortex display different levels and patterns of activity as they process afferent input. This 
is dependent on the amount and type of signals they receive, as well the levels of 
downstream activity- ie. action potentials- they have to produce. In order to maintain 
active signaling in the neuron, levels of ATP and Ca2+ must be tightly regulated, in part 
by mitochondria (Kann and Kovács, 2007). But in order to understand the causal link 
between cellular function and dysfunction in the cell and changes in mitochondrial gene 
expression, the general neuronal properties listed above would need to be perturbed in 
a tightly regulated manner. For instance, if levels of Oxphos gene expression could be 
up- or down-regulated in our two cell types, we could begin to understand the effects of 
changes in mitochondrial gene expression on the regulation of cellular energetics. 
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One caveat to note from the TRAP findings of this study is that while we do 
observe many changes in gene expression due expression of mutant SOD1, we were 
surprised to find no changes in previously reported ER stress, unfolded protein 
response, or cell death gene expression in our datasets, across any time point we 
assayed. It is possible that these cellular mechanisms are activated in an extremely 
transient manner, and would require us to perform RNA-Seq with greater temporal 
resolution during disease progression. For the Gprin3 population, however, we 
additionally observe fewer changes in gene expression between SOD1 and WT overall. 
This may also be in part due to the heterogeneous timing of disease progression that 
we observe anatomically, where more posterior Gprin3 cells appear to be lost first in the 
disease. In a scenario where posterior Gprin3 cells are mixed with anterior Gprin3 cells 
when isolating RNA, the more advanced disease mechanisms would be diluted by the 
earlier responses, minimizing the appearance of both in the dataset. These molecular 
experiments should perhaps be repeated with a more careful anterior-posterior 
anatomical dissection for cellular isolation to assay the distinct “stages” of disease that 
may be occurring across the global Gprin3 population. Nevertheless, the Oxphos gene 
expression changes that we observe in the global populations of Colgalt2 and Gprin3 
cells are robust, and present an avenue for further biological assessment in ALS.
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CHAPTER 5: 
Visualizing and modulating mitochondrial structure and function in the context of 
SOD1-G93A 
Mitochondrial structure and function are regulated by many different cellular 
mechanisms (Boldogh and Pon, 2006; Jeyaraju et al., 2009; Scarpulla, 2011; Vander 
Heiden et al., 1997). Mitochondrial fission, fusion (Cagalinec et al., 2013), trafficking 
(Mironov, 2006), and energetic homeostasis (Kann and Kovács, 2007) are additionally 
influenced by many of the properties and functions of a neuron. Processes such as 
synaptic signaling, axon potential propagation, and membrane potential maintenance 
(Attwell and Laughlin, 2001; MacAskill and Kittler, 2010; Miller and Sheetz, 2004; 
Mironov, 2009) require a substantial amount of energy to carry out. Mitochondrial 
dysfunctions can in turn be found downstream of many cellular pathologies (Budd and 
Nicholls, 1996; Rainbolt et al., 2014), and in fact are often observed in 
neurodegenerative diseases (see Bossy-Wetzel et al., 2003; Chen and Chan, 2009; 
Cozzolino et al., 2013; Knott et al., 2008; Lin and Beal, 2006; Moreira et al., 2010). In 
ALS and its models, changes decreases in ETC complex activity (Borthwick et al., 1999; 
Wiedemann et al., 2002), mitochondrial vacuolization (Dal Canto and Gurney, 1995; 
Kong and Xu, 1998; Wong et al., 1995), and dysregulated structural dynamics (Magrané 
et al., 2009; Song et al., 2013) are often observed (see also Lopez-Gonzalez et al., 
2016; Lu et al., 2012; Mattiazzi et al., 2002; Menzies et al., 2002; Vehviläinen et al., 
2014). But the cell-type specificity of dysfunctional regulation of mitochondrial structure 
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and function in this disease has not been thoroughly assessed. For the SOD1-G93A 
ALS model, elucidating cell-type specific changes to mitochondria is of particular 
interest because of SOD1’s antioxidant role in clearing reactive oxygen species 
generated during ETC (McCord and Fridovich, 1969; Okado-Matsumoto and Fridovich, 
2001), and because many of the dysfunctions observed for mutant SOD1, such as 
oxidative stress (Beal et al., 1997; Casoni et al., 2005; Estévez et al., 1999) and protein 
aggregation (Bruijn et al., 1997b; 1998; Watanabe et al., 2001) can have consequences 
to mitochondrial function (Cole et al., 2010; Salehi et al., 2015). In our studies, despite 
SOD1 ubiquitous expression, we observed contrasting changes in mitochondrial gene 
expression across disease-vulnerable LL5b Gprin3 and disease-resistant UL5b Colgalt2 
cells when SOD1-G93A is expressed in the animal (Chapter 4). In Colgalt2 cells, at a 
symptomatic stage of disease, Oxphos gene expression increased relative to a healthy 
age-matched control. In vulnerable Gprin3 cells, we detected a decrease in the level of 
Oxphos gene expression that contrasted the change in Colgalt2 cells. When we 
assessed the levels of mitochondrial gene expression between Colgalt2 and Gprin3 
cells in healthy animals, we determined that Gprin3 cells are enriched for Oxphos genes 
relative to Colgalt2 cells, indicating that these cell types enter into a disease context 
with differing levels of expression of respiration genes to begin with. 
In order to more precisely understand how levels of mitochondrial gene expression 
and expression of SOD1-G93A affect the structure and function of mitochondria, we set 
out to characterize mitochondrial morphology in a cell-type specific manner in L5b cells 
across both healthy and ALS animals. Additionally, we attempted to modulate levels of 
94 
Oxphos to determine the causal relationship between levels of Oxphos gene expression 
and disease progression in our cell types. 
5.1 Mitochondria of upper and lower L5b cells occupy similar volumes in the 
soma. 
In order to understand how UL5b and LL5b cell types differ in their mitochondrial 
composition, we set out to visualize the mitochondria in these cells in a cell-type specific 
manner. We chose to virally target expression of a mitochondrial reporter to L5b cells 
that express Cre-recombinase in the Gng7-Cre KH67 mouse line. To accomplish this, 
we cloned the coding region for an EGFP construct with an N-terminal mitochondrial 
localization signal (MitoGFP, Addgene plasmid #50057; Sancak et al., 2013) into a 
pAAV plasmid that contained DIO Lox sites (Figure 5.1B). We packaged the construct 
into rAAV2/9 for neuronal transduction. When the virus is injected into the pons of 
Gng7-Cre mouse, which expresses Cre in L5b cells across the cortex (Figure 5.1B), 
expression of MitoGFP can be observed in L5b cells across the entire cortex (Figure 
5.1C). Because expression is observed in both the upper and lower sublayers of M1, 
the cells can be specifically classified as UL5b or LL5b cells depending on their visual 
depth in L5b, thereby giving us visual access to mitochondria within both L5b cell types 
in an internally controlled system. 
Given that Gprin3 cells show a higher level of expression of Oxphos genes when 
compared to Colgalt2 cells (see Chapter 2 and 4), we wanted to determine if this had 

















Figure 5.1: Generating a construct for expressing a mitochondrially localized GFP 
reporter in a cell type-specific manner. (A) Schematic illustration of the mitoGFP 
expression construct cloned into a viral expression plasmid and packaged into 
an AAV capsid. The EGFP coding sequence with an N-terminal mitochondrial 
localization signal (MLS) was DIO floxed for Cre-dependent constitutive 
expression by an eF1a promoter. (B) Schematic illustration of the experimental 
design showing the pontine viral injection paradigm and expected expression 
patterns in M1 of the Gng7-Cre mice. MitoGFP will be expressed in 
Cre-expressing L5b cells by transduction of the virus because of their projections 
to the pons. (C) Representative confocal image of mitoGFP expression (green) 
in M1 of a Gng7-Cre mouse following an injection of AAV.DIO.mitoGFP into the 
pons. Dashed line delineates the estimated boundary between UL5b and LL5b 
used to classify the cells during subsequent analysis. Both sublayers of L5b 




Cre-dependent mitoGFP virus into the pons of Gng7-Cre mice. In this way, we were 
able to label the mitochondria of UL5b and LL5b cells with mitoGFP that could be 
visualized by confocal microscopy (Figure 5.2A). Additionally, to visualize Oxphos 
machinery in our cells, we performed immunostaining for Cox6c, a component of 
complex IV of the ETC, in these tissues. UL5b and LL5b cells were sampled from 
laminar subdivisions that were visually established at low magnification, and high-
magnification (63X) confocal images of individual labeled cells were collected. To 
account for differences in levels of expression of the reporter and in antibody detection 
caused by differential depth within the section, each image was thresholded such that 
the same percentages of total pixels were included above the threshold limit across all 
images. We first assessed what percentage of the cytoplasm was occupied by 
MitoGFP+ mitochondria in L5b cells by calculating the area of GFP signal relative to the 
total area of cytoplasm (Figure 5.2A outlines). Mitochondria appear to occupy 
approximately 24% of the cytoplasmic space in both UL5b and LL5b cells (Figure 5.2B). 
The total number of Cox6c + puncta, in these cells also appeared to be the same 
(Figure 5.2C). We next determined the size of the Cox6c particles in UL5b and LL5b 
cells, and found that LL5b cells showed slightly larger Cox6c+ particles than UL5b cells 
(difference of 0.0196 µm2), although this difference was not statistically significant. 
When we normalized the Cox6c+ area to the MitoGFP+ area, we also found that LL5b 
cells show a slightly greater level of Cox6c signal per area of MitoGFP+ mitochondria 
(difference of 0.1333), although again, this difference was not significant. Together 




































































Figure 5.2: UL5b and LL5b cells show similar mitochondrial volume. (A) 
Representative 100X confocal images of UL5b (left) and LL5b (right) cells expressing 
mitoGFP (green). Dashed white lines outline the areas of cytoplasmic space in the cells 
that were delineated for analyses of mitochondrial size, number, etc. (scale bar = 10 µm). 
(B) Distributions of cytoplasmic area occupied by mitoGFP signal shown as box and 
whisker to highlight median and quartile boundaries and expressed as percent of total 
cytoplasmic area. UL5b (purple; n = 13 cells) and LL5b (green; n = 14 cells) cells do not 
appear to differ in mitochondrial density. (C) Number of Cox6c immunostaining “particles” 
after thresholding. There was no difference in the number of Cox6c “particles” found 
between UL5b (n  = 14 cells) and LL5b (n = 14 cells) cells. (D) Box and whisker plots 
showing the quantification of the size of Cox6c immunostaining “particles”. There 
appeared to be no difference between UL5b and LL5b Cox6c particle size. (E) Cox6c 
density per mitochondrial area, expressed as a ratio of Cox6c immunostaining area to 
mitoGFP area. LL5b cells show a slightly greater density of Cox6c staining per 
mitochondrial area, although this difference was not statistically significant (p = 0.1071; 
n.s. = not significant by two-tailed t-test). 
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UL5b and LL5b cells, the number of ETC components per mitochondrion may be subtly 
different, with LL5b cells showing a slightly greater density of Cox6c signal than UL5b 
cells. 
5.2 Gprin3 cells display wider cristae than Colgalt2 cells. 
Inner mitochondrial membrane complexity, or cristae morphology, is often used as 
a proxy for levels of ETC machinery in mitochondria, as structural determinants, such as 
Opa1, interact with some components of the ETC to physically produce the bend in the 
inner mitochondrial membrane that creates cristae structure (Lee and Yoon, 2018; 
Quintana-Cabrera et al., 2018). In order to determine how different levels of Oxphos 
gene expression observed between healthy Colgalt2 and Gprin3 cells affect 
mitochondrial morphology in these cells with greater detail, we visualized mitochondria 
by EM in healthy Colgalt2 and Gprin3 TRAP animals. To identify our cell types of 
interest under the microscope, we immunostained for GFP using a standard 
immunogold amplification protocol for EM imaging. In images of Colgalt2 and Gprin3 
soma, we measured the widths of individual cristae when they could be visualized 
readily (Figure 5.3A). These analyses revealed that Colgalt2 cells had significantly 
narrower cristae than Gprin3 cells, with average cristae appearing 59% as wide (21.58 
nm Colgalt2, 36.31 nm Gprin3) as Gprin3 cristae (Figure 5.3B). This suggests that 
Colgalt2 cells have more complex inner mitochondrial membrane structure that may 
contain greater levels of ETC machinery. These findings are inconsistent with the 




















Figure 5.3: Gprin3 cells show larger mitochondrial cristae widths than Colgalt2 
cells. (A) Representative electron micrographs of Colgalt2 and Gprin3 cytoplasm 
containing mitochondria, outlined in purple for Colgalt2 and green for Gprin3. 
Immunogold particles in the image indicate the presence of EGFP-L10a used to 
determine cell type identity (scale bar = 500 nm). (B) Quantification of cristae widths (in 
µm) observed across cell types. Colgalt2 cristae (purple) had a mean width of 21 nm (n = 
101 cristae), with Gprin3 cells (green) showing a larger mean cristae width of 36 nm (n = 
103 cristae; **** p < 0.0001 by two-tailed t-test).
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observe that Gprin3 cells express Oxphos genes at a higher level than Colgalt2 cells. 
These findings are preliminary, and should therefore be repeated to confirm the 
difference observed. Additionally, further investigation into Oxphos output in Colgalt2 
and Gprin3 cells is required in order to understand how Oxphos gene expression leads 
to differences in the energetic biology of these cells. 
 
5.3 LL5b cells but not UL5b cells show greater size and decreased number of 
mitochondria when SOD1-G93A is expressed. 
 It is often difficult to maintain Cre transgenic expression when studying the effects 
of an additional disease transgene, such as SOD1-G93A, on organismal biology. For 
this reason, we sought to develop a viral expression system that would allow for cell 
type-specific visualization of mitochondria without the expression of Cre. For this, we 
chose to employ a new retrograde AAV variant, rAAV2-retro (Tervo et al., 2016), here 
referred to as “SL1”. Because different cell types often show distinct projection patterns 
to various regions of the brain, targeting injections of this Cre-independent retrograde 
expression vector to the unique projections of these cells can label them in a type-
specific manner. We cloned a C-terminal mCherry-tagged human TOMM20, an outer 
mitochondrial membrane transporter, into a Cre-independent pAAV plasmid (Addgene 
plasmid # 55146, Michael Davidson, Figure 5.4A). In collaboration with the Janelia Farm 
Virus Core, the vector was packaged into the SL1 virus, which enters neurons at the 
pre-synaptic terminal and is transported retrogradely to the nucleus where it can be 














Figure 5.4: Generating a Cre-independent construct for expression of 
TOM20-mCherry mitochondrial reporter in a cell type-specific manner across 
healthy and disease L5b. (A) Schematic diagram of construct for eF1a-driven 
constitutive expression of TOM20-mCherry. Construct was packaged into a retrograde 
AAV capsid (SL1) for retrograde transduction of neurons. (B) Illustration of the 
experimental design paradigm for pontine injection of SL1.TOM20-mCherry (red), and 
resulting expression in M1 following retrograde transport from pontine terminals. (C) 
Representative confocal image of TOM20-mCherry expression in M1 of a WT mouse. 
Dashed line indicates the approximate boundary between UL5b and LL5b that was used 
to classify the cell types for analysis. Both sublayers show expression of the construct 




expression of the TOM20-mCherry construct is observed across L5b the cortex(Figure 
5.4C), allowing for visualization of UL5b and LL5b mitochondria in a once again 
internally controlled system. 
Because we observed contrasting changes in Oxphos gene expression between 
Colgalt2 and Gprin3 mice during disease, we wanted to assess gross morphological 
differences between WT and SOD1-G93A mitochondria in UL5b and LL5b cells at a 
symptomatic stage. Because we already required the SOD1-G93A transgenic mouse 
line for these experiments, to avoid introducing a second transgenic Cre mouse, we 
used the Cre-independent SL1.TOM20-mCherry retrograde viral system to visualize 
L5b mitochondria in disease. By injecting this virus into the pons, we were able to label 
both UL5b and LL5b cells in M1 of WT and SOD1-G93A mice (Figure 5.4C). After 
visually assessing upper or lower L5b identity at low magnification, we acquired high-
magnification (100X) images of individual cells containing mCherry+ mitochondria 
(Figure 5.5A) in order to quantify gross morphological features. Once again, images 
were thresholded so that the upper 25% of all pixels in the pixel value distribution were 
included above the threshold limit. In UL5b cells, the size of mCherry+ particles was the 
same between WT and SOD. Similarly, there was no difference in the total area of the 
cytoplasm occupied by mCherry+ mitochondria or in the number of mitochondrial 
particles per cell (Figure 5.5B). This suggests that while Colgalt2 cells up-regulate levels 
of Oxphos gene expression in disease, there may not be an overt change in 
mitochondrial size or shape to reflect this change. We next analyzed morphology of 
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Figure 5.5: LL5b cells show changes in TOM20-mCherry distributions that are not 
observed in UL5b cells. (A) Representative confocal images of TOM20-mCherry 
labeling (red) in UL5b (left) and LL5b (right) cells. Dashed lines indicate the boundaries of 
cytoplasmic space that were analyzed for various properties of TOM20-mCherry labeling, 
such as size, area, etc. (scale bar = 10 µm). (B) Distributions of quantified properties of 
thresholded TOM20-mCherry labeling “particles” in UL5b cells across WT (black) and 
SOD1-G93A (SOD; blue). No significant difference was observed between WT (n = 11 
cells) and SOD (n = 9 cells) for particle size (µm2; left), total labeled area (µm2; middle), 
or total number (right; n.s. = not significant by two-tailed t-test). (C) Distributions of 
quantified properties of thresholded TOM20-mCherry labeling “particles” in LL5b cells 
across WT and SOD. No significant difference was observed between WT (n = 15 cells) 
and SOD (n = 21 cells) for total area of TOM20-mCherry labeling (µm2; middle). However, 
a significant difference was noted for TOM20-mCherry particle size and total number, 




relative to WT cells (Figure 5.5C). There was no difference in the total area occupied by 
these particles in the cytoplasm, however. This necessitated that the number of 
mitochondria be lower in SOD, which is indeed what was observed. These data indicate 
that LL5b cells may decrease the number of discrete mitochondria in response to 
SOD1-G93A, while maintaining total mitochondrial volume. It is difficult to reconcile 
these findings with the Oxphos gene expression decrease that we observe by TRAP, as 
it does not address morphology due to Oxphos changes, but rather broad morphological 
rearrangements of mitochondria. But, together, these data highlight that UL5b and LL5b 
cells may show contrasting mitochondrial changes at the level of gross morphology and 
distribution in SOD1-G93A, where LL5b cells show a decrease in the number of 
mitochondria that is not observed in UL5b cells. 
5.4 Gprin3 and surrounding cells expressing SOD1-G93A show changes in cristae 
morphology by EM. 
To better visualize mitochondrial ultrastructure and its changes in LL5b Gprin3 
cells, we visualized WT and SOD1-G93A Gprin3 cells by EM. We immunostained for 
GFP with immunogold amplification in order to easily identify our cells of interest under 
the microscope. In images of Gprin3 soma (Figure 5.6A), we measured individual 
cristae widths in the mitochondria of Gprin3 cells, as well as in cells that were 
immediately adjacent to the GFP+ Gprin3 cells. The widths of cristae in both Gprin3 and 
neighboring cells appeared to increase in SOD1-G93A (Figure 5.6B), suggesting that 
these cells may be decreasing levels of ETC components in the inner mitochondrial 
**** ****























Figure 5.6: Cells in LL5b of M1 show increased cristae width in SOD1-G93A. (A) 
Representative electron micrographs of WT (left) and SOD1-G93A (SOD; right) LL5b, 
containing GFP+ Gprin3 cells (outlined in green) and adjacent GFP- cells of 
indeterminate identity (outlined in yellow; scale bar = 1 µm). (B) Quantification of cristae 
widths (nm) between WT (black) and SOD (blue) for GFP+ Gprin3 cells (WT n = 316, 
SOD n = 302 cristae) and adjacent GFP- cells (WT n = 76, SOD n = 72 cristae). Both cell 
types show an increase in cristae width in SOD (****p < 0.0001 by two-tailed t-test). (C) 
Quantification of density of matter within each mitochondrion, reported as the mean pixel 
value measured within each mitochondrion normalized to the mean pixel value of “empty” 
cytoplasm, and represented as a frequency distribution of normalized pixel values. In 
both GFP- and GFP+ cells, SOD mitochondria (blue distribution) showed a decrease in 
normalized pixel value relative to WT mitochondria (black line), suggesting that the mean 
pixel value in SOD mitochondria became darker. This in turn suggests that more 
“material” is found inside each mitochondrion in disease. Yellow and green bars highlight 
the distance between the WT and SOD distribution means for GFP- (WT n = 80, SOD n 




membrane in disease. These results require a more exhaustive study of cell-type 
specific mitochondrial changes in SOD1-G93A to understand, including staining for 
components of the Oxphos pathway, and functional analyses of mitochondrial function 
across different cell types in disease. 
5.5 Strategies for modulating levels of respiration and ETC activity in UL5b and 
LL5b cells. 
Our characterization of mitochondrial morphology, alongside our TRAP gene 
expression findings, suggests that there are some changes in structural mitochondrial, 
and possibly respiration, during disease progression. In order to determine how these 
changes may affect the survival or vulnerability of L5b cells to SOD1-G93A, particularly 
because we observed an increase in Oxphos gene expression in ALS-resistant UL5b 
cells, we attempted to increase the levels of respiration in these cells. We first opted to 
leverage an endogenous signaling mechanism to increase the levels of Oxphos in the 
mouse by injecting mice with all-trans retinoic acid (RA). RA treatment in cell culture has 
been shown to increase the levels of respiration in cells (Tourniaire et al., 2015), and 
retinoid signaling additionally appears to be disrupted in ALS (Kolarcik and Bowser, 
2012; Malaspina et al., 2001). We wanted to determine if increased Oxphos by RA 
signaling would change the survival time or disease progression of SOD1-G93A mice. 
We performed intraperitoneal (IP) injections of RA (1 mg/kg animal weight) or corn oil 
vehicle (4 ul/g animal weight) every two days into SOD1-G93A mice beginning at a 
symptomatic stage to determine if increased RA levels would have any effect on 
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disease survival time or progression. Survival time did not appear to be affected in RA-
injected animals (Figure 5.7A). To determine any changes to symptom onset or 
progression, we also subjectively assessed symptom severity during treatment by 
noting the presence of tremors, limb weakness, limb dragging, and overall mobility 
impairment. However, we found no significant difference in symptom progression 
between RA- and vehicle-injected animals (Figure 5.7B). 
The lack of cell-type specificity in this RA strategy set us to next attempt a more 
targeted modulation of Oxphos gene expression using a cell-type specific approach. 
Pgc1a has been shown to induce mitochondrial biogenesis and respiration through 
increased expression and activation of nuclear respiratory factors (NRFs; Uldry et al., 
2006; Wu et al., 1999). Additionally, exogenous expression of Pgc1a in cultured SOD1-
G93A cells was shown to normalize mitochondrial structural changes and prevent cell 
death (Song et al., 2013). We therefore packaged a pAAV plasmid containing a human 
copy of the Pgc1a coding sequence under the control of a constitutive CMV promoter 
(Figure 5.8A, Xiong et al., 2015) into the retrograde SL1 virus for overexpression. By 
injecting this virus into the left pons of pre-symptomatic Gprin3 animals, we could 
retrogradely target the GFP+ LL5b cells and in the ipsilateral left hemisphere of M1 for 
Pgc1a overexpression, while leaving the contralateral right hemisphere unaffected as 
an internal control (Figure 5.8B). Tissues were collected when mice reached end stage 
of disease and required euthanasia. We immunostained for GFP and counted the 
number of GFP+ Gprin3 cells in the left and right hemispheres in both WT and SOD1-
G93A to determine if increased Oxphos by Pgc1a overexpression had any effect on cell 
A B






















































Figure 5.7: Modulating levels of Oxphos by retinoic acid injections does not alter 
disease progression. (A) Survival curves showing survival of SOD1-G93A mice that 
received IP injections of either oil vehicle (yellow curve; median survival = 150 days; n = 
3 mice) or retinoic acid (RA; magenta curve; median survival = 177 days; n = 3 mice). (B) 
Subjective symptom severity score plotted as a function of time for SOD1-G93A mice that 
received IP injections of either oil vehicle (yellow curve; n = 3 mice) or RA (magenta 
curve; n = 3 mice). Increased symptom severity score indicates increased overt symptom 
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Figure 5.8: Modulating levels of Oxphos in L5b cells by Pgc1a overexpression does 
not alter disease progression. (A) Schematic of viral construct for constitutive 
CMV-driven overexpression of exogenous Pgc1a. (B) Schematic illustration of the 
experimental design showing the pontine viral injection paradigm and expected ipislateral 
(cyan) expression patterns relative to contralateral cortex (purple) in M1 of WT or 
SOD1-G93A mice. (C) Cell counts along the AP extent of M1 for M1 ipsilateral to the 
injection site (“Ipsi M1”; cyan) and M1 controlateral to the injection site (“Contra M1”; 
purple). No significant difference in cell number was noted between Ipsi M1 (n = 6 
animals) and Contra M1 (n = 6 animals). Values are reported as a percent of the 
Pgc1a-injected WT mean at the matching anatomical coordinate (points indicate mean 
values for each coordinate, with bars showing SEM).
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survival. We found no significant difference between the number of Gprin3 cells across 
the ipsilateral left and contralateral right hemispheres (Figure 5.8C), suggesting that 
Pgc1a overexpression in these cells may does not affect cell survival. One notable 
caveat to this experimental design was that we relied on the HA and His tags to 
visualize exogenous Pgc1a overexpression. Immunodetection of these tags proved 
difficult in our tissues, so we were not able to determine to what extent Pgc1a 
overexpression overlapped with our Gprin3 population. This confound could be 
corrected if the experiment were repeated with a Pgc1a construct that additionally 
expresses a reporter that can be easily visualized in tissue. Additionally, Pgc1a 
activation is post-translationally regulated by many upstream molecular signaling 
pathways (see Austin and St-Pierre, 2012), potentially limiting an overexpression 
strategy. Overall, our two Oxphos modulation strategies were technically limited in 
various ways, making it difficult to interpret the results from each experiment in the 
biological context of mutant SOD1. However, they serve to highlight the need for careful 
targeting and assessment of gene expression modulation when studying neuronal ATP-
synthesis, and reveal how even heavy-handed approaches to modulate levels of 
Oxphos may not always present the most effective strategies for studying the effect of 
changes in respiration on cellular biology. 
5.6 Discussion 
Mitochondrial morphology can reflect many functional and dysfunctional states of a 
cell. In particular, many neurodegenerative diseases display changes in mitochondrial 
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structure and function (Bossy-Wetzel et al., 2003; Burté et al., 2015; Chen and Chan, 
2009; Itoh et al., 2013; Knott et al., 2008). In the ALS SOD1-G93A model, we observed 
contrasting changes in Oxphos gene expression between degeneration-vulnerable 
Gprin3 and resistant Colgalt2, as well as baseline differential enrichment of these genes 
in healthy Gprin3 cells over Colgalt2 cells (Chapter 4). We therefore set out to 
determine if changes in gene expression reflect alterations in mitochondrial structure 
that could be visualized at the subcellular level. We observed that in healthy Colgalt2 
and Gprin3 cells, there is a slightly greater amount of Cox6c signal per mitochondrial 
area in Gprin3 cells, but Colgalt2 cells show narrower cristae by EM (Figure 5.9). These 
findings lie in opposition to each other, indicating that Gprin3 neurons display greater 
levels of the Oxphos component Cox6c, but wider cristae that are associated with lower 
levels of ATP synthesis. Because cristae width can be regulated at the level of energetic 
demand based on activity patterns (Cserép et al., 2018), one possible explanation for 
this finding is Colgalt2 neurons are more active than Gprin3 cells, and per-
mitochondrion levels of Oxphos proteins that are higher than in Gprin3 neurons. It is 
also possible that cristae width does not provide the best proxy for overall levels of ETC 
proteins in these cells, or that the Oxphos enrichment that we observe in Gprin3 gene 
expression reflects a cell-type specific assembly of ETC components. Indeed, it has 
been shown that for Complex IV (COX) in particular, there are tissue-specific isoforms 
that differ across cell types (Hüttemann et al., 2001; Stiburek et al., 2005). It is therefore 
possible that different expression levels of Cox6c and other subunits observed between 
Colgalt2 and Gprin3 cells do not reflect different levels of Oxphos, but rather cell-type 
Figure 5.9: Summary of mitochondrial morphology analysis in Colgalt2 and Gprin3 
cells. Mitochondria of Colgalt2 cells (purple) appear to have narrower cristae by EM, but 
fewer Cox6c puncta (red) per mitochondrial area than Gprin3 mitchondria (green). Gprin3 
mitochondria appear to have wider cristae (left panel). In SOD1-G93A mitochondria 
(blue), cristae of L5 cells appear to increase in size relative to healthy L5 mitochondria 















specific differences in complex make-up. These differences would still present a very 
interesting avenue for the establishment of potential cell-type specific differences in how 
ATP is synthesized, even if rates of synthesis are not affected by different subunit 
composition of the ETC complexes. 
Because metabolism appears to be affected with mutant SOD1 expression (Allen 
et al., 2014), and because we observed contrasting changes in Oxphos gene 
expression changes between resistant Colgalt2 and vulnerable Gprin3 cells (Chapter 4), 
we next determined how these changes manifest themselves in mitochondrial structure 
during disease. We found no significant changes in overt mitochondrial morphology in 
Colgalt2 cells when SOD1-G93A was expressed, but observed that Gprin3 neurons 
show a decrease in mitochondrial number coupled with an increase in individual 
mitochondrion size. By EM, cristae widths appeared to increase in SOD1-G93A in both 
Gprin3 mitochondria and GFP- neighboring mitochondria. These data indicate that in 
Gprin3 cells, the overt size and number of mitochondria are regulated simultaneously 
with inner mitochondrial membrane structure. In mutant SOD1 animals, dilated cristae 
and overt vacuolization of mitochondria have been reported during disease progression 
(Dal Canto and Gurney, 1995; Kong and Xu, 1998; Wong et al., 1995). The increased 
width of Gprin3 cell cristae is consistent with these findings, and suggests that these 
cells produce less ATP in the disease state. It is not clear to what extent this is causal to 
cell death, however, as these changes appear to precede apoptosis in LMNs (Bendotti 
et al., 2001). Additionally, the cristae widening we observed does not appear to be cell 
type specific, as neighboring cells show a similar phenotype, suggesting it may be a 
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generic response to SOD1-G93A expression. While we were not able to identify the 
types of cells that composed these neighboring populations, whether glial or neuronal, it 
is possible that dysfunction in these surrounding cells influences Gprin3 cells in a 
likewise adverse way (Tripathi et al., 2017; Vargas et al., 2005). In order to understand 
this further, we must perform the same assessment of mitochondrial structure in 
Colgalt2 cells during disease, and compare the changes to changes in neighboring 
cells. It will also be important to identify the cell types that represent these neighboring 
populations, particularly because neighboring astrocytes may be experiencing 
mitochondrial dysfunction as well (Cassina et al., 2008). 
We next wanted to understand how modulation of Oxphos gene expression may 
affect disease progression by employing both global and cell-type specific inducers of 
respiration and Oxphos gene expression. Neither strategy provided conclusive results 
with regards to disease progression or survival, as there were various technical 
limitations with each strategy. This does not except dysfunction of mitochondria from 
affecting disease progression, however, because our sequencing data and 
morphological analyses suggest that there may be disease-related changes in 
mitochondrial function in L5b cells. Given the link between mitochondrial dysfunction 
and neurodegenerative diseases, including ALS (Chen and Chan, 2009; Cozzolino et al., 
2013; Lin and Beal, 2006; Moreira et al., 2010), it is very much worth exploring how cell 
type-specific changes in mitochondrial structure and function affect the health of the 
vulnerable LL5b cells in ALS, particularly in the context of underlying cell-specific 
differences in respiration in the healthy brain. 
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CHAPTER 6: 
Finding markers for L5 cell types in human motor cortex 
The diversity of L5b projection neuron types in the motor cortex of rodents is only 
now being elucidated. Using BAC transgenic animals expressing TRAP, we have shown 
that in mice, M1 L5b contains two distinct populations of corticofugal neurons that each 
occupies its own discrete sublayer. Colgalt2 cells of the upper L5b sublayer (UL5b) 
project to the pons but not spinal cord, while Gprin3 neurons found in the lower sublayer 
(LL5b) project to both the pons and the spinal cord (see Chapter 2). This newly 
described heterogeneity in L5b cell type identity in mouse M1 now raises the question of 
whether a similar diversity exists across L5 of the motor cortex in other species. This is 
particularly important to understand in the context of ALS, where we show that 
corticospinal LL5b Gprin3 cells are vulnerable to degeneration. Because corticospinal 
neurons of the human primary motor cortex are thought to be the most vulnerable 
cortical population in ALS (Eisen and Weber, 2001; Eisen et al., 1992; Tandan and 
Bradley, 1985), it is important to understand whether our mouse findings represent a 
cell type-specific vulnerability that recapitulates the human condition. Uncovering the 
cell-type specificity of L5 neuron degeneration in human ALS would ultimately allow us 
to explore the translatability of our findings in ALS mouse models to relevance in human 
disease. 
The cell type diversity of human cortex has been challenging to define. While 
many have shown the laminar distributions of single markers through 
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immunohistochemical staining (see Jacobs et al., 2018), they have rarely been able to 
determine the cell type-specificity of these markers across neurons in the same layer. 
This is primarily due to the technical limitations present in performing combinatorial 
immunofluorescence staining in tissues that, through the various stages of post-mortem 
handling, develop high levels of auto-fluorescence. However, combinatorial marker 
staining through multi-channel immunofluorescence is required to understand the 
molecular overlap of different cortical populations in the absence of anatomical tracing 
and transgenic reporters. For this reason, we set out to first establish a reliable 
immunofluorescence protocol for human neuronal staining and visualization in the 
primary motor cortex. Using the molecular profiles for the distinct mouse L5b cell types 
available through our Gprin3 TRAP profiling, we also sought out a combination of 
markers that can allow us to distinguish populations of L5 cells across mouse and 
human motor cortex. With the EGFP expressed in these TRAP cells, we are additionally 
able validate the specificity of candidate markers to L5b cells. With these markers, we 
aim to not only characterize the heterogeneity of L5 pyramidal neuron types in this 
region of cortex, but also to provide a system for reliably visualizing the populations of 
cells that are relevant to cortical degeneration in ALS. 
6.1 Narrowing down candidate markers for L5b cells across species. 
In order to identify combinations of markers that are able to distinguish L5b 
subpopulations in mouse and human tissue, we first generated a list of possible 
candidate genes thought to be specifically expressed in L5 cells. Using a combination of 
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TRAP data, available ISH data from the Allen Brain Atlas, as well as previously reported 
markers for L5b cells, a set of candidate genes was generated (Table 6.1). We tested 
antibodies against these markers, or in situ hybridization (ISH) probes when efficacious 
antibodies could not be obtained, and assessed the specific localization of staining 
within L5b of mouse M1. Results from this screen are summarized in Table 6.1. We 
found that in some cases, markers were distributed across more layers than just L5b in 
mouse (labeled “~Yes” in Table 6.1), but were still included for human L5 marker 
screening as long as strong staining in mouse L5b cells was evident. Many of the 
markers that showed L5b staining in mouse did not work in human primary motor cortex 
staining (labeled “No” in Table 6.1), however we did see L5 staining for three of the 
markers that we tested across mouse and human tissue: Pcp4, SMI-32 (a non-
phosphorylated variant of Nefh) and Crym (Figure 6.1). Pcp4 was more broadly 
distributed across all cells in the deep layers of mouse M1 from L5a to L6a (Figure 6.1A, 
top panel). Crym was visible in what appeared to be LL5b cells, but was also observed 
in some L6a cells (Figure 6.1A, middle panel). SMI-32 appeared to more selectively 
label neurons across upper and lower L5b, with very few cells observed in other layers 
(Figure 6.1A, bottom panels). In human motor cortex, Pcp4 staining appeared to be 
principally localized to a visually estimated L5, with a small subset of cells visible in L3 
(Figure 6.1B, top panel). Crym staining appeared to label L5 cells exclusively (Figure 
6.1B, middle panel), while SMI-32 appeared to label a diverse set of neurons across L5 
and L3 (Figure 6.1B, lower panel). Because they appeared to more selectively label 
specific subpopulations of L5b cells in the mouse, we selected Crym and Nefh/SMI-32 
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Stains L5b in Mouse Stains L5b in Human
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Table 6.1: Candidate markers for L5b cells across species. If marker appeared to 
specifically stain L5b in M1 of either mouse or human, it appears labeled as “Yes”. If a 
marker stained L5b cells as well as other cells in the cortex, it is labeled as “~Yes”. If a 
marker failed to stain L5b cells, it appears labeled as “No”. Markers were selected based 
on apparent specificity in published studies, Allen Brain Atlas data, and RNA-Seq data 
from motor cortex.














Figure 6.1 Staining for Pcp4, Crym, and SMI-32 in mouse and human tissue allows 
for visualization of deep layer neurons in the motor cortex. (A) Representative 
confocal images of Pcp4 and SMI-32 immunofluorescence, and Crym FISH, showing the 
laminar distribution of signal across mouse motor cortex. Solid white lines indicate the 
visually estimated dorsal and ventral boundaries of L5b, with the dashed line showing the 
approximate location of the subdivision between UL5b and LL5b (scale bar = 300 µm). 
(B) Representative confocal images of Pcp4, Crym, and SMI-32 immunostaining in 
human motor cortex. Solid white lines indicate visually estimated dorsal and ventral 
boundaries of L5 in each section (scale bar = 500 µm).
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as our markers of interest for determining subpopulation distributions across L5 in 
mouse and human primary motor cortex. Additionally, Crym and SMI-32 have been 
individually used to label L5 neurons across species in other studies, with SMI-32 the 
most commonly used to visualize large neurons in the motor cortex of many animals 
(Arlotta et al., 2005; Campbell and Morrison, 1989; Fink et al., 2015; Molnár and 
Cheung, 2006; Rouaux and Arlotta, 2013). We therefore additionally took this as an 
opportunity to clarify the subpopulation specificity of these markers within L5 of mouse 
and human.  
 
6.2 Crym and Nefh ISH label populations of neurons in L5b of mouse primary 
motor cortex. 
 Crym and SMI-32 have previously been used as markers for L5b cells (Arlotta et 
al., 2005; Campbell and Morrison, 1989; Fink et al., 2015; Molnár and Cheung, 2006; 
Rouaux and Arlotta, 2013). However, until recently, the heterogeneity of cell types in 
L5b was poorly understood, so it was not clear what subpopulations may be targeted in 
staining for these markers. Unfortunately, we were not able to visualize 
immunofluorescence staining for Crym tissue sections, so we opted to instead perform 
fluorescence in situ hybridization (FISH) on sections from Gprin3-TRAP brains using 
probes against Crym and Nefh to determine marker co-localization with our LL5b cell 
types. Immunofluorescence staining for GFP was performed following ISH for these 
markers, and the sections were imaged by confocal microscopy (Figure 6.2A). Crym+ 
cells were distributed across the deepest layers of the cortex, including L5a and L6a  
Figure 6.2:  FISH against Crym and Nefh labels populations of L5b cells in M1 of 
mouse. (A) Representative confocal images of Gprin3 M1 showing GFP immunostaining 
(green; top row), Crym ISH (red; middle row), and Nefh ISH (magenta; bottom row). In 
L5b, Crym is primarily observed in LL5b, while Nefh signal appears to span both UL5b 
and LL5b. Solid white lines delineate the estimated upper and lower boundaries of L5b, 
and dashed white line indicates the approximate division between UL5b and LL5b (scale 
bar = 300 µm). (B) Heatmaps indicating the depths of L5b marker+ cells within L5b, 
shown as percent of depth from the pial surface and represented as frequency of 
appearance at that depth. Gprin3 cells (green; n = 62 cells) were found deep in the cortex 
at ~75% depth, and represent a LL5b population. Crym+ cells (red; n = 106 cells) were 
also seen at this depth, suggesting they also label LL5b cells. Nefh+ cells (magenta; n = 
183 cells) were found in this LL5b region as well as superficially, in what is likely UL5b. 
Frequencies ≥ 6 are shown in the same shade to more readily highlight the depths at 
which cells were the most concentrated. (C) Quantification for co-localization of Gprin3 
GFP (n = 73 cells) with Crym and Nefh ISH labeling. 92% of GFP+ cells were Crym+ (red 



















































(Figure 6.2A, middle panel), but within L5b, were only observed in the lower sublayer 
(Figure 6.2B). Nefh+ cells in L5b were instead distributed across both sublayers of M1 
L5b (Figure 6.2A, bottom panel), although their distribution appeared to be slightly more 
concentrated to LL5b (Figure 6.2B). Crym co-localized with 92% of Gprin3 cells, and 
Nefh co-localized with 89% of Gprin3 cells (Figure 6.2C). These data suggest that while 
Nefh may label cells across both sublayers of L5b based on its broader distribution 
across this layer, Crym appears to more exclusively label the corticospinal Gprin3 
population over other L5b cells. We will need to carry out the same marker staining 
approach in Colgalt2 tissues to determine the specificity of these markers in UL5b, but 
with these results, we have established a combinatorial set of markers that may allow 
for the visualization of this LL5b population in non-transgenic animals. 
 
6.3 Crym and SMI-32 staining allows for visualization of L5 cells in human primary 
motor cortex. 
 To determine if Crym and Nefh additionally allow for visualization of L5 cell types 
in human motor cortex, we performed dual staining for Crym and SMI-32 (the non-
phosphorylated variant of Nefh), in human primary motor cortex sections (Figure 6.3). 
Paraffin-embedded blocks of different regions of motor cortex were sectioned to 
between 10 and 14 µm (depending on brain bank source). Slides with mounted sections 
were deparaffinized before performing acid and heat-based antigen retrieval and 
immunofluorescence staining. Images of Crym and SMI-32 immunostained sections 
were then collected by confocal microscopy. Boundaries of cortical lamination were 
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estimated visually based on neuron size and approximate depth, and with the help of 
published data on cortical lamination in primates. In a lateral area of motor cortex 
associated with the control of facial and neck muscles (Figure 6.3A, see Penfield and 
Boldrey, 1937), the distribution of SMI-32+ cells appeared broad. Large SMI-32+ cells 
were observed in deep L3, with a subset of SMI-32+ cells in L5 showing lower levels of 
signal (Figure 6.3B, right panel). The distribution of SMI-32 staining that we observed 
here is consistent with previously reported localization of SMI-32+ cells across different 
areas of primate cortex (Campbell and Morrison, 1989). Additionally, this distribution is 
distinct from what we observed for Nefh staining in mouse, where Nefh+ cells were 
found almost entirely in L5b. Crym+ cells in the lateral region of human motor cortex 
were observed in deeper L5, with a small subset of cells positive for both Crym and 
SMI-32 found at this depth. In a medial area of motor cortex that maps to limb control 
(Figure 6.3A), a subset of SMI-32+ cells was also observed in deep L3, with the majority 
of SMI-32+ cells localizing to L5 (Figure 6.3B, right panel). Many of the SMI-32+ cells in 
L5 appeared to also be positive for Crym in this medial region, with the exception of the 
occasional very large pyramidal neuron that appeared to be selectively positive for SMI-
32 (white arrow in Figure 6.3B, right panel). These anatomical data suggest that, even 
across different subregions of human motor cortex, the laminar distribution of Crym and 
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Figure 6.3: Crym and SMI-32 staining reveals distinct laminar populations of cells 
across human primary motor cortex. (A) Schematic representation of the regions of 
primary motor cortex that were targeted for staining. The medial region of motor cortex 
functionally maps to limb regions, and is thought to be the primary area containing Betz 
cells. The lateral area maps to facial regions and is thought to not contain many 
corticomotoneurons. Axial legend is shown in the bottom right (D = dorsal, V = ventral, M 
= medial, L = lateral). (B) Representative confocal images showing the laminar 
distribution of Crym and SMI-32 marker immunostaining in lateral motor cortex (left) and 
medial motor cortex (right). In lateral motor cortex, Crym (red) appeared to specifically 
label a population of L5 cells. SMI-32 (green) strongly labeled a population of large L3 
cells and weakly labeled a subset of L5 cells. In medial motor cortex, Crym again 
appeared to specifically label a population of L5 cells. SMI-32 in this medial region also 
strongly labeled the same subset of L5 cells, and weakly labeled a small subset of L3 
cells. Occasionally, a very large SMI-32+ cell that was negative for Crym was also seen 
in L5 of this medial region (white arrow). Approximate layer boundaries according to cell 
sizes and published marker distributions.
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6.4 Basic distinguishing features of marker-positive cells in medial human motor 
cortex and mouse M1. 
 In order to determine if human and mouse L5 share similar Crym and SMI-32 cell 
type composition and features, we broadly assessed the population make-up of the 
marker stained cells, as well the relative size for each type across species. In LL5b of 
mouse M1, 64% of labeled cells were positive for both Crym and Nefh ISH, 31% were 
positive for Nefh only, and 5% were positive for Crym only (Figure 6.4C). Using Gprin3 
GFP as a marker for corticospinal identity, we then assessed the population make-up of 
corticospinal LL5b cells (Figure 6.4A). 90% of Gprin3 cells were positive for both Crym 
and Nefh, 7% were positive for Nefh only, and 3% were positive for Crym only (Figure 
6.4C). The Gprin3 population that was positive for only Nefh did not show any difference 
in soma size to Gprin3 cells that were positive for both Crym and Nefh (Figure 6.4D). 
Together, these data suggest that, while marker stained cells do not differ in size, even 
within LL5b, there may be further subpopulations of neurons that have yet to be defined.  
 In human medial motor cortex, Crym and SMI-32 double positive cells made up 
96% of labeled cells in L5 (Figure 6.4B-C). Additionally, we observed a very small 
proportion of L5 cells (3%) that showed strong SMI-32 signal, but weakly stained or did 
not stain for Crym. These SMI-32-positive/Crym-negative cells display significantly 
larger soma than the rest of the Crym+ population of L5 cells (Figure 6.4E), and were 
primarily found in deep L5. The very large neurons that reside in the medial regions of 
motor cortex in L5 of human motor cortex are thought to represent the 





























































































Figure 6.4: Crym and SMI-32 staining can anatomically dissociate putative Betz 
cells from other neurons in L5 of human motor cortex. (A) Representative images of 
LL5b Gprin3 cells in mouse M1, stained for GFP (green), Crym ISH (blue), and Nefh ISH 
(red). Most GFP+ cells stain positive for both Crym and Nefh ISH (left), with a small 
subset only staining positive for Nefh ISH (right; scale bar = 25 µm). (B) Representative 
images of human L5 cells that were double-positive for Crym (red) and SMI-32 (green; 
left), and a putative Betz cell that was only positive for SMI-32 (scale bar = 50 µm). (C) 
Stacked bar graphs show composition of marker+ cells for all cells in LL5b, Gprin3 GFP+ 
cells in LL5b, and human L5. Across all of mouse LL5b (including GFP+ and GFP- cells), 
64% of cells are double positive for Crym and Nefh ISH (blue bar), 31% were positive for 
only Nefh ISH (magenta bar), and 5% were positive for Crym ISH (red bar; n = 229 cells). 
90% of LL5b Gprin3 cells are positive for both Crym and Nefh ISH, 7% were only Nefh 
ISH+, and 3% were only Crym ISH+ (n = 60 cells). In human, 96% of L5 cells are positive 
for both Crym and SMI-32, with remaining 4% showing only SMI-32 labeling (n = 158 
cells). (D-E) Quantifications of soma size for different marker+ cell types in mouse LL5b 
and human L5. In mouse (D), all cell types appeared to be of similar size (Both n = 19 
cells; Nefh only n = 24 cells; n.s. = not significant by two-tailed t-test).In human (E), cells 
that were positive for only SMI-32 tended to be larger than cells that were double-positive 




and distal limbs (Kaiserman-Abramof and Peters, 1972; Rivara et al., 2003; Walshe, 
1942). Our marker staining suggests that the very large L5 cells that we observed as 
being SMI-32-positive and Crym-negative in medial motor cortex may also represent 
this Betz cell population. If so, these results present the first combinatorial molecular 
marker staining that has dissociated Betz cells from the broader L5 population of human 
primary motor cortex. 
 Together, these anatomical data suggest that using Crym and SMI-32 marker 
staining in tandem can reveal diverse populations of L5 cell types across both mouse 
and human motor cortex, and that even within the mouse corticospinal population 
(represented by Gprin3), there may be more cell type heterogeneity than originally 
thought. More experiments must be carried out to understand the anatomical and 
molecular relationship between these L5 cells across species, particularly if the Gprin3 
cells are to be treated as representative of ALS-vulnerable populations in humans.  
  
6.5 Discussion 
 Parsing the cell types that compose the human cortex has proven very difficult. 
Without the ability to perform anatomical tracing, differentiating the cell types by 
projection pattern in tissue has not been possible. Cell types in the motor cortex have 
until now primarily been classified by their electrophysiological responses during 
functional motor tasks in vivo (Phillips, 1956), and by their relative cell body sizes in 
tissue sections (Kaiserman-Abramof and Peters, 1972; Rivara et al., 2003). Discovering 
markers that allow us to visually distinguish motor cortical cell types from each other 
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would greatly advance our ability to anatomically characterize subpopulations of L5 cells 
in both healthy and disease tissues.  
 In rodents, it is possible to easily screen markers for specific neuronal 
subpopulations alongside anatomical tracing or transgenic cell type reporters. However, 
the extent to which these populations represent human neuron types is a subject of 
much controversy, particularly in the motor cortex, where the divergence in axonal 
projection anatomy and functional contributions of this area to movement across 
species are readily evident (see Lemon and Griffiths, 2005; Yoshida and Isa, 2018). But 
in order to begin establishing cell type relationships across L5 of rodents and primates, 
we must first determine the cellular make-up of the population important for motor 
cortex output. 
 We set out to screen various putative L5 markers and their antibodies for the 
ability to stain specific subpopulation of L5b cell types in mouse and human motor 
cortex. We show that staining for Crym and SMI-32 (a variant of Nefh), markers 
previously used separately to visualize populations of L5b cells across species, can 
successfully be carried out in tandem in post-mortem, fixed human cortex sections. In 
combination, these markers reveal distinct subpopulations of L5 cells in human: a 
Crym+/SMI-32+ population that appears to account for the vast majority of L5 cells in 
the medial motor region and likely includes corticospinal neurons, and a subset that is 
only positive for SMI-32 (Figure 6.5). This cells of the latter population are not only 
larger than their Crym+ counterparts, but it is only found in medial and not lateral 
regions of the motor cortex of the human. These characteristics suggest that these  
Figure 6.5: Summary of Crym and SMI-32 L5 cell type distribution across mouse 
and human motor cortex. Within L5b of the mouse, Crym staining (red) appears to be 
primarily restricted to LL5b, where cells are primarily double positive for Crym and SMI-32 
(yellow). Rare subsets of LL5b cells only stain positive for either SMI-32 (green) or Crym. 
In human medial motor cortex, L5 shows a majority of pyramidal neurons that are positive 
for both Crym and SMI-32. Rarely, a very large SMI-32+ neuron is seen among these 
cells. These may be Betz cells




















neurons may be Betz cells, which are thought to be corticomotoneurons that synapse 
directly onto alpha motor neurons of the spinal cord (Kaiserman-Abramof and Peters, 
1972; Walshe, 1942). It is thought that these neurons participate in the control of 
proximal and distal limb movements and produce dexterous movement by so doing 
(Heffner and Masterton, 1983; Yoshida and Isa, 2018). Until now, Betz cells have been 
typically identified solely by their large size relative to other L5 cells (Braak et al., 2017; 
Genç et al., 2017; Hammer et al., 1979). However, in conditions where Betz cells 
atrophy and therefore change in size (Genç et al., 2017), this strategy would not allow 
for the identification of Betz cells that fall below a size threshold due to pathological 
changes. For this reason, having markers that can be used to visualize these cells 
reliably is key for further study of changes in Betz cell morphology and number in 
diseases such as ALS. 
 Even with marker staining, we cannot know whether the Crym+/SMI-32+ human 
L5 cells that we observe share the same anatomical identity as Gprin3 cells by 
projection pattern. In other words, if a subset of Crym-/Nefh+ Gprin3 cells molecularly 
represents a Betz-like population that projects directly onto alpha motor neurons, why 
does this Gprin3 subpopulation not directly innervate spinal motor neurons in the 
mouse? Interestingly, during post-natal rodent development, a subset of corticospinal 
projection cells extend a collateral axon into the ventral horn that is then retracted (Gu 
et al., 2017b; Kuang and Kalil, 1994; Maeda et al., 2016). If these collaterals are instead 
allowed to endure by conditionally knocking-out PlexA1, a semaphorin receptor that is 
important in axon guidance and pruning (Bagri et al., 2003; Winberg et al., 1998), these 
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animals outperform WT mice in dexterous movement tasks (Gu et al., 2017a). This 
suggests that while LL5b cells of M1 may not directly innervate alpha motor neurons in 
mice, they may have the capacity to do so. Does this mean that the molecular identity of 
the corticospinal population is similar to Betz cells even transiently? This may be 
reflected in their molecular identity, so it would be very interesting to determine to what 
extent a corticomotoneuron Gprin3 population in PlexA1 cKO mice overlaps with 
corticospinal and cortiomotorneuron populations in human motor cortex.  
 While it is currently not feasible to confirm the corticospinal identity of our marker+ 
cells in human tissue, however, it may be possible to do so in non-human primates, 
which also contain Betz cells in primary motor cortex (Jacobs et al., 2018). Staining for 
Crym and Nefh in non-human primate non-human primate (NHP) motor cortex, coupled 
with retrograde tracing from the spinal cord, could give us a better understanding of how 
translatable this marker identity for corticospinal neurons is across rodents and 
primates. Extrapolating the projection patterns and marker staining of NHP Betz cells to 
human Betz cells is likely the only way to know how well our combinatorial marker 
staining distinguishes cells based on projection identity. Corroborating marker staining 
with NHP anatomical tracing would also allow us to determine with greater certainty, 
what neuron types in human L5 are likely the most vulnerable in ALS, and to 
understand to what extent projection identity contributes to this vulnerability. Using our 
markers, we should therefore attempt to determine whether Crym+ and Nefh+ cell types 
show greater vulnerability in disease, and whether loss of these cells reflects 





 This study represents an endeavor to determine how cortical L5b neurons of 
primary motor cortex are uniquely defined in both healthy and disease contexts. Using a 
combination of anatomical, molecular, and sequencing techniques, we have begun to 
outline the features that distinguish these cells, and how these features may be relevant 
in the study of cell type-specific vulnerability in ALS.  
 We show that L5b is laminarly composed of two distinct sublayers: upper L5b 
(UL5b) and lower L5b (LL5b; Chapter 2, Figure 2.14). UL5b contains cells that project to 
the pons but not the spinal cord (Figure 1.4). LL5b instead contains neurons that send 
axon collaterals to both the pons and cervical spinal cord. Using BAC transgenic 
animals, we show that two cell types that occupy these sublayers, Colgalt2 cells of 
UL5b and Gprin3 cells of LL5b, appear to be molecularly similar by TRAP RNA-Seq 
relative to other cell types in the cortex, but are nevertheless distinct in ways that may 
be functionally important. In an animal model of ALS carrying the SOD1-G93A mutation, 
the Colgalt2 population does not degenerate, while the Gprin3 population is lost as the 
disease progresses (Chapter 3, Figure 3.5). Colgalt2 cells appear to increase their 
levels of Oxphos gene expression during disease, while Gpri3 cells decrease it (Chapter 
4, Figure 4.11), potentially revealing a coping strategy in the case of Colgalt2 cells, and 
a dysfunctional mechanism in the case of Gprin3 cells. Underlying these disease-
related changes are intrinsic differences in mitochondria between the two cell types that 
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may predispose the cells to differentially respond to mutant SOD1 expression. Finally, 
we show that gene expression profiles of these L5b cells in mouse primary motor cortex 
can be used to screen for markers of L5 cells in human primary motor cortex (Chapter 
6, Figure 6.5), and that these markers allow for distinguishing a putative ALS-vulnerable 
Betz cell population from other pyramidal neurons in L5.  
 The projection patterns of L5 of the cortex have been broadly characterized 
(Arlotta et al., 2005; Economo et al., 2018; Feng et al., 2000; Gerfen et al., 2016; 
Oswald et al., 2013). While it was known that deep layer 5b cortiospinal neurons in the 
motor cortex have collateral projections to the pons in rodents (Heffner et al., 1990; 
Ugolini and Kuypers, 1986), we and others are providing novel evidence that reveals 
that within M1 L5b, there exists an upper sublayer just above the corticospinal L5b cells 
that contains a second corticofugal population that projects no further than the pons 
(Chapter 2; Economo et al., 2018). Independently, the corticopontine population has 
been described for many regions of the cortex across many species (Leergaard and 
Lakke, 1995; Moya et al., 2014; Wiesendanger and Wiesendanger, 1979; 1982). During 
early post-natal development in the visual cortex, these corticopontine are initially 
corticospinal and have a collateral to the pons. By ~P10, the spinal collateral is retracted 
(Stanfield and O'Leary, 1985). A similar pattern of development was incidentally 
described for corticopontine cells of the primary motor cortex (Wang et al., 2017). 
Indeed it appears that the field has been circling around the discovery of two distinct 
corticofugal populations in M1 L5b for a long time but, due to limitations in the ability to 
simultaneously visualize multiple cell types, has not managed to distinguish them from 
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each other. The ability to independently visualize the two populations studied here using 
BAC transgenics, with the help of retrograde labeling, was invaluable in being able to 
distinguish these populations. 
 Layer 5b pyramidal neurons in primary motor cortex of rodents were already 
known to be vulnerable in human ALS and its models (Hammer et al., 1979; Ozdinler et 
al., 2011; Tandan and Bradley, 1985; Zang and Cheema, 2002). Because the 
heterogeneity of L5b corticofugal populations in M1 L5b had not yet been established, 
the cellular specificity of this loss has not been addressed. Our corticopontine Colgalt2 
and corticospinal Gprin3 TRAP lines allowed us to confirm that neuronal loss appears to 
be specific to corticospinal L5b neurons in M1, rather than affecting all L5b projection 
neurons. Additionally, the expression of the TRAP construct in these cells presented us 
with the opportunity to molecularly profile a vulnerable and a closely related, but 
resistant, population for innately distinct features, as well as unique responses to 
expression of mutant SOD1. These experiments revealed that UL5b cells respond by 
up-regulating Oxphos gene expression, while LL5b cells down-regulate the expression 
of these metabolic genes (Chapter 4, Figure 4.11). We also observe that the baseline 
levels of Oxphos gene expression between these two cell types are different, with LL5b 
Gprin3 cells displaying 2.8x greater levels of expression than Colgalt2 cells. 
 Very few studies in ALS have attempted to determine the cell type-specificity of 
molecular changes in disease. This is of course extremely valuable, as slowing disease 
progression is valuable in the management of ALS in humans. However, from a basic 
research standpoint, the truly fundamental question in ALS remains: Why do 
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corticospinal motor neurons and spinal motor neurons selectively degenerate in this 
disease? And how is it that many different mutations can lead to the specific 
degeneration of these populations? Because ALS is not a monogenic disease, we must 
consider how the cells may instead be broadly incapable of coping with the stress of 
different types of mutant insult. And so the discussion of cell type specific vulnerability 
leads us think about how the unique features of these cells may be exploited by all of 
the mutations associated with ALS.  
 We have two examples of cell-type specific degeneration in discrete CNS 
structures that allow us to explore possible theories: corticospinal neuron loss in L5b of 
the motor cortex, and alpha motor neuron loss in the ventral horn of the spinal cord. The 
intrinsic features uniquely shared by these two neurons may help us understand what 
establishes them as the most vulnerable in the disease. For instance, within their 
respective regions, these cells are among the largest, as they have very large soma 
relative to other cell types in the same structure. They also have the longest axons in 
the CNS, with terminals extending to very distal regions. These two structural features 
likely require a great deal of energy to maintain, and in fact, our data suggest that 
corticospinal LL5b cells express Oxphos genes at higher levels than their more 
proximally-projecting UL5b counterparts (Chapters 2, Figure 2.14 and 4, Figure 4.11). If 
one additionally considers that motor neurons display high levels of electrophysiological 
activation during motor behaviors (Burke et al., 1973; Evarts, 1966; 1968; Thach, 1978) 
that also demand a great deal of energy to produce, we begin to paint a picture of two 
cell types that must tightly control energetic homeostasis to maintain proper functioning. 
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Disruptions to this metabolic balance via dysfunction of antioxidant mechanisms in the 
case of mutant SOD1, or by introducing additional sources of energetic demand in the 
form of irreversible stress granule formation in the case of mutant TDP-43, FUS, and 
C9orf72 (Mori et al., 2013; Tan et al., 2007; Vance et al., 2009), could have catastrophic 
effects in these neurons. Diverting metabolic resources to coping with these 
dysfunctions could eventually lead the cells to degenerate. In support of this idea, we 
observe an increase in Oxphos gene expression during disease in UL5b Colgalt2 cells 
that are resistant to degeneration in the SOD1-G93A model (Chapter 4, Figure 4.11). 
Perhaps coping with mutant SOD1 expression requires that respiration be increased to 
provide sufficient energy to fuel mechanisms that mitigate mutant SOD1 damage. In the 
case of LL5b Gprin3 cells that do degenerate, they may not be able to sufficiently 
increase Oxphos gene expression because they already express these genes at such 
high levels in their baseline state. Thus the inability to energetically cope with cellular 
dysfunction may be what ultimately leads to their loss. But these theories require us to 
more carefully understand the causal link between respiration and cell death in the 
context of ALS mutations, and to carefully confirm the changes in mitochondrial ATP-
synthesis occurring in cells during disease progression. 
 Another important consideration in the cell type-specificity of vulnerability that we 
observe is the contribution of the anatomical projection itself. The fact that 
corticomotoneurons in the human motor cortex directly innervate LMNs (Kaiserman-
Abramof and Peters, 1972; Walshe, 1942) has led many in the field to consider that the 
disease and its associated dysfunctions may be propagated from one cell type to 
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another via some mechanism of transfer. The “dying-forward” hypothesis for disease 
spread, in particular, has a basis in many studies of dysfunction and symptom origin 
during pathology. For instance, it has been shown that UMNs develop a 
hyperexcitability phenotype pre-symptomatically in disease (Eisen et al., 1993; Mills, 
2003; Mills and Nithi, 1997). It is thought that this increased activity drives the 
downstream LMNs to stress in forcing an electrophysiological response. The “dying-
back” hypothesis also has some basis in ALS symptomology, where some patients 
display the muscle weakness and fatigability associated with LMN loss before showing 
signs of tremor and fasiculation that are more associated with UMN loss (Ravits et al., 
2007). In this scenario, antidromic stimulation initiated at the UMN-LMN synapse could 
propagate a hyperexcitability phenotype originating in LMNs. For both “dying-back” and 
“dying-forward”, the transfer of misfolded and aggregated protein from one motor 
neuron to another via a prion-like mechanism has also been posited as a possible 
mechanism of disease propagation along this circuit (see Braak et al., 2013b; Münch et 
al., 2011; Polymenidou and Cleveland, 2011). But while the direct projection of human 
corticomotoneurons onto LMNs allows us to consider the possibility of direct transfer of 
disease between these cells, it is important to remember that in mice, there is no direct 
projection between vulnerable corticospinal neurons and alpha motor neurons (see 
Chapter 2, Figure 2.14), and yet degeneration of these cells is still observed. The 
intermediate spinal neuron population that exists to disynaptically transmit information 
from the cortex to the spinomuscular system has not been thoroughly characterized. 
Markers for these cells are now being established (Ueno et al., 2018), which will be 
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important tools in the study of potential disease propagation across spinal synapses in 
the ALS mouse. Until we can understand how all the cells of this corticospinomuscular 
circuit are affected during disease progression, we will not be able to determine how the 
corticospinal projection of LL5b cells contributes to establishing their vulnerability in this 
disease. 
 The divergence in corticospinal projection anatomy between rodents and primates 
has been a subject of much evolutionary debate. Functionally, corticospinal neuron 
populations across rodents and primates function in the control of voluntary movement 
and in motor learning (Deecke et al., 1969; Evarts, 1966; 1968; Fischer, 1967; Guo et 
al., 2015; Kawai et al., 2015; Lashley, 1924; Thach, 1978; Wang et al., 2017). The direct 
projections observed for primate corticomotoneurons are thought to additionally be 
important for the execution of more dexterous movements by prehensile appendages in 
primate species (Heffner and Masterton, 1983; Yoshida and Isa, 2018). Rodents display 
a relatively simple repertoire of movements, even for trained dexterous behaviors (Guo 
et al., 2015; Wang et al., 2017), all of which can be carried out without a direct 
projection onto spinal motor neurons. The innate species divergence in corticospinal 
projection anatomy between dexterous and non-dexterous mammals therefore leaves 
open the question of whether L5b cell types across these species are molecularly 
related. 
 We show here that corticospinal LL5b Gprin3 cells, despite not having a direct 
projection onto alpha motor neurons, show the vulnerability in ALS that has been shown 
for corticomotoneurons of the human motor cortex (see Chapter 3, Figure 3.5; Braak et 
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al., 2017; Genç et al., 2017; Hammer et al., 1979; Tandan and Bradley, 1985). We 
therefore ask how L5 cell types may be related to each other across these species. 
Understanding whether molecularly defined L5 cell types of human motor cortex exist in 
mouse motor cortex may allow us to translate the molecular findings from studies of 
disease rodent models to relevance in human ALS. In this work, we show that markers 
identified from molecular and anatomical studies of LL5b Gprin3 cells can be used to 
visualize populations of L5 cells in the human motor cortex (Chapter 6, Figure 6.5). 
Additionally, we were able to use a combinatorial staining approach for Crym and SMI-
32 to distinguish a potential Betz corticomotoneuronal cell type from the broader 
population of L5 cells. These markers will be useful in further understanding the 
relationship between corticospinal and corticomotoneuronal populations across species, 
and will allow for the characterization of cell type specificity of L5 neuronal loss in 
human ALS.  
 Together, the findings of this study carry forward our understanding of cell type-
specific features that define L5b corticofugal cell types in health and disease. We hope 
that these findings help to inform studies of motor cortical anatomy across species and 
ALS disease mechanisms in the motor cortex. 
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MATERIALS AND METHODS 
Animals 
All animal procedures and experiments were done with approval from The Rockefeller 
University Institutional Animal Care and Use Committee (IACUC) and in accordance 
with National Institutes of Health (NIH) policies and guidelines. 
Colgalt2-TRAP DU9 and Gprin3-TRAP ES152 mice, as well as TRAP lines for other 
cortical cell types, were generated using BAC methods and transgenics (Gong et al., 
2010; 2002) at The Rockefeller University. Sequence homology to the region upstream 
of the ATG start codon of the Colgalt2 and Gprin3 genes was cloned into the pS296 
targeting vector (Heiman et al., 2008) containing EGFP-L10a. Recombination was 
performed in competent DH10β bacteria containing a pSV1.RecA plasmid by 
electroporating the BAC into the cells. The modified BAC was isolated and 
microinjected into the pronuclei of fertilized FVB/N mouse oocytes at 0.5 ng/μl. 
Transgenic founder mice were generated and crossed to C57BL/6J mice. F1 progeny 
were screened for proper transgene expression by EGFP genotyping and 
immunohistochemistry. Expression in L5b was used a benchmark for transgenic line 
expansion. C57Bl/6J (Jackson Laboratory, #000664) were used for breeding in this 






Plasmids and vectors 
The pAAV-CMV-Flag-PGC1a-6His was a gift from Connie Cepko (Addgene plasmid 
#67637; http://n2t.net/addgene:67637; RRID:Addgene_67637). The plasmid was 
unedited before packaging into the retroAAV2 (or “SL1; Tervo et al., 2016) virus in 
collaboration with the Janelia Farm Viral core. The MitoGFP construct was acquired 
from the pLYS1-FLAG-MitoGFP-HA plasmid, as a gift from Vamsi Mootha (Addgene 
plasmid #50057; http://n2t.net/addgene:50057; RRID:Addgene_50057). The coding 
region was cloned into a Cre-dependent DIO pAAV plasmid (Nectow et al., 2017) by 
adding plasmid sequence homology to the MitoGFP insert at its 5’ and 3’ ends. The 
virus was then packaged into AAV2/9 by UPenn Viral Vector core. The TOMM20-
mCherry construct was also acquired from the mCherry-TOMM20-N-10 plasmid, as a 
gift from Michael Davidson (Addgene plasmid #55146; http://n2t.net/addgene:55146; 
RRID:Addgene_55146), and was cloned by homologous recombination into a non-Cre-
dependent version of the above pAAV plasmid for constitutive expression. The 
construct was packaged into the “SL1” virus in collaboration with the Janelia Farm Viral 
core. PCR to add sequence homology was performed using CloneAmp HIFI PCR 
reagents (Takara). All cloning reactions were carried out using the In-Fusion HD cloning 
system (Takara) for homologous recombination insertion. 
The following primer sequences were used to add sequence homology for homologous 




Cloning reaction   FWD/REV Sequence (5’ to 3’) 








Reactions for qPCR were carried out using LightCycler 480 SYBR Green I Master 
(Roche). All samples were run in triplicate. A LightCycler 480 (Roche) was used to carry 
out reactions with default SYBR Green I protocol. Primers were targeted to 3’ ends of 
spliced transcript sequences. The maximum second derivative of each amplification 
curve was taken as the cycle time (CT) value for analysis. CT values that were > ±1 CT 
from the rest of the replicate samples were excluded from analysis as long as 2 
replicates still remained. The average of the Actb and Gapdh CTs were used for 
housekeeping gene controls. ddCT calculations for mitochondrial gene qPCR in disease 
cohorts were carried out on average replicate CT values as follows: 
−"CT%&'(	*+,+ −	CT-(./+0++1&,*2345 −	"CT%&'(	*+,+ −	CT-(./+0++1&,*267 
ddCT calculations for mitochondrial gene qPCR in healthy cell type samples were 
carried out on averaged replicate CT values as follows: 
−"CT%&'(	*+,+ −	CT-(./+0++1&,*2819&,: −	"CT%&'(	*+,+ −	CT-(./+0++1&,*2;(<*=<'> 




Gene name FWD/REV Sequence (5’ to 3’) 
Aco2 FWD CCCCTCCGACTATAACAAGATTC 
REV TCTCGTTGAAGGTGTGGTTC 
Actb FWD GGCTGAGGACTTTGTACATT 
REV GGACTTCCTGTAACCACTTATT 
Atp5g3 FWD GATCTTGTTTGCCATGTAACAG 
REV GGAGTCACAGCAAGATACAC 
Bcl2 FWD GATGACTGAGTACCTGAACCG 
REV CAGAGACAGCCAGGAGAAATC 
Colgalt2 FWD CCTTGGGTGTTCGGTATTT 
REV ACTCAGTCTCCCTTCACTT 
Cox6a1 FWD GACCCTTACTCTGTGTGGA 
REV AGCAGAAGGGATGGAAGA 
Gapdh FWD GAGCATCTCCCTCACAATTT 
REV GGGTGCAGCGAACTTTAT 
Gprin3 FWD TCTGAGAGACCTAGGAGTAAAC 
REV GCTTTGCTTCACTCTTGTATTC 
Gpx1 FWD GTTTCCCGTGCAATCAGTTC 
REV AGCCTTCTCACCATTCACTTC 
Mrpl17 FWD TCGATTATGGAAAGCTGGGC 
REV TTGTGTAGTTCCCATTCTGACC 
Mrpl37 FWD GACTCAGACCAGCTCCTTTAC 
REV ACACCATGCAAGTACAGAGC 
Ndufb8 FWD CGAAGCAGTACCCTTACAATAA 
REV CCATCAAGCCTCCTCAGATA 
Sod1 FWD GGGCAAAGGTGGAAATGA 
REV ACCACACAGGGAATGTTTAC 
Sod2 FWD TGCTCTAATCAGGACCCATTG 
REV CATTCTCCCAGTTGATTACATTCC 
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Timm13 FWD TGAGGGTGGGTTAAGTGT 
REV GCTCCTTTGGTGCTTATGT 
Timm44 FWD TCAAGAACTCCAAAGGCGAG 
REV GAGGCTGAGATGTCCAGAAG 
Tomm20 FWD TGACAAATGCCATTGCTGTG 
REV ATCTTCAGCCAAGCTCTGAG 
Tomm40 FWD GTGGGTGTGGAGTTTGAGG 
REV CCCACGATCCAGTTACTGTTC 
Tomm70a FWD CTGAAGCCAGGACATACTTG 
REV TATTGGACAGCTCTGGAAATAC 




WT and SOD1-G93A mice were trained on the apparatus for three days beginning at 
~P35 (5 weeks of age) and then tested once weekly for 6 weeks. During the test, 
acceleration was increased from 5-18 rpm over the course of 180 seconds and the 
latency to fall was measured for two trials. Falls were detected automatically by a 




Animals were anesthetized via IP injection of 1% Ketamine/0.1% Xylazine (doses 1 
mL/kg and 0.1 mL/kg respectively) in 0.9% saline. Following anesthesia, animals were 
positioned on the stereotaxic apparatus and skin was incised above the skull. 
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Coordinates (from bregma) for thalamus injections were AP -1.85 mm, ML +/- 1.5 mm, 
DV -3.2 mm.  Pons injections were made at AP -4.1 mm, ML +/-0.6 mm, DV -5.2 mm. 
Holes were drilled in the skull at the target coordinates using a dental drill. Cholera toxin 
beta (Alexa 555-conjugated CTB, Thermo Fisher) was injected using a Hamilton syringe 
with a pulled glass capillary pipette at a rate of 0.1 µL/min to a total volume of 0.25 µL. 
Incisions were closed using Vetbond (3M) For spinal cord injections, an incision was 
made from the base of the neck down between the shoulder blades to target the 
cervical vertebrae. Back and shoulder muscles were separated by cutting connective 
ligaments with a scalpel. Once the spinal column was exposed, connective tissue was 
pushed aside slowly using the scalpel blade. Using forceps and surgical scissors, the 
C6 vertebrae was cut away to reveal the dura and spinal tissue. After carefully cutting a 
hole in the dura using forceps and scalpel, CTB was injected at a rate of 0.1 µL/min to a 
total of 0.15-0.20 µL at the following coordinates: AP C6, ML +/-0.4 mm, DV ~ -1.1 mm. 
Sutures were used to reposition back and shoulder muscles before suturing the incision. 
Animals were allowed to recover in clean cages over a warming plate, and were given 
low dose ibuprofen in drinking water during recovery. Animals were perfused after at 
least 48 hrs following surgery to allow tracer to fully travel the length of the axons. 
 
AAV Injections: 
Animals were anesthetized via IP injection of 1% Ketamine/0.1% Xylazine (doses 1 
mL/kg and 0.1mL/kg respectively) in 0.9% saline. Mice were then head-fixed into 
stereotaxic apparatus, and the scalp was resected before drilling small bores over target 
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injection sites. For labeling LL5b terminals in the spinal cord, AAV.DIO.EYFP was 
injected at a rate of 0.1 µL/min to a total of 0.15-0.25 µL into the motor cortex of Gng7-
Cre mice at AP +0.5 mm, ML +/-1.3 mm, DV -0.75 mm from bregma. Mice were allowed 
to recover post-operatively before being placed back into the colony room. The virus 
was allowed to express for 4-5 weeks before collecting tissues, with weekly checks of 
mouse health being performed throughout. For mitochondrial labeling and Pgc1a 
overexpression experiments, AAV9.Ef1a.DIO.mitoGFP.WPRE.hGH, 
SL1.Ef1a.TOM20.mCherry, or SL1.CMV.FLAG.Pgc1a.6XHis was injected into the pons 
of mice via angled injection to AP -4.15, ML +/-2.01, DV -5.05, 15° from vertical. After 
suturing was completed, mice were allowed to recover in clean cages over a warming 
plate, and were given low dose ibuprofen in drinking water for up to one week following 
the surgery. Viral expression was allowed to continue for 4-5 weeks before collecting 
tissues, with periodic health checks performed during this time. 
 
PRV injections: 
HA-mCherry-expressing Pseudorabies virus (PRV) 298 was generously provided by 
Lisa Pomeranz in the lab of Jeffery Friedman at The Rockefeller University. Mice were 
anesthetized as described above. The dorsal face of left upper forelimb muscles were 
exposed by a cutaneous incision extending from the lateral shoulder to just medial to 
the elbow. 1µl injections of PRV were made at a rate of 0.25 µL/min into bicep, tricep, 
trapezius, and deltoideus using a Hamilton syringe with a pulled glass capillary pipette 
for a total of ~5 µl total. Incision was sutured and mice were allowed to recover post-op 
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in BSL-2 quarantine. Mice were given low dose ibuprofen in drinking water during 
recovery. Mice were closely monitored twice daily for 5 days, at which point they were 
perfused and spinal and brain tissues were collected. 
 
RA Injections 
A 40 ml stock solution of 2.5 mg/ml all-trans retinoic acid (RA) in corn oil (100 mg in 40 
ml) was made and stored at -20°C. 0.25 mg/ml working solutions in corn oil were made 
fresh before injections, and animals were injected to a total of 1 mg/kg animal weight, 
twice the dose described in (Kwok et al., 2012). Control mice were injected with corn oil 
vehicle at a dose of 4 µl/g animal weight. IP injections of either RA or vehicle were 
performed three times per week starting from ~P85 until end stage euthanasia. Overt 




Mouse tissue collection: 
Mice received an IP injection of 1% Ketamine/0.1% Xylazine (lethal doses 2 mL/kg and 
0.2 mL/kg respectively). The animals were then perfused transcardially first with 
approximately 40 mL of sterile phosphate buffered saline (PBS) pH 7.4, followed by 
approximately 30 mL of 4% paraformaldehyde (PFA) in PBS. Brain and spinal cord 
were removed and placed in 4% PFA overnight at 4°C with shaking. Tissues were then 
transferred to 30% w/v sucrose in PBS and stored at 4°C. Brain and spinal cord tissues 
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were sectioned on freezing microtome at a thickness of 40 µm. To section spinal cord 
tissue on the microtome, tissue was first embedded in Richard Allen Scientific Neg-50 
(Thermo Fisher) over a slurry of 100% EtOH and dry ice. Sections were stored in non-
freezing storage media (25% w/v ethylene glycol, 25% glycerol, 50% PBS) at -20°C until 
further processing. Before staining or mounting, sections were washed 3 x 5 min with 
PBS. 
Human brain tissue: 
Human cortex tissue samples were received from the Miami Brain Bank, as well at the 
University of Maryland Brain Bank (operating under NIH Neurobio Bank licensing). 
Lateral motor cortex brain tissues were acquired from the University of Maryland Brain 
Bank as formalin-fixed tissue blocks. Blocks were embedded in paraffin and sectioned 
to ~15 µm by the Weill Cornell Medicine Imaging Core. Slides of medial motor cortex 
sections were sent to our lab from the Miami Brain Bank. 
Primate brain tissues: 
Primate brain sections were collected in collaboration with colleagues in the Friewald 
lab at the Rockefeller University. The left hemisphere of a rhesus macaque brain was 
immediately immersed into a solution of 3.75% acrolein/2% PFA in phosphate buffer 
(PB). Tissue was then washed in PB before shipping to Neuroscience Associates 
(Knoxville, TN), where it was embedded in a gelatin-based matrix for serial sectioning. 
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40 µm sections were collected and immersed in a preservation solution before being 
returned to our lab. 
 
Staining and Histology 
Immunostaining: 
The following antibodies were used in study: 
Antigen Species Vendor Catalog # Application Dilution 
GFP Chicken Abcam ab13970 IF, IHC 1:2000 
RFP Rabbit Abcam ab62341 IF 1:1000 
NeuN Mouse Millipore MAB377 IF 1:1000 
GFAP Rabbit Thermo F. Ab-4 IF 1:500 
ChAT Goat Millipore AB144P IF 1:100 
CTB Rabbit Abcam ab34992 IF 1:1000 
SMI-32 Mouse Millipore NE-1023 IF 1:250 
SMI-32 Rabbit Abcam ab8135 IF 1:1000 
Crym Rabbit Santa Cruz sc-366780 IF 1:100 
Crym Mouse Abcam ab54669 IF 1:500 
Pcp4 Rabbit Santa Cruz sc-74816 IF 1:100 




All fluorescent antibody staining experiments were performed on free-floating tissue as 
follows: sections were washed in PBS pH 7.4, 3 x 5 min to remove anti-freezing storage 
solution. Sections were incubated with 2.5% Normal Donkey serum (NDS, Jackson 
Immuno) and 2.5% TritonX-100 for approximately 30 mins. Sections were then 
incubated in 1% NDS and 1% TritonX-100 with primary antibodies overnight at room 
temperature with shaking. Sections were washed with PBS 3 x 5 min before incubating 
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in 1% NDS with fluorescent secondary antibodies for approximately 1 hour. Sections 
were washed with PBS 3 x 5 min before being mounted on slides and coverslipped with 
Prolong Gold with DAPI (Thermo). Sections were then visualized using a confocal 
microscope. On-slide staining was performed in largely the same way, with antibody 
incubations being carried out in a humidified chamber. 
For non-fluorescent immunohistochemistry, a 10 min incubation in 0.3% hydrogen 
peroxide in PBS and 3 x 5 min PBS washes preceded the blocking/permeabilization 
step. A biotinylated secondary antibody was used, followed by a 1 hr incubation in ABC 
solution (Vector Labs). DAB (Vector Labs) was then used to deposit the stain at the site 
of antigen. Sections were then visualized using a brightfield microscope. 
 
Primate tissue staining: 
Because primate sections that were used in this study were made from acrolein-fixed 
tissue, Schiff bases needed to be reduced prior to staining to quench auto-fluorescence 
caused by fixation. For this, we adapted the protocol from (Luquin et al., 2010). Briefly, 
prior to staining, free-floating primate sections were washed 3 x 5 min 0.1M phosphate 
buffer (PB), pH 7.4. They were then incubated in a freshly-made solution of 1% sodium 
borohydride (NaBH4) in 0.1M PB for 30 min at RT with agitation. Sections were then 
washed 3 x 5 min in 0.1M PB, followed by 3 x 5 min PBS pH 7.4. Sections were 
incubated for 30 min in a solution of 50% EtOH/0.3% H2O2 in PBS at RT with agitation. 
Sections were washed 3 x 5 min in PBS and mounted onto charged slides. Sections 
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were dried on a 60°C heat block, re-submerged briefly in PBS and dried again. On-slide 
staining was performed as described above for free-floating sections. 
 
Human tissue staining:  
All human sections were stained on slides, as tissue was collected from FFPE blocks. 
Immediately before staining, slides were deparaffinized by first submerging the sections 
in Xylenes for 6 min, and subsequently washing in descending concentrations of EtOH 
in water (100%, 100%, 95%, 70%, 50%) for 3 min each. Slides were then rinsed twice in 
water before being submerged in PBS. Antigen unmasking was performed before 
immunostaining. A solution of 0.1M sodium citrate, pH 6.0 with 0.5% TritonX-100 was 
brought to 90°C using a microwave, and sections were immersed in this solution for 10 
min. Solution was maintained at 90°C as needed during incubation with low power 
microwave heating. The solution with submerged slides was allowed to come to room 
temperature before the slides were removed and washed with PBS. Concentrations for 
serums, Triton, and antibodies, as well as incubation times, were identical to free-
floating protocol.  
 
Fluorescence In-situ hybridization (FISH): 
Cryostat sections (14 µm) for FISH experiments were made from PFA perfusion-fixed 
and 30% sucrose cryopreserved brains that we were embedded in OTC freezing media. 
On-slide labeling was performed using RNAscope ISH technology and its associated 
kits. Probes against Crym (ACD Biotech, #466131) and Nefh (ACD Biotech, #443671) 
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were used to label L5b cells in Colgalt2 and Gprin3 sections using the RNAscope 
Multiplex Fluorescent Reagent Kit v2 (ACD Biotech, #323100). All steps were carried 
out according to manufacturer recommendations in protocol #323100-USM, available 
on the manufacturer website. Immunostaining after ISH was performed on-slide as 
described above. 
 
Confocal fluorescence and brightfield microscopy 
A Zeiss Axio Observer.Z1 with LSM 700 confocal microscope equipped with 50 mW, 
400-640 nm lasers was used for all fluorescent visualizations. Zen software (Zeiss) was 
used for acquisition of images. For brightness and contrast adjustments, as well as 
image analysis, FIJI was used (ImageJ, SciJava; Rueden et al., 2017; Schindelin et al., 
2012; Schneider et al., 2012). For acquisition of brightfield images of DAB-stained 
sections, a Zeiss Axio Imager.M2 was used. Neurolucida was used to acquire tiled 
images of whole sections. 
 
Electron Microscopy (EM) 
Immunostaining: 
EM experiments were performed in collaboration with the Electron Microscopy 
Resource Center at The Rockefeller University, and the following procedure was 
adapted from the protocol written by K. Uryu. “Base buffer” below refers to either 75 mM 
Na-cacodylate buffer pH 7.4, used for immunostaining in WT Colgalt2 sample 
preparations, or 100 mM Tris buffer, pH 7.4 at 4°C used in immunostaining of WT vs 
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SOD Gprin3 samples. Animal tissues were perfuse-fixed in 4% PFA (Electron 
Microscopy Sciences) in 75 mM Na-cacodylate buffer. 50 µm sections were collected in 
cold base buffer using a vibratome (Leica). Sections were washed in 0.5% H2O2 in base 
buffer to quench endogenous peroxidase activity. After washing in base buffer 4 x 15 
min, sections were washed in a blocking solution of 3% Bovine Serum Albumin (BSA), 
and 0.1% saponin in base buffer. Anti-GFP primary antibody incubations were done in a 
solution of 3% BSA with 0.1% saponin in base buffer for 48 hrs at 4°C. Sections were 
washed 4 x 15 min in base buffer, and were then incubated with biotinylated secondary 
antibody in base buffer containing 3% BSA and 0.1% saponin for 2 hrs at 4°C. Sections 
were washed in base buffer 4 x 15 min, then incubated in ABC complex solution (1 µL 
solution A + 1 µL solution B per 1 mL of base buffer; Vector Science Labs) with 3% BSA 
and 0.1% saponin for 1 hr. Sections were washed 3 x 15 min before being incubated in 
a solution of DAB (Vector Science Labs) + Urea H2O2 in base buffer for several minutes 
until proper tissue contrast was achieved. Sections were rinsed in base buffer and fixed 
in 2.5% gluteraldehyde in 75 mM Na-Cacodylate buffer overnight at 4°C. 
 
Silver enhancement: 
Fixed sections were washed with 75 mM Na-cacodylate buffer before being rinsed with 
2% sodium acetate in H2O for 10 min. Sections were then incubated in a developer 
solution of 3% Methenamine, 5% silver nitrate, and 1% sodium tetraborate for 15 min at 
60°C. Sections were then washed once again in 2% sodium acetate, followed by an 
incubation in 3% sodium thiosulfate. Gold toning was performed by incubating sections 
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in 0.1% gold chloride for 5 min. Sections were then washed in 2% sodium acetate for 10 
min, 3% sodium tetraborate for 5 min, and 2% sodium acetate again for 10 min. After 
rinsing in 75 mM Na-cacodylate buffer, sections were fixed with 2.5% gluteraldehyde in 
75 mM Na-cacodylate overnight at 4°C. 
 
Osmication and Eponate infiltration: 
Sections were washed in 75 mM Na-cacodylate before Osmication for ultra-structure 
preservation. Sections were then incubated in a solution of 1% osmium tetra-oxide with 
1% potassium ferrocyanide in cacodylate buffer for 30 min on ice. Sections were then 
washed 3 x 5 min in Na-cacodylate buffer. They were then treated with a 2% solution of 
uranium acetate in H2O for 30 min. Sections were then progressively dehydrated in 
increasing concentrations of ethanol (50%, 70%, 95%, 100% x 2) 5 min each using a 
microwave oven. Resin was then infiltrated into the sections by first immersing in a 1:1 
solution of acetone and resin mixture (25 mL EPON812, 18 mL NMA, 7 mL DDSA, and 
0.60 mL DMP-30) in a microwave under vacuum. Sections were immersed in 100% 
resin mixture for further infiltration 2 x, then left in fresh resin in a 70°C incubator to 
polymerize overnight. Sections were immersed one last time in 100% resin under 
vacuum for 4 hrs. Resin-embedded sections were placed between two sheets of aclar 






Multi-channel signal co-localization: 
For co-localization analyses, position markers were placed in FIJI over any cells that 
appeared subjectively positive for a marker. The position markers were saved as ROIs 
in the ROI manager and placed over the next channel image of interest. The number of 
points that were positive in this second channel was counted as being double-positive. 
This analysis framework was used for CTB/GFP and PRV-mCherry/GFP co-localization 
in retrograde tracing, and for L5b marker co-localization in mouse and human tissues. 
 
Cell counts: 
For determining loss of GFP+ cells in SOD1-G93A mice, a 3 x 2 x 3 (w x h x z) z-stack 
tile scan of 20X fields was acquired on the confocal microscope. Every 6th section 
between +1.00 mm and +0.00 mm to Bregma was imaged (one section every ~240 
µm), with each hemisphere being imaged separately. The z-stacks were collapsed in 
FIJI using the maximum intensity projection. Cells were then counted only if apical 
dendrite was clearly visible. All counting was performed blind to disease condition. 
 
Cell depth analyses: 
Cell depths were determined using a custom script (github.com/mvmoya) written for 
FIJI/ImageJ that calculates the percentage depth from pia and white matter. The pial 
and white matter surfaces are manually delineated, and the points are placed on the 
image to mark the locations of the cells. The algorithm then draws a reference line that 
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is perpendicular to the pial line and intersects the cell’s point and terminates at the 
intersection with the white matter line. The cell’s percent distance from the pial line 
along the reference line is then calculated reported and as a percentage depth from pia. 
 
Terminal densities in spinal cord: 
Terminal densities for Gng7-Cre EYFP+ axon terminals were measured by thresholding 
the EYFP channel image until terminals were exclusively visible in the image. The 
ventral horn ROI was generated by outlining the area that contained ChAT+ alpha motor 
neurons in the ChAT channel, and overlaying the resulting ROI onto the EYFP channel. 
The density of thresholded terminals was returned by the built-in “Area Fraction” tool 
found in FIJI/ImageJ. The density of terminals in the intermediate lamina was measured 
by drawing a representative rectangular ROI over these regions and returning the same 
measurement as described above. 
 
Mitochondrial signal quantification: 
Images of fluorescently-labeled mitochondria following mitoGFP or TOM20-mCherry 
viral expression and immunostaining were collected at 63X-100X magnification and 
analyzed in FIJI/ImageJ. Cytoplasmic space (excluding the nucleus) was outlined for 
each neuronal cell body for which an apical dendrite could be observed. The area within 
this cytoplasmic region was thresholded so as to only include the upper 25% of values 
in the pixel depth distribution. This proportional thresholding strategy was chosen over 
setting a fixed value for upper thresholding in order to normalize across cells located at 
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different depths in the section that presumably were exposed to different levels of 
antibody penetration. The thresholded image was then run through the “Particle 
Analyzer” built into FIJI/ImageJ, to assess size, total area, number, and density of 
discrete “particles” containing mitochondrial signal. 
 
Cristae width measurements: 
Electron micrographs were analyzed in FIJI/ImageJ. After importing the image, the 
spatial resolution of the image was set in FIJI according to the magnification settings 
and resolution used for acquiring the image. The width was measured in the narrowest 
dimension for all cristae where both apposing membranes could be readily seen. All 
mitochondria found in each micrograph were scanned for detectable cristae, regardless 
of size, shape or subcellular location.  
  
TRAP and RNA-Seq analyses  
TRAP: 
TRAP experiments from cortical cell types were performed as previously described 
(Heiman et al., 2008). For cell type characterizations, ~P40 animals were sacrificed, and 
whole cortex dissected in ice-chilled HBSS containing 2.5 mM HEPES-KOH (pH 7.4), 
35 mM glucose, 4 mM NaHCO3, and 100 μg/ml cycloheximide. Cortices from 3 animals 
were pooled per biological replicate, with 3 replicates per cell type being prepared in 
total (9 animals). Samples were homogenized in extraction buffer containing 10 mM 
HEPES-KOH (pH 7.4), 150 mM KCl, 5 mM MgCl2, 0.5 mM DTT, 100 μg/ml 
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cycloheximide, RNasin (Promega) and SUPERas-In (Life Technologies) RNase 
inhibitors, and Complete-EDTA-free protease inhibitors (Roche), and then centrifuged at 
2000 x g to clear lysate debris. IGEPAL CA- 630 (NP-40, Sigma) and DHPC (Avanti 
Polar Lipids, Alabaster, AL) were added to the resulting supernatant to a concentration 
of 1% each, followed by 20,000 x g centrifugation. Polysomes were immunoprecipitated 
(IP’ed) using 100 µg custom monoclonal anti-GFP antibodies (50 µg of clone 19C8 with 
50 µg of clone 19F7) bound to biotinylated Protein L (Pierce, Thermo Fisher) coated 
streptavidin-coated magnetic beads (Thermo Fisher), and washed with high salt buffer 
containing 10 mM HEPES-KOH (pH 7.4), 350 mM KCl, 5 mM MgCl2, 1% IGEPAL CA-
630, 0.5 mM DTT, 100 μg/ml cycloheximide, and RNasin RNase inhibitors (Promega). 
Overnight IP’s were eluted and purified using Absolutely RNA Nanoprep kit (Agilent). 
RNA quality was assessed using Nanodrop spectrophotometer and Agilent 2100 
Bioanalyzer. Samples with RNA integrity values  > 7 were used to prepare libraries for 
sequencing.  
RNAs from TRAP IPs (15 ng per sample) were converted to cDNA using the Nugen 
Ovation RNA-Seq System V2 kit. cDNAs were then fractionated by sonication and 
libraries were made using the Illumina TrueSeq RNA Sample Preparation kit v2, 
following manufacturer’s instructions. Sequencing was run on a machine at The 
Rockefeller University Genomics core using the Illumina HiSeq 2500 platform (Illumina). 
For disease TRAP cohorts, whole cortices from ~P70 (pre-symptomatic) and ~P110 
(symptomatic) timepoints were collected from healthy and SOD1-G93A-crossed 
Colgalt2 and Gprin3 animals and homogenized, and polysomes were IP’ed also as 
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described above. At this point, Gprin3 RNA was sent to Dr. Hemali Phatnani at the New 
York Genome Center (NYGC) for cDNA conversion, library sample preparation, and 
sequencing. Colgalt2 cDNA libraries were instead prepared in our lab as described 




Returned sequences in FASTQ files were first aligned to mm10 annotated mouse 
genome using STAR aligner (Dobin et al., 2013) version 2.0.0e_r291. Whole gene 
counts from exon-mapping aligned reads were quantified using HTSeq (Anders et al., 
2015) version 0.6.0, and the htseq-count module. Differential expression analysis on 
whole gene counts was performed in DESeq2 version 1.22.2 in RStudio version 1.1.463 
(Love et al., 2014), RStudio Team (2015). RStudio: Integrated Development for R. 
RStudio, Inc., Boston, MA, URL http://www.rstudio.com/) using all default parameters. 
Additional analysis packages can be found in the analysis source code, available on 
github.com/mvmoya. For determining significantly enriched genes in Colgalt2, Gprin3, 
and whole cortex cell type characterizations, adjusted p-values were used to determine 
statistically significant relevant genes (p < 0.05). Because very few genes showed 
adjusted p-values below 0.05 when comparing the same cell type across healthy and 
disease conditions, un-adjusted p-values were used in disease analyses so as to 
increase the number of genes available for gene ontology enrichment. Gene ontology 
enrichment analyses were performed using Metascape (metascape,org; Zhou et al., 
	 160 
2019) with default parameters. Transcription factor motif enrichment analysis were 
performed using HOMER (Heinz et al., 2010), searching -1500 upstream of the 
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